text
stringlengths
2
190k
url
stringlengths
22
593
crawl_date
timestamp[us, tz=UTC]date
2022-04-01 00:00:56
2022-09-19 05:15:05
id
stringlengths
22
593
label
bool
2 classes
minhash_count
stringclasses
349 values
Foreclosure Starts Decrease 4 Percent from Last Month; While Completed Foreclosures Also Decrease 5 Percent from Last Month IRVINE, Calif., Aug. 9, 2022 /PRNewswire/ -- ATTOM, a leading curator of real estate data nationwide for land and property data, today released its July 2022 U.S. Foreclosure Market Report, which shows there were a total of 30,358 U.S. properties with foreclosure filings — default notices, scheduled auctions or bank repossessions — down 4 percent from a month ago but up 143 percent from a year ago. "While it's encouraging to see both foreclosure starts and completions drop off a bit in July, it's also worth noting that there may be some seasonality impacting the numbers," said Rick Sharga, executive vice president of market intelligence at ATTOM. "In eight of the last 10 years Q3 foreclosure activity has been lower than the previous quarter, so we might just be seeing a return to a more normal seasonal pattern of delinquencies and defaults." Nationwide one in every 4,628 housing units had a foreclosure filing in July 2022. States with the highest foreclosure rates were Delaware (one in every 2,127 housing units with a foreclosure filing); Illinois (one in every 2,334 housing units); New Jersey (one in every 2,564 housing units); Nevada (one in every 2,609 housing units); and South Carolina (one in every 2,976 housing units). Among the 223 metropolitan statistical areas with a population of at least 200,000, those with the highest foreclosure rates in July 2022 were Elkhart, IN (one in every 1,592 housing units with a foreclosure filing); Davenport, IA (one in every 1,626 housing units); Fayetteville, NC (one in every 1,673 housing units); Cleveland, OH (one in every 1,757 housing units); and Atlantic City, NJ (one in every 1,886 housing units). Those metropolitan areas with a population greater than 1 million, with the worst foreclosure rates in July 2022 including Cleveland, OH were: Chicago, IL (one in every 2,082 housing units); Las Vegas, NV (one in every 2,190 housing units); Riverside, CA (one in every 2,431 housing units); and Philadelphia, PA (one in every 2,519 housing units). Lenders started the foreclosure process on 21,428 U.S. properties in July 2022, down 4 percent from last month but up 226 percent from a year ago. States that had at least 100 foreclosure starts in July 2022 and saw a monthly increase in foreclosure starts included: Michigan (up 42 percent); Massachusetts (up 39 percent); Iowa (up 26 percent); Wisconsin (up 25 percent); and Indiana (up 22 percent). "It appears that a few states are still catching up on processing foreclosures on loans that were seriously delinquent prior to the pandemic, which accounts for the year-over-year spike in foreclosure starts," Sharga added. "But early-stage delinquencies continue to be lower than normal, so once these older loans have re-entered the foreclosure process, it will be interesting to see if foreclosure starts fall off significantly." Those major metropolitan areas with a population greater than 200,000 that had the greatest number of foreclosures starts in July 2022 included: New York, NY (1,380 foreclosure starts); Chicago, IL (1,247 foreclosure starts); Los Angeles, CA (678 foreclosure starts); Miami, FL (666 foreclosure starts); and Philadelphia, PA (652 foreclosure starts). Lenders repossessed 3,068 U.S. properties through completed foreclosures (REOs) in July 2022, down 5 percent from last month but up 27 percent from last year. Counter to the national trend, those states that saw a monthly increase in REOs in July 2022, included: Maryland (up 147 percent); Hawaii (up 58 percent); North Dakota (up 38 percent); Massachusetts (up 38 percent); and Michigan (up 27 percent). States that saw the greatest number of REOs in July 2022, included: Illinois (359 REOs); Pennsylvania (185 REOs); Ohio (184 REOs); Michigan (182 REOs); and New York (167 REOs). Those major metropolitan statistical areas (MSAs) with a population greater than 1 million that saw the greatest number of REOs in July 2022 included: Chicago, IL (270 REOs); New York, NY (90 REOs); Philadelphia, PA (89 REOs); Detroit, MI (82 REOs); and Birmingham, AL (66 REOs). The ATTOM U.S. Foreclosure Market Report provides a count of the total number of properties with at least one foreclosure filing entered into the ATTOM Data Warehouse during the month and quarter. Some foreclosure filings entered into the database during the quarter may have been recorded in the previous quarter. Data is collected from more than 3,000 counties nationwide, and those counties account for more than 99 percent of the U.S. population. ATTOM's report incorporates documents filed in all three phases of foreclosure: Default — Notice of Default (NOD) and Lis Pendens (LIS); Auction — Notice of Trustee Sale and Notice of Foreclosure Sale (NTS and NFS); and Real Estate Owned, or REO properties (that have been foreclosed on and repurchased by a bank). For the annual, midyear and quarterly reports, if more than one type of foreclosure document is received for a property during the timeframe, only the most recent filing is counted in the report. The annual, midyear, quarterly and monthly reports all check if the same type of document was filed against a property previously. If so, and if that previous filing occurred within the estimated foreclosure timeframe for the state where the property is located, the report does not count the property in the current year, quarter or month. ATTOM provides premium property data to power products that improve transparency, innovation, efficiency and disruption in a data-driven economy. ATTOM multi-sources property tax, deed, mortgage, foreclosure, environmental risk, natural hazard, and neighborhood data for more than 155 million U.S. residential and commercial properties covering 99 percent of the nation's population. A rigorous data management process involving more than 20 steps validates, standardizes, and enhances the real estate data collected by ATTOM, assigning each property record with a persistent, unique ID — the ATTOM ID. The 20TB ATTOM Data Warehouse fuels innovation in many industries including mortgage, real estate, insurance, marketing, government and more through flexible data delivery solutions that include bulk file licenses, property data APIs, real estate market trends, property reports and more. Also, introducing our newest innovative solution, that offers immediate access and streamlines data management – ATTOM Cloud. Media Contact: Christine Stricker 949.748.8428 [email protected] Data and Report Licensing: 949.502.8313 [email protected] SOURCE ATTOM
https://www.prnewswire.com:443/news-releases/us-foreclosure-activity-drops-4-percent-in-july-2022-301602220.html
2022-08-09T11:17:59Z
https://www.prnewswire.com:443/news-releases/us-foreclosure-activity-drops-4-percent-in-july-2022-301602220.html
true
10
TOKYO (AP) — Issey Miyake, who built one of Japan’s biggest fashion brands and was known for his boldly sculpted pleated pieces as well as former Apple CEO Steve Jobs’ black turtlenecks, has died. He was 84. Miyake died Aug. 5 of liver cancer, Miyake Design Office said Tuesday. Miyake defined an era in Japan’s modern history, reaching stardom in the 1970s among a generation of designers and artists who reached global fame by defining a Japanese vision that was unique from the West. Miyake’s origami-like pleats transformed usually crass polyester into chic. He also used computer technology in weaving to create apparel. His down-to-earth clothing was meant to celebrate the human body regardless of race, build, size or age. Miyake even detested being called a fashion designer, choosing not to identify with what he saw as a frivolous, trend-watching, conspicuous consumption. Again and again, Miyake returned to his basic concept of starting with a single piece of cloth — be it draped, folded, cut or wrapped. Over the years, he took inspiration from a variety of cultures and societal motifs, as well as everyday items — plastic, rattan, “washi” paper, jute, horsehair, foil, yarn, batik, indigo dyes and wiring. He sometimes evoked images of Jimi Hendrix and Janis Joplin, or collaborated with Japanese painter Tadanori Yokoo in images of monkeys and foliage in vibrant, psychedelic hues. He also collaborated with furniture and interior designer Shiro Kuramata, photographer Irving Penn, choreographer and director Maurice Bejart, pottery maker Lucie Rie and Ballet Frankfurt. In 1992, Miyake was commissioned to design the official Olympic uniform for Lithuania, which had just gained independence from the Soviet Union. Born in Hiroshima in 1938, Miyake was a star as soon as he hit the European runways. His brown top, which combined the Japanese sewn fabric “sashiko” with raw silk knit, was splashed on the cover of the September 1973 issue of Elle magazine. Miyake was also a pioneer in gender roles, asking feminist Fusae Ichikawa in the 1970s — when she was in her 80s — to be his model, sending the message that garments must be comfortable and express the natural beauty of real people. Although he made clothes that went beyond the mundane, appearing to reach for the spiritual, he made a point to never get pretentious, always approving of the T-shirt-and-jeans look. “Designing is like a living organism in that it pursues what matters for its well-being and continuity,” Miyake once wrote in his book. His office confirmed a private funeral had already been held and other ceremonies will not be held in accordance with Miyake’s wishes. Miyake kept his family life private, and survivors are not known. ___ Yuri Kageyama is on Twitter at https://twitter.com/yurikageyama
https://www.wwlp.com/news/entertainment/ap-entertainment/reports-famed-japanese-designer-issey-miyake-dies-at-84/
2022-08-09T11:18:07Z
https://www.wwlp.com/news/entertainment/ap-entertainment/reports-famed-japanese-designer-issey-miyake-dies-at-84/
false
50
South Africa have made getting opening bowler Kagiso Rabada fit for the three-Test series against England their top priority, captain Dean Elgar said. Radaba hurt ligaments in his left ankle in last month’s Twenty20 series against England but has been bowling in the nets since the Test squad began a pre-series camp in Canterbury, Elgar told a virtual news conference. “The workload is maybe the biggest concern, whether he can get himself throughout a Test match with the intensity and obviously the volume of overs in a day’s play,” Elgar said. Strike bowler “For now he’s doing all the right things but I can’t say ‘yes or no’ as yet,” Elgar added about Rabada’s chances of making the first Test at Lords on Aug. 17. “But it’s high on our list to get him fit and giving us more resources going into the first Test.” The 27-year-old Rabada is the team’s lead strike bowler with 243 Test wickets at an average of 22.41. South Africa must already do without middle order batsman Temba Bavuma, who has an elbow injury, but Elgar said he was pleased with the strength of his available squad and their form. Massive asset “I think the options are brilliant for us and I think we’re ticking the boxes in the right way. Some of ours guys have been doing well in county cricket and that’s a massive asset for us going into this Test series, just from knowing more about the conditions,” he said. “Another thing we got is white-ball cricketers that have had a pretty successful series over here so far, they’ve got a lot of confidence coming into the Tests and it’s almost like a breath of fresh air having those guys come in, just knowing that they’ve done pretty well in the last month.” South Africa beat England 2-1 in the Twenty20 series and drew the One Day International campaign with the decisive match washed out.
https://gulfnews.com/sport/cricket/icc/rabada-fitness-is-top-priority-for-south-africas-test-team-1.89809583
2022-08-09T11:19:08Z
https://gulfnews.com/sport/cricket/icc/rabada-fitness-is-top-priority-for-south-africas-test-team-1.89809583
false
1
Oil City TOPS Twelve TOPS and six KOPS attended last week’s meeting of Oil City TOPS Chapter 0977. Please log in, or sign up for a new account and purchase a subscription to continue reading. Please log in, or sign up for a new account to continue reading. Thank you for reading! We hope that you continue to enjoy our free content. Twelve TOPS and six KOPS attended last week’s meeting of Oil City TOPS Chapter 0977. SCHOLARSHIPS — Mia Gourley, a 2022 graduate of Redbank Valley High School, and Darcie Maul, a 2022 graduate of West Forest High School, were each awarded a $1,000 scholarship from the Clarion Hospital Foundation to pursue their education through the nursing program at Penn West Clarion (form… Manuel and Mary Nazario of Cranberry will celebrate their 25th wedding anniversary today. Bill and Denise Miller of Franklin will celebrate their 50th wedding anniversary Friday. The 2022 finalists of the Oil Region Alliance Outdoor Recreation Business Plan Contest have been selected by a panel of judges. The City of Oil City is reminding residents to properly dispose of wipes so as to avoid clogging sewage lines. RECOGNIZED — Edward Jones Financial advisor Jon Williams, of Clarion, was named to the Forbes Next-Gen Best-in-State Wealth Advisors for 2022 by Forbes and SHOOK Research, ranking No. 34 in Pennsylvania. The list is composed of 1,000 financial advisors nationwide, all under age 40 with at le… Pennsylvania Department of Labor & Industry (L&I) Secretary Jennifer Berrier announced that changes to regulations in Pennsylvania’s Minimum Wage Act took effect Friday. Several members of the Venango County, Pennsylvania Senior Environmental Corps (VenangoPaSEC) conducted a stream study along Shull Run in southern Venango County near Rockland. The Pennsylvania Department of Transportation has scheduled line painting for next week in Forest County, between 7 p.m. and 7 a.m., weather permitting, which is expected to take place on various roadways. The Franklin Area School District (FASD) is updating its cyberschool for the 2022-23 school year. This year, the program will offer live classes. The Allegheny Boys Quartet will hold a final concert at 6 p.m. Saturday, Aug. 13, at the Sandy Lake Wesleyan Church, 3096 Sandy Lake-Grove City Road. The Oil City Main Street Program’s “Music on the Square” outdoor concert series continues at 7 p.m. Thursday in the city’s Town Square, featuring the Route 8 Band. Wesley Grange will host an open house at 7 p.m. Wednesday, Aug. 17, at the grange hall, located at 601 Old Route 8, Harrisville. The Redbank Valley Historical Society will host a presentation of one-room and two-room schoolhouses of the past at their monthly meeting at 6:30 p.m. Monday at the History Center at the corner of Broad and Lafayette Streets in New Bethlehem. The Valley Grove School District will hold registration for students who need to enroll for the 2022-23 school year Monday, Aug. 15, to Thursday, Aug. 18, and Monday, Aug. 22, and Tuesday, Aug. 23. The Venango Area Chamber of Commerce will host a mixer for chamber members from 5 to 7 p.m. Wednesday in Foxburg. A virtual public workshop will be held at 6:30 p.m. Thursday, Aug. 18, via Zoom, to gather public input for the Northwest Pennsylvania Greenways Plan Update. This year, The United Way of Venango County boosted the National Night out events locally by awarding mini grants to six community locations throughout Venango County. The Pennsylvania Capitol Police Department announced the launch of a new internship program that provides training and certification, as well as most associated costs. The Oil City Redevelopment Authority welcomed a new member and appointed a new vice chairwoman during its meeting on Wednesday. APPOINTED — Dr. Stephanie Fiely, who has served in many administrative roles at the University of Pittsburgh at Titusville for more than 20 years, has been appointed executive director of Pitt-Titusville’s Education and Training Hub. Fiely served as the hub’s assistant executive director sin… CLARION —Representatives from the Clarion community and Penn Highlands Healthcare participated in a ribbon-cutting at the Clarion Community Medical Building on Wednesday. The new center is located on Holiday Inn Road, Route 68. Community Action, Inc. is asking residents of Clarion and Jefferson counties to complete a short Community Needs Assessment Survey regarding critical issues confronting these communities. According to the Pennsylvania Department of Health, the entire region for the second consecutive week reported increases in the average number of daily COVID-19 cases during the latest seven-day reporting period. The Penn State Extension Master Gardeners are accepting applications for Venango and Clarion counties’ next virtual basic training to become a Master Gardener. HARRISBURG — The Pennsylvania Turnpike Commission (PTC) has approved a 5% toll increase for 2023 for all E-ZPass and Toll By Plate customers. The new rates will take effect across the toll-highway system on Jan. 8. JOINS TEAM — Board Certified Orthopedic Surgeon Charley Gates MD, will join the team at Titusville Area Hospital. Dr. Gates received his medical degree and completed his residency at the University of Pittsburgh School of Medicine. Dr. Gates worked in New York before returning to his home st… Franklin Yard Sale Fri. Aug. 12th & Sat. Aug. 13th 9-… Free garage sale. Something for everyone! Come and Get It… Wanted to Buy - A small trailer to move a motorcycle with… Peaches, cherries, canning tomatoes, sweet corn. Baughman… -Petersheim’s- Red Haven peaches, sweet corn, cucumbers, … Thank you to the good Samaritan who turned my keys in to … The family of Leah Gesing wishes to thank family and frie…
https://www.thederrick.com/news/community_news/club-notes/article_ee86fe02-1724-11ed-96ee-b7fcc0675e41.html
2022-08-09T11:19:33Z
https://www.thederrick.com/news/community_news/club-notes/article_ee86fe02-1724-11ed-96ee-b7fcc0675e41.html
false
6
eScrip has 53,000 schools and nonprofits as beneficiaries in its fundraising program, with 800,000 eligible organizations in its database TORONTO, Aug. 9, 2022 /PRNewswire/ - eScrip, the longest running, most successful shop-to-fundraise "electronic scrip" program in the United States, announced today that it has officially reached the $450 million milestone of contributions to schools and nonprofits across the country. Launched in 1999, eScrip provides retailers and customers the opportunity to give back to schools and nonprofits in their local community. Retailers allocate their existing community giving to the charities that their shoppers designate when they enroll. Much like rewards programs that allow customers to earn points, eScrip enables its customers to automatically earn money for the organizations of their choice by shopping at participating locations. eScrip has 53,000 schools and nonprofits in all 50 states enrolled as beneficiaries in its fundraising program. eScrip can run independently on a retailer's POS or can be plugged into existing loyalty rewards and digital coupon platforms. "The COVID-19 pandemic has had a significant impact on schools and nonprofit fundraising activities, making the need to support our local community more important than ever," said Andy Ruff, Vice President of eScrip. "Customers are increasingly showing their willingness to shop with the brands that support those causes that are important to them. Using eScrip is a no-brainer for brands to manage their giving programs without having to do any of the heavy lifting." Retailers can view contribution activity, access customer-specific analytics reports and more. eScrip verifies the charitable organizations and automates donation payments, making it easy for customers to select schools, parent/teacher associations, animal welfare organizations, school districts and more as donation recipients. "We are proud of the eScrip network that we have built and the product that we have refined over the last 20-plus years, and look forward to expanding our reach this coming school year," said Ruff. "We partner with generous merchants in our communities that give back to the causes that matter to their loyal customers. Whether a retailer has one or thousands of locations, eScrip is free to customers and easy to integrate into existing technology, making it a turnkey experience for retailers – and customers – to enroll in the program." eScrip and its parent company Loyalty Lane were acquired by Givex, a global leader in omnichannel processing of gift cards, loyalty, and digital merchandise credit, in February 2022. Givex has a global footprint of more than 115,000 merchant locations using at least one Givex service. Loyalty Lane has invested in refreshing the UI of eScrip, making it easier for shoppers, retailers and charities to engage in charitable giving. "With Loyalty Lane and eScrip, Givex is well-positioned to continue embarking on our ambitious global growth strategy," said Don Gray, CEO of Givex. "Technology has continued to play a key role in the lives of customers across the globe, and most recently during the COVID-19 pandemic. eScrip utilizes technology to make fundraising for the local community as easy and seamless as possible for both customers and retailers." Since 1999, eScrip has helped over 82,000 schools and nonprofit organizations earn more than $450 million for much needed programs and activities. Founded by Electronic Scrip, Inc., the vision was to establish relationships between commerce and community, and to support education and projects that benefit children. Givex (TSX: GIVX) (OTCQX: GIVXF) is a global fintech company providing merchants with customer engagement, point of sale and payment solutions, all in a single platform. We are integrated with 1000+ technology partners, creating a fully end-to-end solution that delivers powerful customer insights. Our platform is used by some of the world's largest brands, comprising approximately 100,000+ active locations across more than 100 countries. Learn more at www.givex.com. View original content: SOURCE Givex
https://www.wctv.tv/prnewswire/2022/08/09/givex-subsidiary-electronic-scrip-escrip-reaches-450-million-donations-local-schools-nonprofits/
2022-08-09T11:21:41Z
https://www.wctv.tv/prnewswire/2022/08/09/givex-subsidiary-electronic-scrip-escrip-reaches-450-million-donations-local-schools-nonprofits/
false
12
Did you lose money on investments in Waste Management? If so, please visit Waste Management, Inc. Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased certain redeemable senior notes (the “Notes”) of Waste Management, Inc. (“WM” or the “Company”) (: WM) between February 13, 2020 and June 23, 2020, inclusive (the “Class Period”). The Notes include the following senior redeemable notes issued by WM in May 2019: (i) 2.95% Senior Notes due 2024; (ii) 3.20% Senior Notes due 2026; (iii) 3.45% Senior Notes due 2029; and (iv) 4.00% Senior Notes due 2039. The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934. On April 14, 2019, WM entered into an agreement and plan of merger (the “Merger”) to acquire Advanced Disposal Systems, Inc. (“ADS”) for $4.9 billion, or $33.15 per share. The Merger was conditioned upon an ADS shareholder vote and obtaining antitrust clearance from regulators, including the U.S. Department of Justice (“DOJ”). On October 25, 2019, WM, ADS, and the DOJ entered into a timing agreement that provided for a minimum 70-day settlement period during which the parties would attempt to reach an agreement on DOJ approval for the Merger, which included DOJ approval of the amount of WM’s asset divestures. Unbeknownst to investors, during this process the DOJ informed WM that its agreement to divest $200 million in revenue-producing assets to address antitrust concerns would be insufficient for regulatory approval. The DOJ concluded that the combination of WM and ADS would, without divestures significantly in excess of $200 million, cause harm to municipal solid waste disposal in 24 geographic markets across 8 states, and cause harm to small container commercial waste collection in 33 geographic markets located in 6 states. Plaintiff alleges that Defendants made materially false and misleading statements throughout the Class Period, including omitting material facts relating to: (i) the DOJ’s indication to WM that it would require WM to divest significantly more than $200 million; and (ii) the impact of the DOJ’s indication on the completion of the Merger and the redemption of the Notes. On June 24, 2020, WM disclosed that the Company and ADS had revised the terms of the Merger and that WM needed to divest substantially more assets than previously disclosed to receive DOJ approval for the deal. Under the revised Merger terms, WM agreed to purchase ADS for $4.6 billion, or $30.30 per share, thereby reducing WM’s acquisition cost by approximately $300 million to $4.6 billion. In addition, WM and ADS had agreed to sell $835 million worth of assets in an attempt to satisfy antitrust regulators, which assets were responsible for generating approximately $345 million in 2019 revenue. WM also revealed that the deal was now not expected to close until “the end of the third quarter of 2020” – six months later than had been represented by defendants at the start of the Class Period and, critically, after the end date which triggered the redemption feature of the Notes. On this news, the prices of the Notes fell significantly. For example, the 3.45% Notes fell from 109% on June 23, 2020 to just 103% of par on June 24, 2020. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. If you purchased the Notes, and/or would like to discuss your legal rights and options please visit Waste Management, Inc. Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected]. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years. ATTORNEY ADVERTISING. © 2022 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information: Peter Allocco Bernstein Liebhard LLP https://www.bernlieb.com (212) 951-2030 [email protected]
https://www.gurufocus.com/news/1844835/waste-management-inc-nyse-wm-class-action-alert-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-waste-management-inc-nyse-wm
2022-08-09T11:22:03Z
https://www.gurufocus.com/news/1844835/waste-management-inc-nyse-wm-class-action-alert-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-waste-management-inc-nyse-wm
false
71
Biden to sign $280B CHIPS act in bid to boost US over China WASHINGTON (AP) — President Joe Biden is preparing to sign a $280 billion bipartisan bill to boost domestic high-tech manufacturing. The measure is part of his administration’s push to boost U.S. competitiveness over China. The Rose Garden ceremony Tuesday morning comes as Biden looks to highlight a new law that will incentivize investments in the American semiconductor industry. The aim is to ease U.S. reliance on overseas supply chains for critical, cutting-edge goods. The White House says Micron is announcing a $40 billion plan to boost domestic manufacturing of memory chips. Qualcomm and GlobalFoundries are announcing a $4.2 billion expansion of an upstate New York chip plant.
https://ktvz.com/news/ap-national-business/2022/08/09/biden-to-sign-280b-chips-act-in-bid-to-boost-us-over-china-2/
2022-08-09T11:23:21Z
https://ktvz.com/news/ap-national-business/2022/08/09/biden-to-sign-280b-chips-act-in-bid-to-boost-us-over-china-2/
true
null
Sage Group PLC with ticker (LON:SGE) now has a potential downside of -2.7% according to Barclays. Barclays set a target price of 720 GBX for the company, which when compared to the Sage Group PLC share price of 740 GBX at opening today (09/08/2022) indicates a potential downside of -2.7%. Trading has ranged between 587 (52 week low) and 862 (52 week high) with an average of 2,365,997 shares exchanging hands daily. The market capitalisation at the time of writing is £7,459,985,373. The Sage Group plc is a United Kingdom-based company, which provides accounting and business management software. The Company’s segments include Northern Europe, Central and Southern Europe and North America. The Company offers software and services for small or medium business, people and payroll, business management, payments and banking, and accountants and partners. Its accounting, finance and payroll solutions include Accounting, Sage 50cloud Accounting, Sage Timeslips, Sage HR, Sage X3 and Sage Intacct. Its construction and real estate solutions include Sage Intacct Construction, Sage 100 Contractor and Sage 300 CRE. Its business management solutions include Sage X3, Sage 100cloud, Sage 300cloud and Sage Fixed Assets. Its human resources and customer relationship management (CRM) solutions include Sage HRMS, Sage People and Sage CRM. It also offers end-to-end retail financial management, inventory planning, sales and order management, purchasing and supplier management solutions.
https://www.directorstalkinterviews.com/sage-group-plc--2.7-potential-downside-indicated-by-barclays/4121076842
2022-08-09T11:23:30Z
https://www.directorstalkinterviews.com/sage-group-plc--2.7-potential-downside-indicated-by-barclays/4121076842
false
1
Famed Japanese fashion designer Issey Miyake dies at 84 By YURI KAGEYAMA Associated Press TOKYO (AP) — Issey Miyake, who built one of Japan’s biggest fashion brands and was known for his boldly sculpted pleated pieces as well as former Apple CEO Steve Jobs’ black turtlenecks, has died. He was 84. Miyake died Aug. 5 of liver cancer, Miyake Design Office said Tuesday. Miyake defined an era in Japan’s modern history, reaching stardom in the 1970s among a generation of designers and artists who reached global fame by defining a Japanese vision that was unique from the West. Miyake’s origami-like pleats transformed usually crass polyester into chic. He also used computer technology in weaving to create apparel. His down-to-earth clothing was meant to celebrate the human body regardless of race, build, size or age. Miyake even detested being called a fashion designer, choosing not to identify with what he saw as a frivolous, trend-watching, conspicuous consumption. Again and again, Miyake returned to his basic concept of starting with a single piece of cloth — be it draped, folded, cut or wrapped. Over the years, he took inspiration from a variety of cultures and societal motifs, as well as everyday items — plastic, rattan, “washi” paper, jute, horsehair, foil, yarn, batik, indigo dyes and wiring. He sometimes evoked images of Jimi Hendrix and Janis Joplin, or collaborated with Japanese painter Tadanori Yokoo in images of monkeys and foliage in vibrant, psychedelic hues. He also collaborated with furniture and interior designer Shiro Kuramata, photographer Irving Penn, choreographer and director Maurice Bejart, pottery maker Lucie Rie and Ballet Frankfurt. In 1992, Miyake was commissioned to design the official Olympic uniform for Lithuania, which had just gained independence from the Soviet Union. Born in Hiroshima in 1938, Miyake was a star as soon as he hit the European runways. His brown top, which combined the Japanese sewn fabric “sashiko” with raw silk knit, was splashed on the cover of the September 1973 issue of Elle magazine. Miyake was also a pioneer in gender roles, asking feminist Fusae Ichikawa in the 1970s — when she was in her 80s — to be his model, sending the message that garments must be comfortable and express the natural beauty of real people. Although he made clothes that went beyond the mundane, appearing to reach for the spiritual, he made a point to never get pretentious, always approving of the T-shirt-and-jeans look. “Designing is like a living organism in that it pursues what matters for its well-being and continuity,” Miyake once wrote in his book. His office confirmed a private funeral had already been held and other ceremonies will not be held in accordance with Miyake’s wishes. Miyake kept his family life private, and survivors are not known. ___ Yuri Kageyama is on Twitter at https://twitter.com/yurikageyama
https://ktvz.com/news/ap-national-news/2022/08/09/famed-japanese-fashion-designer-issey-miyake-dies-at-84/
2022-08-09T11:23:58Z
https://ktvz.com/news/ap-national-news/2022/08/09/famed-japanese-fashion-designer-issey-miyake-dies-at-84/
false
50
HEIDELBERG, Germany, and CAMBRIDGE, MA, Aug. 9, 2022 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for CyclASol® (cyclosporine ophthalmic solution), a proposed novel treatment for the signs and symptoms of dry eye disease (DED). CyclASol® has demonstrated in two pivotal studies fast onset of therapeutic effect in the indication, clinical meaningful improvement of ocular surface damage, and excellent tolerability. Results from a 12-month long-term study confirmed that the effects are maintained, and even improved for most sign and symptom endpoints. "This is the first submission of a novel product category of water-free topical drug therapies utilizing EyeSol® as a drug carrier", said Christian Roesky, Ph.D., CEO, Novaliq. "CyclASol® is a first-of-a-kind drug therapy and aims to expand treatment success for patients with dry eye disease and their eye care professionals. If approved by the FDA, CyclASol® addresses important unmet medical needs in DED through its ocular surface healing effect combined with high comfort of administration." Dry eye is one of the most common ocular surface disorders, with approximately 18 million Americans diagnosed with DED.1,2 Inflammation and immunologic processes play a key role in the pathology of the disease. A compromised ocular surface secondary to DED may also compromise refractive measurements before keratorefractive and phacorefractive surgeries and adversely impact expected visual outcomes after these surgeries.3,4 The impact of the corneal surface damage secondary to DED on visual function is an underestimated aspect of the disease. Multiple guidelines recommend treatment of the corneal surface damage prior to ocular procedures. A high unmet need remains for better tolerated drugs with an early onset of therapeutic effect, which are compelling to be used and prescribed.5,6 "We are very proud to see another product rapidly moving to the market, which marks yet another important inflection point and milestone in Novaliq's growth trajectory", said Dr. Mathias Hothum, board member and managing director of dievini. "We are currently evaluating the commercialization strategies which includes talking to interested parties." About CyclASol® CyclASol® is a first-of-a-kind topical treatment of cyclosporine, a potent anti-inflammatory and selective immunomodulatory drug. Whilst not water-soluble, cyclosporine is soluble in the EyeSol® excipient perfluorobutylpentane allowing for its improved bioavailability and better efficacy on the target tissue. The product contains no oils, no surfactants and is preservative-free due to the novel carrier. This provides additional clinical benefits for patients, such as improved tolerability and decreased visual disturbances. The NDA is supported by safety and efficacy results in over 1,000 patients with DED from a Phase 2 dose finding study, the Phase 2b/3 ESSENCE-1 study, the Phase 3 ESSENCE-2 study and its open label extension study.7,8 CyclASol® has demonstrated in two independent adequate and well-controlled, multicenter studies (ESSENCE-1 and ESSENCE-2) clinically meaningful and statistically significant improvements in the indication. Effects on the ocular surface include a statistically significant reduction in total corneal fluorescein staining (tCFS) score favoring CyclASol® in both studies at Days 15 and 29. Up to 71.6% of patients responded within four weeks with a clinically meaningful improvement of ≥ 3 grades in total corneal staining. This proportion of responders was significantly higher compared to vehicle-treated patients in both studies. Responders showed also statistically significant improvements in a variety of symptoms compared to non-responders at day 29. The ASCRS guidelines recognize corneal staining as the single most important clinical sign of DED as it indicates the level of epithelial damage and visual impairment, and if left undertreated, DED can become chronic and more difficult to treat.3 Effect on tear production: In both studies, compared to vehicle at the end of treatment, there was a statistically significant (p<0.05) higher percentage of patients with increases of ≥ 10 mm from baseline in Schirmer's tear test score at Day 85 and Day 29, respectively, confirming a known effect of the active ingredient cyclosporine. Meeting this endpoint in two independent studies is clinically meaningful on its own and considered to demonstrate efficacy for the treatment of signs and symptoms of DED. Head-to-head data versus Restasis™ from the phase 2 study suggest that CyclASol® has a stronger and faster therapeutic effect on the ocular surface.8 Maintenance of effect results from the long-term study CYS-005 confirmed that the effect of CyclASol® was maintained, and even improved for most endpoints, over the 52-week treatment period. Safety and Tolerability: Tolerability of CyclASol® was shown by high drop comfort patient ratings in both studies. The most common adverse reaction observed was instillation site reactions, which was reported in 8.1% of patients in the pooled studies. These were in all but one case mild. The only other adverse reaction reported in > 2% of the patients was visual acuity reduced (2.7%). About Novaliq Novaliq is a biopharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free technology. EyeSol® is Novaliq's proprietary water-free technology using ultrapure semifluorinated alkanes (SFAs) that are physically, chemically, and physiologically inert with excellent biocompatibility and a very good safety profile. Novaliq offers an industry-leading portfolio addressing today's unmet medical needs of millions of patients with eye diseases. In July 2022 submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) was announced seeking approval for NOV03 (perfluorohexyloctane), for the proposed indication of treating the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD). In addition to CyclASol®, the company continues to progress multiple additional pipeline opportunities based on its validated EyeSol® platform, both in ophthalmology and adjacent indications like dermatology. Novaliq GmbH is headquartered in Heidelberg, Germany and Novaliq Inc. has an office in Cambridge, MA, USA. The long-term shareholder is dievini Hopp BioTech holding GmbH & Co. KG, an active investor in Life and Health Sciences companies. More on www.novaliq.com. Recommended Readings - Leonardi A, Modugno RL, & Salami E. Allergy and Dry Eye Disease. Ocular immunology and inflammation. 2021; 29:1168–1176 - 2020 Dry Eye Products Market Report: A global Analysis for 2019 to 2025. Market Scope - Starr CE, Gupta PK, Farid M, Beckman KA, Chan CC, Yeu E, Gomes JAP, Ayers BD, Berdahl JP, Holland EJ, Kim T, Mah FS (the ASCRS Cornea Clinical Committee). An algorithm for the preoperative diagnosis and treatment of ocular surface disorders. J Cataract Refract Surg. 2019; 45:669–684 - Donaldson K, Parkhurst G, Saenz B, Whitley W, Williamson B, Hovanesian J. Call to action: treating dry eye disease and setting the foundation for successful surgery. J Cataract Refract Surg. 2022; 48:623–629 - White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM. Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye. Clin Ophthalmol. 2019; 13:2285-2292 - Dunn JD, Karpecki PM, Meske ME, Reissman D. Evolving knowledge of the unmet needs in dry eye disease. Am J Manag Care. 2021; 27:S23-32 - Sheppard JD, Wirta DL, McLaurin E, Boehmer BE, Ciolino CB, Meides AS, Schlüter T, Ousler GW, Usner D, Krösser S. A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase II/III ESSENCE Study. Cornea. 2021; 40:1290-1297 - Wirta DL, Torkildsen GL, Moreira HR, Lonsdale JD, Ciolino JB, Jentsch G, Beckert M, Ousler GM, Steven P, Krösser S. A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease. Ophthalmology. 2019; 126:793-800 Any product/brand names and/or logos are trademarks of the respective owners. © 2022 Novaliq GmbH, Heidelberg, Germany. Novaliq Media Contact: Simone Angstmann-Mehr info@novaliq.com +49 6221 50259-0 Logo: https://mma.prnewswire.com/media/1804666/Novaliq_GmbH_Logo.jpg View original content: SOURCE Novaliq GmbH
https://www.wilx.com/prnewswire/2022/08/09/novaliq-submits-new-drug-application-seeking-approval-first-of-a-kind-dry-eye-disease-treatment-cyclasol/
2022-08-09T11:28:42Z
https://www.wilx.com/prnewswire/2022/08/09/novaliq-submits-new-drug-application-seeking-approval-first-of-a-kind-dry-eye-disease-treatment-cyclasol/
true
10
KNOXVILLE, Tenn., Aug. 9, 2022 /PRNewswire/ -- AtWork, a rapidly growing national staffing franchise announced today that they have once again been ranked as one of the largest staffing firms in the United States by Staffing Industry Analysts (SIA). The list, which has been issued annually for 27 years, ranks firms that have generated at least $100 million in U.S. staffing revenue. In 2021, despite the pandemic, AtWork performed well, being listed at number 87 of 223 qualifying firms. "AtWork is excited to be recognized by Staffing Industry Analysts once again as one of the largest industrial staffing firms in the United States," said Jason Leverant, President and COO of AtWork Group. "Our growth is fueled by our mission, to be AtWork for You. This focus on service allows us to continually be recognized by our clients and job seekers for the outstanding experience that comes from working with our branches." Founded in 1989, SIA is the global advisor on staffing and workforce solutions. SIA's proprietary research covers all categories of employed and non-employed work including temporary staffing, independent contracting, and other types of contingent labor. SIA's independent and objective analysis provides insights into the services and suppliers operating in the workforce solutions ecosystem including staffing firms, managed service providers, recruitment process outsourcers, payrolling/compliance firms, and talent acquisition technology specialists such as vendor management systems, online staffing platforms, crowdsourcing, and online work services. To view the full list of Largest U.S. Staffing Firms, visit www.staffingindustry.com. To learn more about AtWork franchise opportunities, visit www.AtWorkFranchise.com. View original content to download multimedia: SOURCE AtWork Group
https://www.kktv.com/prnewswire/2022/08/09/atwork-group-ranked-one-largest-staffing-firms-us-by-staffing-industry-analysts/
2022-08-09T11:29:40Z
https://www.kktv.com/prnewswire/2022/08/09/atwork-group-ranked-one-largest-staffing-firms-us-by-staffing-industry-analysts/
true
11
Diethylenetriamine (DETA) (CAS 111-40-0) Market 2022 Upcomming Big Trends | DowDuPont, BASF, Akzonbel, Tosoh New Jersey, USA, -The report presented here is a comprehensive account that includes a thorough analysis and forecast of the global Diethylenetriamine (DETA) (CAS 111-40-0) market. The forecast period considered for this research study is 2022-2029, and the review period is 2020-2026. To ensure the highest level of accuracy of the data provided in the report, our analysts have completed an in-depth verification and re-verification process using trusted sources and tools. The report provides an unbiased in-depth assessment of the global Diethylenetriamine (DETA) (CAS 111-40-0) market, taking into account market competition, regional growth, key sectors and other important aspects. This includes accurate market facts, figures and statistics related to revenue, production,consumption, average annual, market share and other factors. The competitive analysis provided in the Diethylenetriamine (DETA) (CAS 111-40-0) report helps players improve their business strategy or create new strategies that can be applied to current or future market conditions. The report provides strong recommendations to help players cement a strong position in the global Diethylenetriamine (DETA) (CAS 111-40-0) market. Its key findings can be used to prepare for future assignments in advance. Each segment is analysed in depth based on various factors such as Diethylenetriamine (DETA) (CAS 111-40-0) market share, average annual and revenue growth. In addition, all regional markets are comprehensively studied, allowing players to identify key growth opportunities in different regions and countries. Get Sample Copy (Including FULL TOC, Graphs And Tables) Of This Report @ https://www.verifiedmarketreports.com/download-sample/?rid=138882 Competitive Landscape The report studies the Diethylenetriamine (DETA) (CAS 111-40-0) market size by player, region, product type and final industry, historical data 2014-2018 and forecast data 2019-2025; the report also studies the global market competitive environment, market drivers and trends, opportunities and challenges, risks and barriers to entry, sales channels, distributors and porters. Leading Diethylenetriamine (DETA) (CAS 111-40-0) Market Players are as followed: - DowDuPont - BASF - Akzonbel - Tosoh - Delamine - Huntsman - Nippon - Hurricane Chemical - Liaoyang Xinyou Chemical Market segmentation of Diethylenetriamine (DETA) (CAS 111-40-0) market: Diethylenetriamine (DETA) (CAS 111-40-0) market is divided by type and application. For the period 2021-2028, cross-segment growth provides accurate calculations and forecasts of sales by Type and Application in terms of volume and value. This analysis can help you grow your business by targeting qualified niche markets. Diethylenetriamine (DETA) (CAS 111-40-0) Market Segment by Type : - Industrial Grade - Pharmaceuticals Grade - Other Diethylenetriamine (DETA) (CAS 111-40-0) Market Segment by Application : - Automotive - Construction - Personal Care - Agriculture - Oil & Gas - Other Get Exclusive Discount on this Premium Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=138882 Diethylenetriamine (DETA) (CAS 111-40-0) Market Report Scope Regional Analysis: – Europe Market (Germany, UK, France, Russia, Italy) – Centre East and Africa Market (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) – South America Market (Brazil, Argentina, Colombia) – North America Market (United States, Canada, Mexico) – Asia Pacific Market (China, Japan, Korea, India, Southeast Asia) To Gain More Insights into the Market Analysis, Browse Summary of the Research Report @ https://www.verifiedmarketreports.com/product/global-diethylenetriamine-deta-cas-111-40-0-market-report-2019-competitive-landscape-trends-and-opportunities/ Visualize Anesthesia Delivery Systems Market using Verified Market Intelligence:- Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future. VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market. Visualize Anesthesia Delivery Systems Market using VMI @ https://www.verifiedmarketresearch.com/vmintelligence/ Top Trending Reports Global Polyamide 6,6 Market Size And Forecast Global Phosphorescent Colorants Market Size And Forecast Global Wheel Cleaners Market Size And Forecast Global Diethylenetriamine (DETA) (CAS 111-40-0) Market Size And Forecast Global Collateralized Debt Obligation Market Size And Forecast Global Processing Aids Market Size And Forecast Global Multi Layer Preforms Market Size And Forecast Global Ferronickel Market Size And Forecast Global Sweeteners Market Size And Forecast Global Auto Catalysts Market Size And Forecast About Us: Verified Market Reports Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions. Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research. Our research spans over a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs. Contact us: Mr. Edwyne Fernandes US: +1 (650)-781-4080 UK: +44 (753)-715-0008 APAC: +61 (488)-85-9400 US Toll-Free: +1 (800)-782-1768 Email: sales@verifiedmarketreports.com Website: – https://www.verifiedmarketreports.com/
https://shanghai.ist/2022/08/09/diethylenetriamine-deta-cas-111-40-0-market-2022-upcomming-big-trends-dowdupont-basf-akzonbel-tosoh/
2022-08-09T11:34:15Z
https://shanghai.ist/2022/08/09/diethylenetriamine-deta-cas-111-40-0-market-2022-upcomming-big-trends-dowdupont-basf-akzonbel-tosoh/
true
127
In the wake of Leandro Lo’s tragic murder in Brazil this past weekend, yesterday’s WNO event headlined by Gordon Ryan and Felipe Pena took on a somber tone. Many of the athletes on the main card had personal connections and rivalries with the grappling legend, and post fight interviews, like those of Nicholas Meregali and Rafael Lovato Jr., filled with expressions of sadness, remembering his life and decrying the horror of his death. That said, the card out of Austin, Texas delivered memorable matches that culminated in a somewhat bizarre main event finish. Ryan defeated Pena after a 44-minute nogi brawl. The third in their series of matches over the years, it marks Ryan’s first victory over Pena and Pena’s first loss of 2022. More shocking than the result to many, however, was Pena’s decision to verbally give up before a more conventional finish could be reached. Both men started making grips on the feet, attempting snap downs and underhooks with little success. Ryan maintained a slight control of the mat’s center, often forcing Pena to the perimeter before disengaging. Pena focused more on foot sweep attempts, finding Ryan to be heavy with his hand fighting. Closing in on the 10-minute mark, a comment from the crowd elicited a brief smile and reply from Pena, breaking up the tense atmosphere of the match to everyone’s relief. Ryan sat to guard, and Pena dropped down into his half guard looking to pass. Rolling through deep half, Ryan nearly took the back as he swept Pena who then turned belly down. Pena turned looking to regain guard, but Ryan responded by passing to three-quarter guard as he isolated Pena’s arms. Pena hip escaped into half guard, and Ryan disengaged back to the feet. Pena kicked Ryan in the stomach as he made his frames, and Ryan moved to pass once again. From the bottom, Pena forced Ryan into 50/50 and isolated his left leg. Unconcerned, Ryan calmly freed his knee as Pena looked to set up his bear trap. Ryan stood to free himself, and Pena nearly held onto a single on the way up. The Jersey native once again sat to guard, inviting Pena to try passing again. Pena spent many minutes held at bay inside half guard, darting to different angles before alternating from the feet to his knees. Gordon briefly looked to stand, but Pena quickly lifted the lead leg and forced him back to the ground. But Ruan soon shot under Pena’s arm to grab the hip, scooting towards the edge of the mat as he escaped. Pena forced him down, but Ryan swept him after a brief scramble. But Pena didn’t stay on his back for long, as a single leg attempt brought both men back to their feet. The back and forth would continue, with Ryan pulling guard and frustrating Pena with his legs. Pena would remain trying to pass, eventually forcing Ryan to stand and try wrestling. Ryan began employing a footsweep/collar tie combination to try grounding Pena, but Found little success against the Gracie Barra black belt. 30-minutes passed, and Gordon launched his first throw attempt by turning and hooking Pena’s inner leg. Pena countered, extending said leg and pushing Ryan to the floor. Both stood quickly, neither capitalizing on the exchange. But Pena’s momentum was halted with a beautiful snap down into a back take from Ryan. The Danaher disciple lifted the Brazilian and tossed him to the floor, forcing Pena to invert and immediately attack the left leg. Once again utilizing the bear trap, Pena moved to the right leg before attempting to stand and sweep Ryan. Ryan moved through several defensive steps in quick succession, bending and freeing his leg from danger and shoving the rising Pena out of bounds. The reff halted the action, resetting the two to center. Pena briefly refused to restart the match on the floor, eliciting a chorus of boos from the audience. Finally complying, Pena locked in single leg x-guard as Ryan moved to pass. Ryan escaped the guard and set a frenetic pace in his attempts to isolate Pena. Turning after inverting, Pena moved to stand facing away from Ryan. The 27-year-old jumped forward to take the back, grabbing his waist and sweeping Pena’s left foot. After denying Ryan the pass once again, Pena threw his legs up to lock Ryan in 50/50 again. But Ryan stayed heavy on top, and defended his leg from a leglock attempt. As Ryan freed his leg, both stood to be recentered again. Once again seemingly refusing to start, Pena had a brief exchange with FloGrappling Senior Editor Hywel Teauge at matside before allowing the fight to resume. “I couldn’t understand what Felipe Pena was trying to communicate to me,” Teauge said during the broadcast. “I asked him if he was done, and he didn’t respond.” Returning to collar ties, Ryan landed a rough takedown just past the 43-minute mark. Keeping Pena pinned and defending his passing attempts, Ryan also had to stuff some leg attacks from his old rival before both stood again. Ryan landed a huge footsweep, bringing the now clearly exhausted Pena down once more. Pena defended again but, just past the 44:40 mark, the referee called a stop to the fight. Pena, almost undetectable to the microphones, uttered a verbal submission and delivered Ryan his long-sought victory. Pena later fully addressed his decision to retire in a post to Instagram: “I wasn’t mentally stable to do this fight and I shouldn’t have done! I looked for the organizers and said I didn’t want to fight so they offered to set a time limit of [one] hour and be the first fight of the event so I could leave right after but Gordon [Ryan] didn’t accept. Anyway, in the end it was my decision and I accepted as long as I has a rematch already agreed. Sorry to everyone who was cheering.” With a rematch seemingly possible in the near future, Pena and the rest of the grappling world have time to heal from their loss before stepping on the mat again. Full Event Results: Gordon Ryan def Felipe Pena: verbal tap Nicholas Meregali def Rafael Lovato Jr: unanimous decision Mica Galvao def Alan Sanchez: RNC Bia Mesquita def Elisabeth Clay: unanimous decision Jacob Couch def Jay Rodriguez: unanimous decision Fabricio Andrey def Fabaian Ramirez: unanimous decision Diogo Reis def Estevan Martinez: unanimous decision
https://www.bloodyelbow.com/2022/8/9/23297336/felipe-pena-verbally-taps-vs-gordon-ryan-at-wno-says-he-wasnt-mentally-stable-after-los-death
2022-08-09T11:36:07Z
https://www.bloodyelbow.com/2022/8/9/23297336/felipe-pena-verbally-taps-vs-gordon-ryan-at-wno-says-he-wasnt-mentally-stable-after-los-death
true
1
The latest research report provides a complete assessment of the External Fixator Devices market for the forecast year 2022-2031, which is beneficial for companies regardless of their size and revenue. This survey report covers the major market insights and industry approach towards COVID-19 in the upcoming years. The External Fixator Devices market report presents data and information on the development of the investment structure, technological improvements, market trends and developments, capabilities, and comprehensive information on the key players of the External Fixator Devices market. The worldwide market strategies undertaken, with respect to the current and future scenario of the industry, have also been listed in the study. The report begins with a brief presentation and overview of the External Fixator Devices market, about the current market landscape, market trends, major market players, product type, application, and region. It also includes the impact of COVID-19 on the global External Fixator Devices market trends, future forecasts, growth opportunities, end-user industries, and market players. It also provides historical data, current market scenario and future insights on External Fixator Devices market. This study provides a comprehensive understanding of market value with the product price, demand, gross margin, and supply of the External Fixator Devices market. The competitive perspective section of the report presents a clear insight into the market share analysis of the major players in the industry. To know about more drivers and challenges -Download a PDF sample now @ https://market.us/report/external-fixator-devices-market/request-sample/ Representative image 1: Y-O-Y Growth Rate Executive Summary Competitive Spectrum – Top Companies Participating in the External Fixator Devices Market are: Biomet DePuy Stryker Smith & Nephew External Fixator Devices market research report will be sympathetic for: 1. New Investors 2. Propose investors and private equity companies 3. Cautious business organizers and analysts 4. Intelligent network security Suppliers, Manufacturers and Distributors 5. Government and research organizations 6. Speculation / Business Research League 7. End-use industries And much more External Fixator Devices Market Segments Evaluated in the Report: Product Overview: Metal Plates Screws Others Representative image 2: Global Market Y-O-Y Growth Analysis, By Product Type 2022-2032 Classified Applications of External Fixator Devices Market: Hospital Clinic Do You Have Any Query Or Specific Requirement? Ask Our Industry Expert@ https://market.us/report/external-fixator-devices-market/#inquiry Key regions divided during this report: – The Middle East and Africa External Fixator Devices Market (Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa) – North America External Fixator Devices Market (United States, Canada, Mexico) – Asia Pacific External Fixator Devices Market (China, Japan, Korea, India, Southeast Asia) – South America External Fixator Devices Market (Brazil, Argentina, Colombia) – Europe External Fixator Devices Market (Germany, UK, France, Russia, Italy) The External Fixator Devices market research is sourced for experts in both primary and developed statistics and includes qualitative and quantitative details. The analysis is derived Manufacturers’ experts work around the clock to recognize current circumstances, such as COVID-19, the possible financial reversal, the impact of a trade slowdown, the importance of the limitation on export and import, and all the other factors that may increase or decrease market growth during the forecast period. Table Of Contents Highlights: Chapter 1. Introduction The External Fixator Devices research work report covers a brief introduction to the global market. this segment provides opinions of key participants, an audit of External Fixator Devices industry, outlook across key regions, financial services and various challenges faced by External Fixator Devices Market. This section depends on the Scope of the Study and Report Guidance. Chapter 2. Outstanding Report Scope This is the second most important chapter, which covers market segmentation along with a definition of External Fixator Devices. It defines the entire scope of the External Fixator Devices report and the various facets it is describing. Chapter 3. Market Dynamics and Key Indicators This chapter includes key dynamics focusing on drivers[ Includes Globally Growing External Fixator Devices Prevalence and Increasing Investments in External Fixator Devices, Key Market Restraints [High Cost of External Fixator Devices], opportunities [Emerging Markets in Developing Countries] and also presented in detail the emerging trends [Consistent Launch of New Screening Products] growth challenges, and influence factors shared in this latest report. Chapter 4. Type Segments This External Fixator Devices market report shows the market growth for various types of products marketed by the most comprehensive companies. Chapter 5. Application Segments The examiners who wrote the report have fully estimated the market potential of key applications and recognized future opportunities. Chapter 6. Geographic Analysis Each regional market is carefully scrutinized to understand its current and future growth, development, and demand scenarios for this market. Chapter 7. Impact of COVID-19 Pandemic on Global External Fixator Devices Market 7.1 North America: Insight On COVID-19 Impact 7.2 Europe: Serves Complete Insight On COVID-19 Impact 7.3 Asia-Pacific: Potential Impact of COVID-19 7.4 Rest of the World: Impact Assessment of COVID-19 Pandemic Chapter 8. Manufacturing Profiles The major players in the External Fixator Devices market are detailed in the report based on their market size, market served, products, applications, regional growth, and other factors. Chapter 9. Pricing Analysis This chapter provides price point analysis by region and other forecasts. Chapter 10. North America External Fixator Devices Market Analysis This chapter includes an assessment on External Fixator Devices product sales across major countries of the United States and Canada along with a detailed segmental outlook across these countries for the forecasted period 2022-2031. Chapter 11. Latin America External Fixator Devices Market Analysis Major countries of Brazil, Chile, Peru, Argentina, and Mexico are assessed apropos to the adoption of External Fixator Devices. Chapter 12. Europe External Fixator Devices Market Analysis Market Analysis of External Fixator Devices report includes insights on supply-demand and sales revenue of External Fixator Devices across Germany, France, United Kingdom, Spain, BENELUX, Nordic and Italy. Chapter 13. Asia Pacific Excluding Japan (APEJ) External Fixator Devices Market Analysis Countries of Greater China, ASEAN, India, and Australia & New Zealand are assessed and sales assessment of External Fixator Devices in these countries is covered. Chapter 14. Middle East and Africa (MEA) External Fixator Devices Market Analysis This chapter focuses on External Fixator Devices market scenario across GCC countries, Israel, South Africa, and Turkey. Chapter 15. Research Methodology The research methodology chapter includes the following main facts, 15.1 Coverage 15.2 Secondary Research 15.3 Primary Research Chapter 16. Conclusion Browse Full Report with Facts and Figures of External Fixator Devices Market Report at: https://market.us/report/external-fixator-devices-market/ Get in Touch with Us : Global Business Development Team – Market.us Market.us (Powered By Prudour Pvt. Ltd.) Send Email: inquiry@market.us Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States Tel: +1 718 618 4351 Website: https://market.us Research Analysis and More Market Reports: https://www.einpresswire.com/market_us/
https://www.taiwannews.com.tw/en/news/4620883
2022-08-09T11:36:24Z
https://www.taiwannews.com.tw/en/news/4620883
false
1851
Milestone underscores CEVA's central role in the IoT era, enabling wireless connectivity and intelligence in billions of smartphones, consumer electronics, wearables, IoT endpoints and edge AI devices ROCKVILLE, Md., Aug. 9, 2022 /PRNewswire/ -- CEVA, Inc. (NASDAQ: CEVA), the leading licensor of wireless connectivity and smart sensing technologies and co-creation solutions, announced today that cumulative royalty-bearing chip shipments that include CEVA IP surpassed 15 billion units during the second quarter. This significant milestone has been achieved as CEVA approaches it's 20-year anniversary of being a public company. While the first 10 billion CEVA-powered shipments spanned more than 15 years, the next 5 billion shipments took less than three and a half years. The incredible rapid adoption rate of CEVA's IP in the IoT era is a testament to the company's role in the democratization of wireless connectivity, through the broad licensing of its 5G, cellular IoT, Bluetooth, Wi-Fi and UWB platform IP to hundreds of semiconductors and OEMs. This effectively lowered the entry barriers for embedding wireless connectivity in SoCs, enabling companies to design more cost-effective and power-efficient chips that led to the proliferation of wirelessly-connected devices that we take for granted today. These devices include smartphones, wearables, hearables, wireless speakers, smart home appliances, white goods, plugs, lights and many more. Gideon Wertheizer, CEO of CEVA, stated: "Surpassing the 15 billion CEVA-powered chip shipment milestone is a very noteworthy accomplishment for CEVA and its customers. The steep shipment ramp we have experienced over the past 3 years directly coincides with the explosion of IoT devices, where almost every electronic device that ships today is connected. We have been developing and investing in wireless technologies for two decades, and today CEVA is proud to be at the forefront of wireless connectivity in the IoT era. Going forward, as devices become increasingly smarter, integrating more sensors and intelligence, our sensing technologies and edge AI platforms are primed to build on our wireless success. We are excited and invigorated by what's next for CEVA as the adoption of our technologies continues to grow and we reach new heights." Today, more than 50 CEVA-powered devices are sold every second around the world. For more insight into some of the latest CEVA-powered devices, visit our website at https://www.ceva-dsp.com/powered-products/. About CEVA, Inc. CEVA is the leading licensor of wireless connectivity and smart sensing technologies and co-creation solutions for a smarter, safer, connected world. We provide Digital Signal Processors, AI engines, wireless platforms, cryptography cores and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence. These technologies are offered in combination with our Intrinsix IP integration services, helping our customers address their most complex and time-critical integrated circuit design projects. Leveraging our technologies and chip design skills, many of the world's leading semiconductors, system companies and OEMs create power-efficient, intelligent, secure and connected devices for a range of end markets, including mobile, consumer, automotive, robotics, industrial, aerospace & defense and IoT. Our DSP-based solutions include platforms for 5G baseband processing in mobile, IoT and infrastructure, advanced imaging and computer vision for any camera-enabled device, audio/voice/speech and ultra-low-power always-on/sensing applications for multiple IoT markets. For sensor fusion, our Hillcrest Labs sensor processing technologies provide a broad range of sensor fusion software and inertial measurement unit ("IMU") solutions for markets including hearables, wearables, AR/VR, PC, robotics, remote controls and IoT. For wireless IoT, our platforms for Bluetooth (low energy and dual mode), Wi-Fi 4/5/6 (802.11n/ac/ax), Ultra-wideband (UWB), NB-IoT and GNSS are the most broadly licensed connectivity platforms in the industry. CEVA is a sustainable and environmentally conscious company, adhering to our Code of Business Conduct and Ethics. As such, we emphasize and focus on environmental preservation, recycling, the welfare of our employees and privacy – which we promote on a corporate level. At CEVA, we are committed to social responsibility, values of preservation and consciousness towards these purposes. Visit us at www.ceva-dsp.com and follow us on Twitter, YouTube, Facebook, LinkedIn and Instagram. LOGO: https://mma.prnewswire.com/media/74483/ceva__inc__logo.jpg View original content: SOURCE CEVA, Inc.
https://www.kfvs12.com/prnewswire/2022/08/09/ceva-celebrates-15-billionth-ceva-powered-chip-shipped/
2022-08-09T11:37:33Z
https://www.kfvs12.com/prnewswire/2022/08/09/ceva-celebrates-15-billionth-ceva-powered-chip-shipped/
false
12
Kohima: The Eastern Nagaland Peoples’ Organisation (ENPO) on Tuesday held a public rally in six districts to demand the creation of a separate state of ‘Frontier Nagaland’. ENPO is the apex body of seven tribal organizations in Mon, Tuensang, Kiphire, Longleng, Noklak and Shamator districts and Extra Assistant Commissioner (EAC) Headquarter, Kiusam in Shamator district. The ENPO started demanding ‘Frontier Nagaland’ in 2010 lamenting that their area has been left behind in all aspects of development, including education and infrastructure. The six districts under ENPO have 20 legislators. The public rally which started at around 10 am in all tribal headquarters ended ‘very peacefully’ with the cooperation of the respective tribal organisations, ENPO general secretary Manpang Phom told PTI. During the rally hours, all business establishments, educational institutions and offices remained shut in solidarity with the ENPO’s demand for a separate state. The rally saw the participation of all aged people in their respective traditional attire with banners and placards demanding a separate state. ADVERTISEMENT CONTINUE READING BELOW The tribal organizations after the rally approached the respective Deputy Commissioners in the districts and submitted their demand for the creation of a separate state. Phom said that ENPO has been holding democratic rallies every year pressing for a separate statehood. Phom told PTI, “ENPO will continue pressing for Frontier Nagaland till it is achieved.” Also read | What’s driving the high prevalence of cancer in Nagaland?
https://www.eastmojo.com/nagaland/2022/08/09/eastern-nagaland-tribes-hold-public-rally-demanding-separate-state/
2022-08-09T11:37:49Z
https://www.eastmojo.com/nagaland/2022/08/09/eastern-nagaland-tribes-hold-public-rally-demanding-separate-state/
true
2
(The Hill) — President Joe Biden on Monday, when asked about his low approval ratings and for a response to the notion that his polls were “terrible” said he foresees a change coming. “It’s a long way home, the fact is that we’ve been divided for so long, and it’s only recently that we have any kind of movement, and I think you’re going to see a lot change,” Biden told reporters in Lexington after he toured damage from deadly floods in eastern Kentucky. With the midterm elections exactly three months away, recent polling shows Biden’s approval ratings just shy of 40 percent, where it’s stubbornly stayed for the last several months. A Gallup poll released late last month reported a 38 percent approval rating, a new low for Biden. His approval rating began at 57 percent and was at 41 percent in June, according to the same survey. Facing historical and political headwinds, Democrats are hoping a recent string of legislative victories can boost the party’s standing by the time voters head to the polls in November. Senate Democrats on Sunday passed a sweeping package on taxes, climate change and health care, which included some long-time liberal priorities. That party-line package now heads to the House, but Biden this week will sign two major bills into law that recently passed with bipartisan support. Biden on Tuesday will sign into law a $280 billion bill on Thursday to strengthen the domestic chip manufacturing industry and finance scientific research, and on Wednesday he will sign another bill to expand health care to veterans exposed to toxic burn pits. Democrats also saw glimmers of hope in Kansans’ rejection of a ballot question that would have removed abortion rights from the state constitution, with the measure passing with nearly 60 percent support in the traditionally red state. Prominent analysts indicate Republicans are still heavy favorites to take the House in November, but recent polling shows Democrats making gains on the generic ballot question. Poll aggregator FiveThirtyEight as of Monday evening gave Republicans a 4 in 5 chance of winning the House while indicating Democrats had a 59 percent chance of maintaining Senate control, a significant shift since suggesting Republicans were the favorites as of just two weeks ago.
https://www.valleycentral.com/news/national-news/biden-on-his-own-low-approval-ratings-i-think-youre-going-to-see-a-lot-change/
2022-08-09T11:40:28Z
https://www.valleycentral.com/news/national-news/biden-on-his-own-low-approval-ratings-i-think-youre-going-to-see-a-lot-change/
false
18
SEOUL, South Korea (AP) — Some of the heaviest rain in decades swamped South Korea’s capital region, turning Seoul’s streets into car-clogged rivers and sending floods cascading into subway stations. At least eight people were killed — some drowning in their homes — and seven others were missing, with more rain forecast, officials said Tuesday. More than 43 centimeters (17 inches) of rain was measured in Seoul’s hardest-hit Dongjak district from Monday to noon Tuesday. Precipitation in the area exceeded 14 centimeters (5.5 inches) per hour at one point Monday night, the highest hourly downpour measured in Seoul since 1942. Deserted cars and buses were scattered across streets as the water receded on Tuesday. Workers cleared uprooted trees, mud and debris with excavators and blocked off broken roads. Landslide warnings were issued in nearly 50 cities and towns, and 160 hiking paths in Seoul and mountainous Gangwon province were closed. Emergency crews worked overnight to restore most subway service as of Tuesday morning, but a route linking towns north of Seoul was shut Tuesday evening as continuing rain flooded some stations. Dozens of roads, including major expressways near the swollen Han River, were closed because of rising water levels or partial flooding. “The heavy rainfall is expected to continue for days … we need to maintain our sense of alert and respond with all-out effort,” President Yoon Suk Yeol said at the government’s emergency headquarters. The military was prepared to deploy troops to help with recovery efforts if requested by cities or regional governments, Defense Ministry spokesperson Moon Hong-sik said. The rain began Monday morning and strengthened through the evening. By nightfall, people were wading through thigh-high waters in streets in Gangnam, one of Seoul’s most bustling business and leisure districts, where cars and buses were stuck in mud-brown waters. Commuters evacuated as water cascaded down the stairs of the Isu subway station like a waterfall. In the nearby city of Seongnam, a rain-weakened hillside collapsed into a university soccer field. Rescue workers failed to reach three people -– two sisters in their 40s and a 13-year-old girl -– who called for help before drowning in a basement home in the Gwanak district of southern Seoul on Monday night. Another woman drowned in her home in the nearby Dongjak district, where a public worker died while clearing fallen trees, likely from electrocution. Choi Seon-yeong, an official from the Dongjak district office, said it wasn’t immediately clear whether the death was caused by a damaged power source or equipment the man was using. Three people were found dead in the debris of landslides and a collapsed bus station in the nearby cities of Gwangju and Hwaseong. Four people were missing in southern Seoul’s Seocho district, the home of Yoon, who, according to his office, spent hours on the phone receiving briefings and issuing instructions overnight as rain flooded streets near his high-rise apartment complex. Nearly 800 buildings in Seoul and nearby cities were damaged and at least 790 people were forced to evacuate from their homes, the Ministry of the Interior and Safety said. The country’s weather agency maintained a heavy rain warning for the Seoul metropolitan area and nearby regions on Tuesday and said precipitation may reach 5 to 10 centimeters (2 to 4 inches) an hour in some areas. It said around 10 to 35 centimeters (4 to 14 inches) of additional rain was expected across the capital region through Thursday. Rainstorms also pounded North Korea, where authorities issued heavy rain warnings for the southern and western parts of the country. North Korea’s official Rodong Sinmun newspaper described the rain as potentially disastrous and called for measures to protect farmland and prevent flooding on the Taedong River, which flows through the capital, Pyongyang.
https://www.khon2.com/international/rains-in-s-korea-turn-seouls-roads-to-rivers-leave-7-dead/
2022-08-09T11:41:30Z
https://www.khon2.com/international/rains-in-s-korea-turn-seouls-roads-to-rivers-leave-7-dead/
false
46
The owner of a popular Indian restaurant has hit out after being targeted in a vile racially motivated incident. Abu Raihan, who runs Akbar the Great in Darlington, received a phone call from a caller claiming to have receive uncooked lamb chops in a visit the day before and demanded compensation. The Bondgate eatery does not offer lamb chops on their menu. The 32-year-old, who runs the restaurant alongside his head chef father Abdul Mannan, then politely explained to the caller that they do not serve the dish at Akbar the Great, but was then accused of lying. He was then told to 'f*** off back to where you came from' by the caller. READ MORE:Prohibition-themed bar announced as phase two of Darlington Market regeneration set to get underway Abu said: "It was a short interaction over the phone, but shocking in this day and age that people like this still exist with this narrow-minded racist mentality." When faced with the racially loaded comment, he was quick to respond - asking the caller if he meant Bradford, where his family home is based, Harrogate where he was born, or Darlington where he has set up a successful business. The phone call was then terminated on the other end, but not before swearing at the restaurant manager once more. Abu has expressed how shocked and hurt he felt, and said he knew exactly what the caller was trying to say. Abu explained: "I was born in England and have lived here for the past 32 years. I am British and proud to be." Akbar the Great is loved by Darlington natives and has even been nominated for a 'restaurant of the year' accolade at the English Curry Awards. The restaurant beat out hundreds of other curry houses across the North East to be named in the top 10 best restaurants in the region and the team will attend an awards evening this month. Abu is now trying to put the awful phone call behind him as he looks towards attending the black tie awards ceremony at the end of the month. The event will take place in Birmingham where the country's most esteemed curry houses will gather to celebrate great cuisine. Speaking directly to the caller, Abu said: "Change your mentality, we are in 2022 now in a multi-cultural society." READ NEXT: - Pub owner could face months of waiting for High Court battle as fight to win back licence rumbles on - 'I am so so happy': Independent boutique owner wins legal battle against high street giant ZARA - Charity founder's mural highlights importance of representation in sport after Lionesses' victory - The average wait time for a driving test on Teesside and where you might get in a bit quicker
https://www.gazettelive.co.uk/news/teesside-news/popular-indian-restaurant-owner-left-24707423
2022-08-09T11:41:33Z
https://www.gazettelive.co.uk/news/teesside-news/popular-indian-restaurant-owner-left-24707423
true
1
Ukraine: Shelling hits town near Russian-held nuclear plant KYIV, Ukraine (AP) — At least three Ukrainian civilians were killed and 23 others were wounded by Russian shelling in 24 hours, including an attack not far from a Russian-occupied nuclear power plant, the office of Ukraine’s president reported Tuesday. The Russians fired over 120 rockets from Grad multiple rocket launchers at the southern town of Nikopol, which is across the Dnieper River from the Zaporizhzhia Nuclear Power Plant, Dnipropetrovsk Gov. Valentyn Reznichenko said. Several apartment buildings and industrial facilities were damaged, he said. Ukraine and Russia accused each other in recent days of shelling the nuclear plant, which is the largest one in Europe, and increasing the risks of a nuclear accident. In his nightly video address, Ukrainian President Volodymyr Zelenskyy invoked the 1986 disaster at the Chernobyl nuclear plant in Ukraine, which at the time was a Soviet republic. He called for new sanctions against Russia “for creating the threat” of another nuclear disaster. “We are actively informing the world about Russian nuclear blackmail - about the shelling and mining of the Zaporizhzhia NPP facilities,” Zelenskyy said. “Russia will not pay attention to words and concerns. ... The Chernobyl disaster is an explosion in one reactor; the Zaporizhzhia NPP is six power units.” The Kremlin claimed Monday that Ukraine’s military was attacking the plant and urged Western powers to force Kyiv to stop the activity. A Russian-installed official in the partially occupied Zaporizhzhia region said an air defense system at the plant would be reinforced in the aftermath of last week’s shelling. Evgeny Balitsky, the head of the Kremlin-backed administration, told Russian state TV Tuesday that power lines and damaged blocks of the plant were restored. “The plant is operating normally, but, of course, with an increased degree of security,” Balitsky said. A Ukrainian counteroffensive and Russian defensive actions in occupied areas has increasingly drawn firepower to southern Ukraine. After failing to capture Ukraine’s capital, Kyiv, early in the war, the Russian military focused its strength on trying to seize all of the country’s eastern Donbas region. Pro-Moscow separatists have fought Ukrainian forces in the region for eight years and control some territory as self-proclaimed republics. GRAPHIC WARNING: Videos included in this story may have disturbing content. The British Defense Ministry said Tuesday that Russian forces had made the most progress in the past month in moving toward the town of Bakhmut - an advance limited to about 10 kilometers (6.2 miles). “In other Donbas sectors where Russia was attempting to break through, its forces have not gained more than 3 km during this 30-day period; almost certainly significantly less than planned,” the U.K. ministry said. However, the ministry cautioned that despite the attention required in southern Ukraine, Russia had maintained attacks on Ukrainian positions in the east. The governor of eastern Ukraine’s Donetsk province, Pavlo Kyrylenko, said the Russians were trying to press their offensive in several areas. Kharkiv, the country’s second-largest city, came under the Russian shelling four times over the past 24 hours, and some city infrastructure was damaged. ___ This version has been corrected to show the pro-Moscow separatists are fighting Ukrainian forces, not the Russians. ___ Follow AP’s coverage of the war in Ukraine at https://apnews.com/hub/russia-ukraine Copyright 2022 The Associated Press. All rights reserved.
https://www.kjct8.com/2022/08/09/ukraine-shelling-hits-town-near-russian-held-nuclear-plant/
2022-08-09T11:44:43Z
https://www.kjct8.com/2022/08/09/ukraine-shelling-hits-town-near-russian-held-nuclear-plant/
true
26
PR Newswire NEW YORK, Aug. 9, 2022 NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Nielsen Holdings plc (NYSE: NLSN) today announced that the court meeting and the special meeting of its shareholders ("the Meetings") due to be held today have been postponed. The purpose of the Meetings was to consider and vote on proposals to give effect to the transaction contemplated by the previously announced definitive agreement for the Company to be acquired by a private equity consortium (the "Consortium") composed of Evergreen Coast Capital Corp., an affiliate of Elliott Investment Management L.P., and Brookfield Business Partners L.P. together with other institutional partners (collectively "Brookfield"). The Meetings have been postponed to allow the Consortium to seek to finalize a preliminary agreement with The WindAcre Partnership LLC ("WindAcre"), the beneficial owner of approximately 27% of Nielsen's ordinary shares. Under the preliminary agreement, WindAcre would join the Consortium with respect to a portion of its shares and would receive $28 per share – the same price to be paid to all other shareholders – for its remaining shares. Although there can be no assurance that the preliminary agreement will be finalized, assuming it is finalized, the Company will supplement its proxy statement to reflect the terms of the agreement between the Consortium and WindAcre and will present the transaction to shareholders for approval as expeditiously as possible. Nielsen and the Consortium remain bound by the terms of the definitive agreement to give effect to the proposed transaction, and Nielsen's Board of Directors has made no change to its recommendation that its shareholders vote in favor of all of the proposals at the meetings to approve and give effect to the proposed transaction. Advisors J.P. Morgan and Allen & Company LLC are acting as lead financial advisors to Nielsen. PJT Partners is also acting as an advisor to Nielsen, and Wachtell, Lipton, Rosen & Katz, Clifford Chance LLP, DLA Piper, and Baker McKenzie are serving as legal advisors to Nielsen. Gibson, Dunn & Crutcher LLP and Herbert Smith Freehills LLP are serving as legal advisors to Evergreen and the Consortium, and Davis Polk & Wardwell LLP is acting as legal advisor to Brookfield. BofA Securities, Barclays, Credit Suisse, Mizuho Securities USA LLC, HSBC Securities (USA) Inc., and Citi are serving as financial advisors to Evergreen and Brookfield. About Elliott and Evergreen Elliott Investment Management L.P. manages approximately $55.7 billion of assets as of June 30, 2022. Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds under continuous management. The Elliott funds' investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Evergreen Coast Capital Corp. is Elliott's Menlo Park affiliate, which focuses on technology investing. About Brookfield Business Partners Brookfield Business Partners is a global business services and industrials company focused on owning and operating high-quality businesses that provide essential products and services and benefit from a strong competitive position. Investors have flexibility to invest in our company either through Brookfield Business Corporation (NYSE, TSX:BBUC), a corporation, or Brookfield Business Partners L.P. (NYSE: BBU; TSX:BBU.UN), a limited partnership. For more information, please visit https://bbu.brookfield.com. Brookfield Business Partners is the flagship listed vehicle of Brookfield Asset Management's Private Equity Group. Brookfield Asset Management is a leading global alternative asset manager with over $750 billion of assets under management. More information is available at www.brookfield.com. Forward-Looking Statements This communication includes information that could constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These statements include those set forth above relating to the proposed transaction as well as those that may be identified by words such as "will," "intend," "expect," "anticipate," "should," "could" and similar expressions. These statements are subject to risks and uncertainties, and actual results and events could differ materially from what presently is expected, including regarding the proposed transaction and Nielsen ONE. Factors leading thereto may include, without limitation, the risks related to Ukraine conflict or the COVID-19 pandemic on the global economy and financial markets, the uncertainties relating to the impact of the Ukraine conflict or the COVID-19 pandemic on Nielsen's business, the failure of Nielsen's new business strategy in accomplishing Nielsen's objectives, economic or other conditions in the markets Nielsen is engaged in, impacts of actions and behaviors of customers, suppliers and competitors, technological developments, as well as legal and regulatory rules and processes affecting Nielsen's business, the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction that could reduce anticipated benefits or cause the parties to abandon the proposed transaction, the occurrence of any event, change or other circumstances that could give rise to the termination of the transaction agreement entered into pursuant to the proposed transaction (the "Agreement"), the possibility that Nielsen shareholders may not approve the proposed transaction, the risk that the parties to the Agreement may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all, risks related to disruption of management time from ongoing business operations due to the proposed transaction, the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Nielsen's ordinary shares, the risk of any unexpected costs or expenses resulting from the proposed transaction, the risk of any litigation relating to the proposed transaction, the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Nielsen to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally, the risk the pending proposed transaction could distract management of Nielsen, and other specific risk factors that are outlined in Nielsen's disclosure filings and materials, which you can find on http://www.nielsen.com/investors, such as its 10-K, 10-Q and 8-K reports that have been filed with the Securities and Exchange Commission (the "SEC"). Please consult these documents for a more complete understanding of these risks and uncertainties. This list of factors is not intended to be exhaustive. Such forward-looking statements only speak as of the date of these materials, and Nielsen assumes no obligation to update any written or oral forward-looking statement made by Nielsen or on its behalf as a result of new information, future events or other factors, except as required by law. Additional Information and Where to Find It This communication relates to the proposed transaction involving Nielsen. In connection with the proposed transaction, Nielsen will file relevant materials with the SEC, including Nielsen's definitive proxy statement on Schedule 14A filed on July 8, 2022 (the "Proxy Statement"). This communication is not a substitute for the Proxy Statement or for any other document that Nielsen may file with the SEC and send to its shareholders in connection with the proposed transaction. The proposed transaction will be submitted to Nielsen's shareholders for their consideration. Before making any voting decision, Nielsen's shareholders are urged to read all relevant documents filed or to be filed with the SEC, including the Proxy Statement, as well as any amendments or supplements to those documents, when they become available because they will contain important information about the proposed transaction. Nielsen's shareholders are able to obtain a free copy of the Proxy Statement, as well as other filings containing information about Nielsen, without charge, at the SEC's website (www.sec.gov). Copies of the Proxy Statement and the filings with the SEC that will be incorporated by reference therein can also be obtained, without charge, by directing a request to Nielsen Holdings plc, 675 6th Avenue New York, NY 10010, Attention: Investor Relations; telephone (410) 717-7134, or from Nielsen's website www.nielsen.com. Participants in the Solicitation Nielsen and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information regarding Nielsen's directors and executive officers is available in Nielsen's definitive proxy statement for its 2022 Annual General Meeting, which was filed with the SEC on April 5, 2022. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are contained in the Proxy Statement and other relevant materials to be filed with the SEC in connection with the proposed transaction when they become available. Free copies of the Proxy Statement and such other materials may be obtained as described in the preceding paragraph. About Nielsen Nielsen shapes the world's media and content as a global leader in audience measurement, data and analytics. Through our understanding of people and their behaviors across all channels and platforms, we empower our clients with independent and actionable intelligence so they can connect and engage with their audiences—now and into the future. An S&P 500 company, Nielsen (NYSE: NLSN) operates around the world in more than 55 countries. Learn more at www.nielsen.com or www.nielsen.com/investors and connect with us on Instagram, Facebook, Twitter, LinkedIn. Investor Relations: Sara Gubins, +1 646 283 7571; [email protected] Media Relations: Connie Kim, +1 240 274 9999; [email protected] View original content:https://www.prnewswire.com/news-releases/nielsen-postpones-court-and-special-meetings-of-shareholders-to-permit-finalization-of-preliminary-agreement-between-consortium-and-windacre-301602318.html SOURCE Nielsen Holdings plc
https://www.gurufocus.com/news/1845292/nielsen-postpones-court-and-special-meetings-of-shareholders-to-permit-finalization-of-preliminary-agreement-between-consortium-and-windacre
2022-08-09T11:49:03Z
https://www.gurufocus.com/news/1845292/nielsen-postpones-court-and-special-meetings-of-shareholders-to-permit-finalization-of-preliminary-agreement-between-consortium-and-windacre
false
13
Diaz-Naranjo will see action at National Open Championships TOKYO Olympics gold medalist Hidilyn F. Diaz-Naranjo will see action to the Smart-Samahang Weightlifting ng Pilipinas (SWP) National Open Championships set to start on Wednesday until Friday in Tagbilaran, Bohol where she will officially claim her spot to the national team. The three-day Tagbilaran tilt, bankrolled by the Philippine Sports Commission (PSC), Smart and Manny V. Pangilinan Sports Foundation, will be Ms. Diaz-Naranjo’s first event since announcing she had set aside her family goals to focus at one final shot at Olympic glory in the 2024 Paris Games. “Hidilyn will be performing on an exhibition basis,” said SWP President Monico Puentevella. Ms. Diaz-Naranjo’s presence should also inspire over a hundred young kids and aspirants coming from all over the country trying out for a spot to the national team seeing action in several international meets including 2023 Phnom Penh Southeast Asian and Games, 2023 Hangzou Asian Games. The SWP is also hoping to discover fresh talents that may be included when the country competes in the Asian Senior Championships in Manama, Bahrain next month and World Championships in Tashkent, Uzbekistan in December this year. Also competing are Tokyo Olympian Elreen Ando, Asian senior and junior champion Vanessa Sarno, Southeast Asian Games gold medalist Kristel Macrohon and talented sisters Rosegie and Rose Jean Ramos, both Asian junior gold winners. Tagbilaran Mayor Jane Yap and Bohol Governor Erico Aumentado have been invited to grace the opening ceremony at 2 p.m. There will also be a doping seminar sponsored by PSC under Dr. Alex Pineda before the start of competition. — Joey Villar
https://www.bworldonline.com/editors-picks/2022/08/09/467202/diaz-naranjo-will-see-action-at-national-open-championships/
2022-08-09T11:49:07Z
https://www.bworldonline.com/editors-picks/2022/08/09/467202/diaz-naranjo-will-see-action-at-national-open-championships/
true
3
AJAX, Ont. - The bodies of two men have been recovered from a construction site in Ajax, Ont. where a trench collapsed Monday afternoon. Authorities say the large trench at the site near Rossland and Westney Roads caved in around noon, burying two workers and injuring another two men. One of the injured was airlifted to a Toronto hospital, while another was taken to a local hospital in Durham Region for a broken ankle. Firefighters and crews using heavy excavating equipment worked through the night trying to retrieve the buried men. Durham Regional Police confirmed the bodies of the two missing workers were recovered around 2:30 a.m. Tuesday. The Ontario Ministry of Labour says it is investigating the cause of the collapse. This report by The Canadian Press was first published Aug. 9, 2022.
https://www.chroniclejournal.com/news/national/quebec/rescue-crews-recover-two-bodies-from-construction-site-trench-collapse-in-ajax/article_95530e88-6add-5896-8a56-4472c617fe7f.html
2022-08-09T11:50:54Z
https://www.chroniclejournal.com/news/national/quebec/rescue-crews-recover-two-bodies-from-construction-site-trench-collapse-in-ajax/article_95530e88-6add-5896-8a56-4472c617fe7f.html
false
null
WA Portland OR Zone Forecast for Monday, August 8, 2022 _____ 267 FPUS56 KPQR 091044 ZFPPQR Zone Forecasts for Northwest Oregon and Southwest Washington National Weather Service Portland OR 344 AM PDT Tue Aug 9 2022 Spot Temperatures are for Today, Tonight, Wednesday, Wednesday Night, and Thursday. WAZ021-092330- South Washington Coast- Including the cities of Raymond, Long Beach, Ocean Park, Naselle, Cathlamet, and Cape Disappointment 344 AM PDT Tue Aug 9 2022 .TODAY...Areas of morning fog. Cloudy with isolated showers in the morning, then partly cloudy in the afternoon. Highs 65 to 75. Light wind becoming west 5 to 10 mph in the afternoon. Chance of precipitation 20 percent. .TONIGHT...Partly cloudy in the evening, then mostly cloudy with scattered showers and isolated thunderstorms after midnight. Lows 55 to 60. Southwest wind 5 to 10 mph. Chance of precipitation 50 percent. Rainfall amounts around a tenth of an inch. .WEDNESDAY...Mostly cloudy. Numerous showers and scattered thunderstorms in the morning, then isolated showers and thunderstorms in the afternoon. Highs 65 to 70. Southwest wind 5 to 10 mph shifting to the south in the afternoon. Chance of precipitation 70 percent. Rainfall amounts around a tenth of an inch, except higher amounts possible in thunderstorms. .WEDNESDAY NIGHT...Partly cloudy. Lows around 55. Southwest wind 5 to 10 mph becoming light after midnight. .THURSDAY...Partly sunny in the morning, then mostly sunny. Highs 70 to 75. Light wind. .THURSDAY NIGHT...Partly cloudy. Lows around 55. .FRIDAY...Partly cloudy. Highs 70 to 75. .FRIDAY NIGHT...Partly cloudy in the evening, then mostly cloudy. Lows around 55. .SATURDAY...Partly cloudy. Highs 70 to 75. .SATURDAY NIGHT...Partly cloudy. Lows around 55. .SUNDAY...Partly cloudy. Highs 70 to 75. .SUNDAY NIGHT...Partly cloudy. Lows around 55. .MONDAY...Partly cloudy in the morning, then mostly sunny. Highs 70 to 75. $$ WAZ020-092330- Willapa Hills- Including the cities of Willapa, Frances, Elk Mountain, and Ryderwood 344 AM PDT Tue Aug 9 2022 .TODAY...Mostly cloudy with isolated showers in the morning, then partly cloudy in the afternoon. Highs 75 to 80. Light wind becoming northwest 5 to 10 mph in the afternoon. Chance of precipitation 20 percent. .TONIGHT...Partly cloudy in the evening, then mostly cloudy with scattered showers and isolated thunderstorms after midnight. Lows 55 to 60. Light wind becoming west 5 to 10 mph after midnight. Chance of precipitation 50 percent. Rainfall amounts around a tenth of an inch. .WEDNESDAY...Mostly cloudy. Scattered showers and thunderstorms in the morning, then scattered showers and isolated thunderstorms until midday. Highs 65 to 70. Southwest wind 5 to 10 mph. Chance of precipitation 50 percent. Rainfall amounts less than a tenth of an inch, except higher amounts possible in thunderstorms. .WEDNESDAY NIGHT...Partly cloudy. Lows 50 to 55. West wind 5 to 10 mph becoming light after midnight. .THURSDAY...Partly cloudy in the morning, then mostly sunny. Highs around 75. Light wind becoming northwest 5 to 10 mph in the afternoon. .THURSDAY NIGHT...Mostly clear. Lows around 55. .FRIDAY...Partly cloudy in the morning, then mostly sunny. Highs 70 to 75. .FRIDAY NIGHT...Partly cloudy. Lows around 55. .SATURDAY...Partly cloudy. Highs 70 to 75. .SATURDAY NIGHT...Partly cloudy. Lows around 55. .SUNDAY...Partly cloudy. Highs 70 to 75. .SUNDAY NIGHT...Mostly clear. Lows around 55. .MONDAY...Mostly sunny. Highs 75 to 80. $$ WAZ040-092330- South Washington Cascade Foothills- Including the cities of Toutle, Ariel, Lake Merwin, Yale Lake, and Cougar 344 AM PDT Tue Aug 9 2022 .TODAY...Mostly cloudy with isolated showers in the morning, then partly cloudy with isolated showers and thunderstorms in the afternoon. Highs 75 to 85. Light wind becoming west 5 to 10 mph in the afternoon. Chance of precipitation 20 percent. .TONIGHT...Partly cloudy with isolated showers and thunderstorms in the evening, then partly cloudy with scattered showers and isolated thunderstorms overnight. Lows 55 to 60. Light wind. Chance of precipitation 40 percent. Rainfall amounts less than a tenth of an inch, except higher amounts possible in thunderstorms. .WEDNESDAY...Partly sunny. Scattered showers and isolated thunderstorms in the morning. Highs 70 to 75. Southwest wind 5 to 10 mph. Chance of precipitation 40 percent. .WEDNESDAY NIGHT...Mostly clear. Lows around 55. West wind 5 to 10 mph becoming light after midnight. .THURSDAY...Mostly sunny. Highs 75 to 80. Light wind becoming west 5 to 10 mph in the afternoon. .THURSDAY NIGHT...Clear. Lows around 55. .FRIDAY...Mostly sunny. Highs 75 to 80. .FRIDAY NIGHT...Mostly clear. Lows around 55. .SATURDAY...Partly cloudy in the morning, then mostly sunny. Highs 70 to 80. .SATURDAY NIGHT...Mostly clear. Lows around 55. .SUNDAY...Partly cloudy in the morning, then mostly sunny. Highs 70 to 80. .SUNDAY NIGHT...Mostly clear. Lows around 55. .MONDAY...Mostly sunny. Highs 75 to 85. $$ WAZ019-092330- South Washington Cascades- Including the cities of Coldwater Ridge Visitors Center, Mount St. Helens, and Wind River Valley 344 AM PDT Tue Aug 9 2022 .TODAY...Mostly cloudy with isolated showers in the morning, then partly cloudy with isolated showers and thunderstorms in the afternoon. Snow level above 8000 feet. Light wind becoming southwest 5 to 10 mph in the afternoon. Chance of precipitation 20 percent. .TONIGHT...Partly cloudy with scattered showers and isolated thunderstorms. Snow level above 8000 feet. Light wind. Chance of precipitation 40 percent. Rainfall amounts less than a tenth of an inch. .WEDNESDAY...Partly cloudy. Scattered showers and isolated thunderstorms in the morning. Cooler. Snow level above 8000 feet in the morning. Light wind becoming southwest 5 to 10 mph in the afternoon. Chance of precipitation 40 percent. Rainfall amounts less than a tenth of an inch. .WEDNESDAY NIGHT...Mostly clear. Free air freezing level 13000 feet. West wind 5 to 10 mph becoming light after midnight. .THURSDAY...Mostly sunny. Warmer. Free air freezing level 13000 feet. Light wind becoming west 5 to 10 mph in the afternoon. .THURSDAY NIGHT...Clear. Free air freezing level 14000 feet. .FRIDAY...Mostly sunny. Free air freezing level 14000 feet lowering to 13000 feet in the afternoon. .FRIDAY NIGHT...Mostly clear. Free air freezing level 14000 feet. .SATURDAY...Mostly sunny. Free air freezing level 13000 feet. .SATURDAY NIGHT...Mostly clear. Free air freezing level 13000 feet. .SUNDAY...Partly cloudy in the morning, then mostly sunny. Free air freezing level 13000 feet. .SUNDAY NIGHT...Mostly clear. Free air freezing level 14000 feet rising to 15000 feet after midnight. .MONDAY...Mostly sunny. Free air freezing level 14000 feet. $$ weather.gov/portland _____ Copyright 2022 AccuWeather
https://www.stamfordadvocate.com/weather/article/WA-Portland-OR-Zone-Forecast-17361078.php
2022-08-09T11:52:32Z
https://www.stamfordadvocate.com/weather/article/WA-Portland-OR-Zone-Forecast-17361078.php
true
11
Pensioners are staging a demonstration against 'outrageous' proposals to close railway station ticket offices. It has been reported that all 980 ticket offices in England, including those at Stoke and Stafford stations, could be closed or 'repurposed', with the closure programme set to start next month. Members of North Staffs Pensioners' Convention are holding a protest outside Stoke Station this afternoon (August 9) to express their opposition to the plans. They say that the move away from physical tickets to electronic versions will disadvantage three million older people who do not have access to the internet and cannot afford expensive smart phones – effectively denying them access to rail travel. The NSPC also says the proposals will also affect people with disabilities, including blind people, and foreign visitors, many of whom rely on ticket office staff to help them purchase the correct tickets. The RMT union has also hit out at the plans, saying ticket offices are 'a vital service', the closure of which will have a 'detrimental impact' on vulnerable passengers and staff safety. The Department for Transport had said that no final decision had been made, but that there has been a 'significant decline' in the use of ticket offices over the last decade. NEWSLETTER: Sign up for email alerts direct to your inbox Follow our live blog for updates from today's protest at Stoke Station.
https://www.stokesentinel.co.uk/news/stoke-on-trent-news/live-pensioners-protest-against-outrageous-7440488
2022-08-09T11:57:14Z
https://www.stokesentinel.co.uk/news/stoke-on-trent-news/live-pensioners-protest-against-outrageous-7440488
false
1
Ecolab Inc. with ticker code (ECL) now have 18 analysts in total covering the stock. The consensus rating is ‘Hold’. The range between the high target price and low target price is between 200 and 163 calculating the mean target price we have 179.89. Now with the previous closing price of 166.5 this now indicates there is a potential upside of 8.0%. The 50 day moving average now sits at 159.53 and the 200 moving average now moves to 187.69. The market capitalisation for the company is $47,050m. Company Website: https://www.ecolab.com The potential market cap would be $50,834m based on the market concensus. You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company’s Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
https://www.directorstalkinterviews.com/ecolab-inc.---consensus-indicates-potential-8.0-upside/4121076801
2022-08-09T12:00:37Z
https://www.directorstalkinterviews.com/ecolab-inc.---consensus-indicates-potential-8.0-upside/4121076801
true
2
- Revenues of $1.967 billion - Company to appeal anticipated court decision and vigorously defend XIFAXAN intellectual property - Balance sheet continues to improve with early retirement of $481 million of long-term debt through open market repurchases - Committed to strategic alternatives and will continue to evaluate the distribution of Bausch + Lomb shares as the Company works through patent litigation - Updates guidance LAVAL, QC, Aug. 9, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second-quarter 2022 financial results. "The second quarter was a transitional quarter for Bausch Health as we intensified our focus on the Bausch Pharma and Solta businesses," Thomas J. Appio, Chief Executive Officer, Bausch Health, said. "In our first ninety days, our leadership team has taken immediate action to strengthen execution and accelerate change. We have advanced debt paydown through open market repurchases this quarter. We are focused on creating value through driving growth, profitability and improving our balance sheet." Strategic Alternatives Update The Company believes that spinning off Bausch + Lomb makes strategic sense and it remains committed to doing so as soon as it is able to satisfy all applicable conditions as previously disclosed. The Company is evaluating all relevant factors and considerations regarding the distribution as it assesses the potential impacts of the Norwich XIFAXAN® patent litigation. Second-Quarter 2022 Revenue Performance Total reported revenues were $1.967 billion for the second quarter of 2022, as compared to $2.1 billion in the second quarter of 2021, a decrease of $133 million, or 6%. Excluding the unfavorable impact of foreign exchange of $61 million and the impact of divestitures and discontinuations of $74 million, primarily due to the divestiture of Amoun Pharmaceutical Company S.A.E. ("Amoun") on July 26, 2021, revenue was flat on an organic basis1,2 compared to the second quarter of 2021. Reported revenues by segment were as follows: Salix Segment Salix segment reported and organic1,2 revenues were $501 million for the second quarter of 2022, as compared to $516 million for the second quarter of 2021, a decrease of $15 million, or 3%. The decrease was primarily driven by a decline in sales of TRULANCE® and certain non-promoted products, partially offset by increased sales of XIFAXAN® and PLENVU®. International Segment3 International segment reported revenues were $233 million for the second quarter of 2022, as compared to $313 million for the second quarter of 2021, a decrease of $80 million, or 26%. Excluding the unfavorable impact of foreign exchange of $15 million and the impact of divestitures and discontinuations of $71 million, primarily from the divestiture of Amoun, segment revenues increased organically1,2 by 2% compared to the second quarter of 2021. 2022 includes a provision for expected future product returns of $11 million. Excluding the impact of this returns provision, segment revenues increased by 7% on an organic1,2 basis. Diversified Products Segment3 Diversified Products segment reported and organic1,2 revenues were $235 million for the second quarter of 2022, as compared to $264 million for the second quarter of 2021, a decrease of $29 million, or 11%, primarily attributable to a decrease in volumes attributable to the neurology business and lower net realized pricing. Revenues from Jublia® increased 13% as the brand continues to benefit from marketing investment. Solta Medical Segment3 Solta Medical segment reported and organic1,2 revenues were $57 million for the second quarter of 2022, as compared to $73 million in the second quarter of 2021, a decrease of $16 million, or 22%. Ongoing COVID-related lockdowns in China drove the decline. Bausch + Lomb Segment3 Bausch + Lomb segment reported revenues were $941 million for the second quarter of 2022, as compared to $934 million for the second quarter of 2021, an increase of $7 million, or 1%. Excluding the unfavorable impact of foreign exchange of $46 million and the impact of divestitures and discontinuations of $3 million, the Bausch + Lomb segment revenue increased organically1,2 by 6% compared to the second quarter of 2021, driven by sales growth in Vision Care and Surgical, offset by lower revenues from Ophthalmic Pharmaceuticals. Operating Income/Loss Operating income was $161 million for the second quarter of 2022, as compared to an operating loss of $270 million for the second quarter of 2021, a favorable change of $431 million, primarily driven by a decrease in Other expense, primarily attributable to higher adjustments related to the settlement of certain litigation matters in the second quarter of 2021 and lower amortization of intangible assets in 2022, partially offset by an impairment to goodwill in 2022. Net Loss Attributable to Bausch Health Net loss attributable to Bausch Health for the second quarter of 2022 was $145 million, as compared to $595 million for the second quarter of 2021, a favorable change of $450 million as a result of the change in operating results discussed above and a net gain on extinguishment of debt in 2022, partially offset by an increase in the provision for income taxes and higher interest expense. Adjusted net income attributable to Bausch Health (non-GAAP)1 for the second quarter of 2022 was $201 million, as compared to $352 million for the second quarter of 2021, a decrease of $151 million primarily due to the investment of Amoun, lower gross profit due to sales performance and inflation, higher operating expenses (investments in sales and marketing and research and development) and higher interest and income tax expense. Earnings Per Share Attributable to Bausch Health GAAP Earnings Per Share attributable to Bausch Health for the second quarter of 2022 was ($0.40), as compared to ($1.66) for the second quarter of 2021. Adjusted EBITDA attributable to Bausch Health (non-GAAP)1 Adjusted EBITDA attributable to Bausch Health (non-GAAP)1 was $701 million for the second quarter of 2022, as compared to $826 million for the second quarter of 2021, a decrease of $125 million, primarily due to the divestment of Amoun, lower gross profit as discussed above and higher investments in sales and marketing and research and development. Cash Provided by Operating Activities The Company generated cash provided by operating activities of $123 million in the second quarter of 2022, as compared to $395 million in the second quarter of 2021, a decrease of $272 million due to business results and changes in working capital. Balance Sheet Highlights as of June 30, 2022: - Cash, cash equivalents, restricted cash and other settlement deposits were $1.879 billion5. - The Company executed an open market repurchase program in the second quarter in which the Company purchased $481 million of unsecured bonds for $300 million of cash consideration. - Bausch Health had availability under its 2027 Revolving Credit Facility of approximately $500 million and Bausch + Lomb had availability of approximately $500 million under its Revolving Credit Facility. 2022 Financial Outlook Bausch Health updated its consolidated guidance for the full year 2022 as follows: - Full year revenue range of $8.05 - $8.22 billion compared to prior guidance of $8.25 - $8.40 billion - Full year Adjusted EBITDA (non-GAAP)1 range of $3.02 - $3.12 billion compared to prior guidance of $3.225 - $3.375 billion Other than with respect to GAAP Revenues, the Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking Adjusted EBITDA (non-GAAP)1 to GAAP net income (loss), due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because deductions (such as restructuring, gain or loss on extinguishment of debt and litigation and other matters) used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and, therefore, could result in projected GAAP net income (loss) being materially less than projected Adjusted EBITDA (non-GAAP)1. These statements represent forward-looking information and may represent a financial outlook, and actual results may vary. Please see the risks and assumptions referred to in the Forward-looking Statements section of this news release. The guidance in this news release is only effective as of the date given, August 9, 2022, and will not be updated or affirmed unless and until the Company publicly announces updated or affirmed guidance. Conference Call Details About Bausch Health Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our approximately 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn. Forward-looking Statements This news release contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, Bausch Health's future prospects and performance, including the Company's 2022 full-year guidance, the Company's spinoff of its eye health business from the remainder of Bausch Health and the timing thereof, and commitment to evaluating the distribution, details of the Company's product pipeline and expected regulatory filings, the Company's intention to appeal certain court decisions and orders with respect to XIFAXAN® patents and the anticipated impact of the COVID-19 pandemic on the Company and the Company's recovery therefrom. Forward-looking statements may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and positive and negative variations or similar expressions, and phrases or statements that certain actions, events or results may, could, should or will be achieved, received or taken, or will occur or result, and similar such expressions also identify forward-looking information. These forward-looking statements, including the Company's full-year guidance, are based upon the current expectations and beliefs of management and are provided for the purpose of providing additional information about such expectations and beliefs, and readers are cautioned that these statements may not be appropriate for other purposes. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in these forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company's most recent annual and quarterly reports and detailed from time to time in the Company's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties relating to the Company's proposed plan to separate its eye health business from the remainder of Bausch Health, including the expected benefits and costs of the spinoff transaction, the expected timing of completion of the spinoff transaction and its terms (including the Company's expectation that the spinoff transaction will be completed following the expiry of customary lock-ups related to the Bausch + Lomb IPO and achievement of targeted debt leverage ratios, subject to receipt of applicable shareholder, stock exchange, regulatory and other necessary approvals), the Company's ability to complete the spinoff transaction considering the various conditions to the completion of the spinoff transaction (some of which are outside the Company's control, including conditions related to regulatory matters and a possible shareholder vote, if applicable), that market or other conditions are no longer favorable to completing the transaction, that the previously announced planned IPO of the Company's medical aesthetic business, Solta Medical has been suspended, that any shareholder, stock exchange, regulatory or other approval (if required) is not obtained on the terms or timelines anticipated or at all, business disruption during the pendency of or following the spinoff transaction, diversion of management time on spinoff transaction-related issues, retention of existing management team members, the reaction of customers and other parties to the spinoff transaction, the qualification of the spinoff transaction as a tax-free transaction for Canadian and/or U.S. federal income tax purposes (including whether or not an advance ruling from the Canada Revenue Agency and/or U.S. Internal Revenue Service will be sought or obtained), the ability of the Company and the separated entity to satisfy the conditions required to maintain the tax-free status of the spinoff transaction (some of which are beyond their control), other potential tax or other liabilities that may arise as a result of the spinoff transaction, the potential dis-synergy costs resulting from the spinoff transaction, the impact of the spinoff transaction on relationships with customers, suppliers, employees and other business counterparties, general economic conditions, conditions in the markets Bausch Health is engaged in, behavior of customers, suppliers and competitors, technological developments and legal and regulatory rules affecting Bausch Health's business. In particular, the Company can offer no assurance that any spinoff transaction will occur at all, or that any spinoff or other separation transaction will occur on the terms and timelines anticipated by the Company. They also include risks and uncertainties related to our ability to enforce and defend against challenges to our intellectual property in connection with the filing by Norwich Pharmaceuticals Inc. ("Norwich") of its Abbreviated New Drug Application for Xifaxan® (rifaxamin) 550 mg tablets and the Company's related lawsuit filed against Norwich in connection therewith and the impact of such matter on, among other things, whether any proposed separation or spinoff transaction will occur at all, or that any such transaction will occur on the timelines anticipated by the Company. They also include the challenges the Company faces as a result of the closing of the Bausch + Lomb IPO, including the transitional services being provided by and to the Bausch + Lomb entity, any potential actual or perceived conflict of interest of some of our directors and officers because of their equity ownership in Bausch + Lomb and/or because they also serve as directors or officers of Bausch + Lomb and our ability to timely consolidate the financial results of the Bausch + Lomb business. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, the fear of that pandemic, the availability and effectiveness of vaccines for COVID-19, (including current or future variants and subvariants), COVID-19 vaccine immunization rates, the emergence of variant and subvariant strains of COVID-19 (including the Delta and Omicron variants), and the potential effects of that pandemic, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including, without limitation, assumptions regarding our 2022 full-year guidance with respect to expectations regarding base performance and management's belief regarding the impact of the COVID-19 pandemic and associated responses on such base performance and the operations and financial results of the Company generally, expected currency impact, the expected timing and impact of loss of exclusivity for certain of our products, expectations regarding the impact of a recall of certain Consumer products as a result of a quality issue at a third-party supplier, the impact of the Amoun divestiture, expectations regarding gross margin, adjusted selling, general & administrative expense (non-GAAP) and the Company's ability to continue to manage such expense in the manner anticipated and the anticipated timing and extent of the Company's research and development ("R&D") expense; and the assumption that the risks and uncertainties outlined above will not cause actual results or events to differ materially from those described in these forward-looking statements. Management has also made certain assumptions in assessing the anticipated impacts of the COVID-19 pandemic on the Company and its results of operations and financial conditions, including: that there will be no material restrictions on access to health care products and services resulting from a possible resurgence of the virus and variant and subvariant strains thereof on a global basis in 2022; there will be increased availability and use of effective vaccines; that the strict social restrictions in the first half of 2020 will not be materially re-enacted in the event of a material resurgence of the virus and variant and subvariant strains thereof; that there will be an ongoing, gradual global recovery as the macroeconomic and health care impacts of the COVID-19 pandemic diminish over time; that the largest impact to the Company's businesses were seen in the second quarter of 2020; that, to the extent not already achieved, our revenues will likely return to pre-pandemic levels during 2022, but that rates of recovery will vary by geography and business unit, with some regions and business units expected to lag in recovery possibly beyond 2022; and no major interruptions in the Company's supply chain and distribution channels. If any of these assumptions regarding the impacts of the COVID-19 pandemic are incorrect, our actual results could differ materially from those described in these forward-looking statements. Additional information regarding certain of these material factors and assumptions may also be found in the Company's filings described above. The Company believes that the material factors and assumptions reflected in these forward-looking statements are reasonable in the circumstances, but readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Non-GAAP Information To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses certain non-GAAP financial measures and non-GAAP ratios, including: (i) Adjusted EBITDA attributable to Bausch Health Companies Inc. (non-GAAP), (ii) organic growth/change, (iii) organic revenue and (iv) constant currency. As discussed below, we also provide Adjusted net income attributable to Bausch Health Companies Inc. (non-GAAP) to provide supplemental information to readers. Management uses these non-GAAP measures and ratios as key metrics in the evaluation of the Company's performance and the consolidated financial results and, in part, in the determination of cash bonuses for its executive officers. The Company believes these non-GAAP measures and ratios are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP measures and ratios address questions the Company routinely receives from analysts and investors, and in order to assure that all investors have access to similar data, the Company has determined that it is appropriate to make this data available to all investors. However, these measures and ratios are not prepared in accordance with GAAP nor do they have any standardized meaning under GAAP. In addition, other companies may use similarly titled non-GAAP financial measures and ratios that are calculated differently from the way we calculate such measures and ratios. Accordingly, our non-GAAP financial measures and ratios may not be comparable to such similarly titled non-GAAP financial measures and ratios used by other companies. We caution investors not to place undue reliance on such non-GAAP measures and ratios, but instead to consider them with the most directly comparable GAAP measures and ratios. Non-GAAP financial measures and ratios have limitations as analytical tools and should not be considered in isolation. They should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. The reconciliations of these historic non-GAAP financial measures and ratios to the most directly comparable financial measures and ratios calculated and presented in accordance with GAAP are shown in the tables below. However, as indicated above, for guidance purposes, the Company does not provide reconciliations of projected Adjusted EBITDA attributable to Bausch Health Companies Inc. (non-GAAP) to projected GAAP net income (loss), due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations. Specific Non-GAAP Measures Adjusted EBITDA (non-GAAP) and Adjusted EBITDA attributable to Bausch Health Companies Inc. (non-GAAP) Adjusted EBITDA (non-GAAP) is Net income (loss) (its most directly comparable GAAP financial measure) adjusted for interest expense, net, (Benefit from) provision for income taxes, depreciation and amortization and certain other items described below. Adjusted EBITDA attributable to Bausch Health Companies Inc. (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude the Adjusted EBITDA attributable to noncontrolling interest (non-GAAP) as defined below. Management believes that Adjusted EBITDA (non-GAAP) and Adjusted EBITDA attributable to Bausch Health Companies Inc. (non-GAAP), along with the GAAP measures used by management, most appropriately reflect how the Company measures the business internally and sets operational goals and incentives. In particular, the Company believes that these metrics focus management on the Company's underlying operational results and business performance. As a result, the Company uses these metrics to assess the actual financial performance of the Company and to forecast future results as part of its guidance. Management believes these metrics are a useful measure to evaluate current performance. These metrics are intended to show our unleveraged, pre-tax operating results and therefore reflects our financial performance based on operational factors. In addition, cash bonuses for the Company's executive officers and other key employees are based, in part, on the achievement of certain Adjusted EBITDA (non-GAAP) targets. Adjusted EBITDA (non-GAAP) is Net income (loss) (its most directly comparable GAAP financial measure) adjusted for interest expense, net, (Benefit from) provision for income taxes, depreciation and amortization and the following items: - Asset impairments, including loss on assets held for sale: The Company has excluded the impact of impairments of finite-lived and indefinite-lived intangible assets, as well as impairments of assets held for sale, as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions and divestitures. The Company believes that the adjustments of these items correlate with the sustainability of the Company's operating performance. Although the Company excludes impairments of intangible assets and assets held for sale from measuring the performance of the Company and the business, the Company believes that it is important for investors to understand that intangible assets contribute to revenue generation. - Goodwill impairments: The Company excludes the impact of goodwill impairments. When the Company has made acquisitions where the consideration paid was in excess of the fair value of the net assets acquired, the remaining purchase price is recorded as goodwill. For assets that we developed ourselves, no goodwill is recorded. Goodwill is not amortized but is tested for impairment. The amount of goodwill impairment is measured as the excess of a reporting unit's carrying value over its fair value. Management excludes these charges in measuring the performance of the Company and the business. - Restructuring and integration costs: The Company has incurred restructuring costs as it implemented certain strategies, which involved, among other things, improvements to its infrastructure and operations, internal reorganizations and impacts from the divestiture of assets and businesses. With regard to infrastructure and operational improvements which the Company has taken to improve efficiencies in the businesses and facilities, these tend to be costs intended to right size the business or organization that fluctuate significantly between periods in amount, size and timing, depending on the improvement project, reorganization or transaction. The Company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the Company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. - Acquisition-related costs and adjustments excluding amortization of intangible assets: The Company has excluded the impact of acquisition-related contingent consideration non-cash adjustments due to the inherent uncertainty and volatility associated with such amounts based on changes in assumptions with respect to fair value estimates, and the amount and frequency of such adjustments are not consistent and are significantly impacted by the timing and size of the Company's acquisitions, as well as the nature of the agreed-upon consideration. In addition, the Company excludes the impact of acquisition-related costs and fair value inventory step-up resulting from acquisitions as the amounts and frequency of such costs and adjustments are not consistent and are impacted by the timing and size of its acquisitions. There were no acquisition-related costs or fair value inventory step-up for the periods presented. - Loss on extinguishment of debt: The Company has excluded loss on extinguishment of debt as this represents a cost of refinancing our existing debt and is not a reflection of our operations for the period. Further, the amount and frequency of such charges are not consistent and are significantly impacted by the timing and size of debt financing transactions and other factors in the debt market out of management's control. - Share-based compensation: The Company has excluded costs relating to share-based compensation. The Company believes that the exclusion of share-based compensation expense assists investors in the comparisons of operating results to peer companies. Share-based compensation expense can vary significantly based on the timing, size and nature of awards granted. - Separation and IPO costs and separation-related and IPO-related costs: The Company has excluded certain costs incurred in connection with activities taken to: (i) separate the eye-health and the Solta aesthetic medical device businesses from the remainder of the Company and (ii) register the eye-health and the Solta aesthetic medical device businesses as independent publicly traded entities. Separation and IPO costs are incremental costs directly related to effectuating the separation of the eye-health business and the initial public offering ("IPO") of the Solta aesthetic medical device business (the "Solta IPO"), which has now been suspended, and include, but are not limited to, legal, audit and advisory fees, talent acquisition costs and costs associated with establishing a new board of directors and related board committees. Separation-related and IPO-related costs are incremental costs indirectly related to the separation of the eye-health business and the Solta IPO and include, but are not limited to, IT infrastructure and software licensing costs, rebranding costs and costs associated with facility relocation and/or modification. As these costs arise from events outside of the ordinary course of continuing operations, the Company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the Company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. - Other Non-GAAP adjustments: The Company has excluded certain other amounts, including legal and other professional fees incurred in connection with legal and governmental proceedings, investigations and information requests regarding certain of our legacy distribution, marketing, pricing, disclosure and accounting practices, litigation and other matters, and net gain on sale of assets. Given the unique nature of the matters relating to these costs, the Company believes these items are not normal operating expenses. For example, legal settlements and judgments vary significantly, in their nature, size and frequency, and, due to this volatility, the Company believes the costs associated with legal settlements and judgments are not normal operating expenses. In addition, as opposed to more ordinary course matters, the Company considers that each of the recent proceedings, investigations and information requests, given their nature and frequency, are outside of the ordinary course and relate to unique circumstances. The Company has also excluded expenses associated with in-process research and development, as these amounts are inconsistent in amount and frequency and are significantly impacted by the timing, size and nature of acquisitions. Furthermore, as these amounts are associated with research and development acquired, the Company does not believe that they are a representation of the Company's research and development efforts during any given period. The Company has also excluded IT infrastructure investments that are the result of other, non-comparable events to measure operating performance. These events arise outside of the ordinary course of continuing operations. The Company has also excluded certain other costs, including settlement costs associated with the conversion of a portion of the Company's defined benefit plan in Ireland to a defined contribution plan. The Company excluded these costs as this event is outside of the ordinary course of continuing operations and is infrequent in nature. The Company believes that the exclusion of such out-of-the-ordinary-course amounts provides supplemental information to assist in the comparison of the financial results of the Company from period to period and, therefore, provides useful supplemental information to investors. However, investors should understand that many of these costs could recur and that companies in our industry often face litigation. Adjusted EBITDA attributable to Bausch Health Companies Inc. (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude the Adjusted EBITDA attributable to noncontrolling interest (non-GAAP). Adjusted EBITDA attributable to noncontrolling interest (non-GAAP) is Net income attributable to noncontrolling interest (its most directly comparable GAAP financial measure) adjusted for the portion of the adjustments described above attributable to noncontrolling interest. Adjusted Net Income (non-GAAP) and Adjusted Net Income attributable to Bausch Health Companies Inc. (non-GAAP) Adjusted net income (loss) (non-GAAP) (its most directly comparable GAAP financial measure), adjusted for restructuring and integration costs, acquired in-process research and development costs, loss on extinguishment of debt, asset impairments (including loss on assets held for sale), acquisition-related adjustments, excluding amortization, separation and IPO costs and separation-related and IPO-related costs and other non-GAAP charges as these adjustments are described above, and amortization of intangible assets as described below: - Amortization of intangible assets: The Company has excluded the impact of amortization of intangible assets, as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. The Company believes that the adjustments of these items correlate with the sustainability of the Company's operating performance. Although the Company excludes the amortization of intangible assets from its non-GAAP expenses, the Company believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets. Adjusted net income attributable to Bausch Health Companies Inc. (non-GAAP) is Adjusted net income (non-GAAP) further adjusted to exclude the Adjusted net income attributable to noncontrolling interest (non-GAAP). Adjusted net income attributable to noncontrolling interest (non-GAAP) is Net income attributable to noncontrolling interest (its most directly comparable GAAP financial measure) adjusted for the portion of the adjustments described above attributable to noncontrolling interest. Historically, management has used Adjusted net income (loss) (non-GAAP) (the most directly comparable GAAP financial measure for which is GAAP net income (loss)) for strategic decision making, forecasting future results and evaluating current performance. This non-GAAP measure excludes the impact of certain items (as described above) that may obscure trends in the Company's underlying performance. By disclosing this non-GAAP measure, it is management's intention to provide investors with a meaningful, supplemental comparison of the Company's operating results and trends for the periods presented. Management believes that this measure is also useful to investors as such measure allowed investors to evaluate the Company's performance using the same tools that management uses to evaluate past performance and prospects for future performance. Accordingly, the Company believes that Adjusted net income (non-GAAP) is useful to investors in their assessment of the Company's operating performance. It is also noted that, in recent periods, our GAAP net income (loss) was significantly lower than our Adjusted net income (non-GAAP). Commencing in 2017, management of the Company identified and began using certain new primary financial performance measures to assess the Company's financial performance. In addition, a subsequent to the Bausch + Lomb IPO, the Company presenting Adjusted net income (non-GAAP) attributable to Bausch Health Companies Inc. may be useful to investors in their assessment of the Company and its performance. Organic Revenue and Organic Revenue Change Organic revenue and organic revenue change are non-GAAP measures. Non-GAAP measures are not standardized measures under the financial reporting framework used to prepare the Company's financial statements and might not be comparable to similar financial measures disclosed by other issuers. Organic revenue and change in organic revenue (non-GAAP), are defined as GAAP Revenue and changes in GAAP revenue (the most directly comparable GAAP financial measures), adjusted for changes in foreign currency exchange rates (if applicable) and excluding the impact of recent acquisitions, divestitures and discontinuations, as defined further below. Organic revenue (non-GAAP) is impacted by changes in product volumes and price. The price component is made up of two key drivers: (i) changes in product gross selling price and (ii) changes in sales deductions. The Company uses organic revenue (non-GAAP) and organic revenue changes (non-GAAP) to assess performance of its reportable segments, and the Company in total, The Company believes that providing these measures is useful to investors as they provide a supplemental period-to-period comparison. The adjustments to GAAP Revenue and changes in GAAP revenue to determine Organic Revenue (non-GAAP) and changes in Organic Revenue (non-GAAP) are as follows: - Foreign currency exchange rates: Although changes in foreign currency exchange rates are part of our business, they are not within management's control. Changes in foreign currency exchange rates, however, can mask positive or negative trends in the business. The impact of changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. - Acquisitions, divestitures and discontinuations: In order to present period-over-period organic revenue (non-GAAP) growth/change on a comparable basis, revenues associated with acquisitions, divestitures and discontinuations are adjusted to include only revenues from those businesses and assets owned during both periods. Accordingly, organic revenue and organic growth/change exclude from the current period, revenues attributable to each acquisition for twelve months subsequent to the day of acquisition, as there are no revenues from those businesses and assets included in the comparable prior period. Organic revenue and organic growth/change exclude from the prior period, all revenues attributable to each divestiture and discontinuance during the twelve months prior to the day of divestiture or discontinuance, as there are no revenues from those businesses and assets included in the comparable current period. Constant Currency Changes in the relative values of non-U.S. currencies to the U.S. dollar may affect the Company's financial results and financial position. To assist investors in evaluating the Company's performance, we have adjusted for foreign currency effects. Constant currency impact is determined by comparing 2022 reported amounts adjusted to exclude currency impact, calculated using 2021 monthly average exchange rates, to the actual 2021 reported amounts. Please also see the reconciliation tables below for further information as to how these non-GAAP measures and ratios are calculated for the periods presented. FINANCIAL TABLES FOLLOW View original content to download multimedia: SOURCE Bausch Health Companies Inc.
https://www.kcbd.com/prnewswire/2022/08/09/bausch-health-announces-second-quarter-2022-results/
2022-08-09T12:05:09Z
https://www.kcbd.com/prnewswire/2022/08/09/bausch-health-announces-second-quarter-2022-results/
true
29
VANCOUVER, British Columbia (AP) _ Endeavour Silver Corp. (EXK) on Tuesday reported a second-quarter loss of $11.9 million, after reporting a profit in the same period a year earlier. The Vancouver, British Columbia-based company said it had a loss of 7 cents per share. Losses, adjusted for non-recurring costs, were 2 cents per share. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share. The silver mining company posted revenue of $30.8 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $36 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXK at https://www.zacks.com/ap/EXK
https://www.middletownpress.com/business/article/Endeavour-Silver-Q2-Earnings-Snapshot-17361125.php
2022-08-09T12:05:13Z
https://www.middletownpress.com/business/article/Endeavour-Silver-Q2-Earnings-Snapshot-17361125.php
true
null
Reported positive eplontersen ATTRv-PN data, on track to file NDA in H2:22 Tofersen NDA under priority review, PDUFA January 25, 2023 Completed enrollment in pelacarsen Lp(a) HORIZON and olezarsen BALANCE Phase 3 studies On track to achieve 2022 financial guidance Webcast today, August 9, 2022, at 11:30 a.m. Eastern Time CARLSBAD, Calif., Aug. 9, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the second quarter of 2022 and recent business achievements. "Over the first half of this year, we moved significantly closer to delivering an abundance of new medicines to the market. We reported positive Phase 3 data from the NEURO-TTRansform study of eplontersen in patients with hereditary ATTR polyneuropathy and we are on track to file an NDA in the second half of this year. We were also pleased that the FDA accepted the NDA for tofersen and granted priority review, enabling tofersen to potentially be the first disease modifying treatment approved for a genetic form of ALS. These achievements mean eplontersen and tofersen could be our next marketed products as early as next year," said Brett P. Monia, Ph.D., chief executive officer of Ionis. "We also significantly advanced our late- and mid-stage pipeline. The pelacarsen Lp(a) HORIZON and olezarsen BALANCE Phase 3 studies recently completed enrollment. Additionally, we reported positive data from six mid-stage programs, positioning us to grow our rich Phase 3 pipeline to at least eight medicines across 10 indications. We are looking forward to continuing our positive momentum in the second half of this year by presenting Phase 3 eplontersen data at the International Symposium on Amyloidosis in September, filing our eplontersen NDA, and reporting data from several important programs. These upcoming catalysts, together with our recent achievements, position us well to drive increasing value for all stakeholders." Second Quarter 2022 Summary Financial Results On track to achieve 2022 financial guidance, based on the following second quarter results: - $134 million in total revenues - $195 million of operating expenses on a non-GAAP basis(1) and $220 million on a GAAP basis - $80 million net loss on a non-GAAP basis(1) and $105 million on a GAAP basis - $2.0 billion of cash and short-term investments "We had a strong first half with year-over-year revenue growth of more than 15 percent. We continued to generate revenue from multiple diverse sources, with just over half from our marketed products and the balance from our numerous advancing partnered medicines. Additionally, our financial results reflect our accelerating investments in our rich late-stage pipeline and in our commercial readiness activities for eplontersen, olezarsen and donidalorsen," said Elizabeth L. Hougen, chief financial officer of Ionis. "With $2 billion of cash and investments, we have the financial resources to achieve our goal of bringing transformational medicines to the market. These results for the first half of the year keep us on track to meet our 2022 financial guidance." Recent Marketed Products Highlights SPINRAZA®: the global market leader for the treatment of spinal muscular atrophy (SMA) patients of all ages - $431 million in worldwide SPINRAZA sales in the second quarter - Biogen reported new results from the RESPOND study of SPINRAZA, stating the results indicate there are residual unmet clinical needs in infants and toddlers with SMA who were previously treated with gene therapy - Biogen reported final data from Part A of the ongoing, three-part DEVOTE study demonstrating that a higher dosing regimen of SPINRAZA leads to higher levels of the drug in the cerebrospinal fluid and is generally well-tolerated TEGSEDI® and WAYLIVRA®: important medicines approved for the treatment of patients with polyneuropathy caused by hereditary TTR amyloidosis (ATTRv-PN) and familial chylomicronemia syndrome (FCS), respectively - Continued to expand into new markets in Europe and Latin America through Swedish Orphan Biovitrum AB (Sobi) and PTC Therapeutics, respectively Second Quarter 2022 and Recent Events Advancing Ionis' next two potential marketed products - Reported eplontersen met the co-primary and key secondary endpoints in the interim analysis of the Phase 3 NEURO-TTRansform study in patients with ATTRv-PN; on track to file the New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) in the second half of this year - Biogen reported longer-term data from the Phase 3 VALOR study and ongoing open-label extension study of tofersen showing clinical benefit in patients with SOD1-ALS at the European Network to Cure ALS (ENCALS) meeting - Biogen reported that an NDA for tofersen was accepted and granted priority review by the FDA with a Prescription Drug User Fee Act (PDUFA) action date of January 25, 2023 Advancing Ionis' late-stage pipeline - Novartis achieved full enrollment in the Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen in patients with established cardiovascular disease and elevated Lp(a) with data expected in 2025 - Achieved full enrollment in the Phase 3 BALANCE study of olezarsen in patients with FCS with data expected in 2023 Advancing Ionis' mid-stage pipeline - GSK presented positive data from the Phase 2b B-Clear study of bepirovirsen in patients with chronic hepatitis B at the European Association for the Study of the Liver's (EASL) International Liver Congress™. Based on these results, GSK plans to advance bepirovirsen into a Phase 3 monotherapy study in the first half of 2023 - Roche reported positive data from the Phase 2 study of IONIS-FB-LRx in patients with immunoglobulin A nephropathy (IgAN). Based on these results, Roche licensed and plans to advance IONIS-FB-LRx into a Phase 3 study - Bayer reported fesomersen met the primary endpoint in the Phase 2b RE-THINc ESRD study in patients with end-stage renal disease. Fesomersen also demonstrated substantial and statistically significant reductions in Factor XI activity levels - Achieved full enrollment in the Phase 2b study of IONIS-AGT-LRx in patients with treatment-resistant hypertension, with data expected in the second half of 2022 - Initiated a Phase 2 study of ION904, a follow-on medicine to IONIS-AGT-LRx in patients with treatment-resistant hypertension - Granted orphan drug designation and rare pediatric disease designation by the FDA for ION582 for the treatment of patients with Angelman syndrome 2022 Pipeline Milestones(2) Second Quarter 2022 Financial Results Revenue Ionis' revenue was comprised of the following (amounts in millions): The Company's revenue in the first half of 2022 increased more than 15 percent compared to the same period last year. The increase was driven by significant partner payments Ionis earned across multiple partnered programs, including $37 million from AstraZeneca for its share of the global Phase 3 development costs for eplontersen. Refer to the detailed table of costs and reimbursements for the eplontersen collaboration provided later in this release. The Company also earned $57 million from Biogen for advancing several neurology disease programs and $22 million from Roche for advancing IONIS-FB-LRx. Already in the third quarter of 2022, the Company has earned nearly $45 million from Roche and Biogen. The Company's commercial revenue in the first half of 2022 decreased 12 percent compared to the same period last year. SPINRAZA royalties decreased primarily due to competition outside of the U.S. In the U.S., SPINRAZA sales stabilized in the first half of 2022 compared to the same period last year, increasing two percent. TEGSEDI and WAYLIVRA revenue decreased due to the shift from product sales to distribution fees based on net sales generated by Sobi. The Company successfully completed the transition of its TEGSEDI and WAYLIVRA operations in the EU and North America to Sobi in the first and second quarters of 2021, respectively. As part of the transition, Ionis restructured its commercial operations in 2021 resulting in substantial cost savings. These decreases were partially offset by increasing licensing and royalty revenue. Operating Expenses Ionis is advancing a large late-stage pipeline and as a result, its non-GAAP operating expenses increased in the first half of 2022 compared to the same period in 2021. Higher R&D expenses were driven by the expanded number of Phase 3 studies the Company is conducting, which doubled from three to six studies in 2021. Lower SG&A expenses were largely due to the substantial savings Ionis achieved from integrating Akcea and restructuring its commercial operations in 2021. Ionis is redeploying these savings to advance its pipeline and go-to-market activities for eplontersen, donidalorsen and olezarsen. Net Loss Ionis' non-GAAP net loss in the first half of 2022 increased compared to the same period in 2021, primarily related to higher R&D expenses, partially offset by higher revenue and lower SG&A expenses, as discussed above. Balance Sheet As of June 30, 2022, Ionis had cash, cash equivalents and short-term investments of $2.0 billion, compared with $2.1 billion at December 31, 2021. Ionis' debt obligations and working capital did not change significantly from December 31, 2021 to June 30, 2022. Webcast Ionis will conduct a webcast today at 11:30 a.m. Eastern time to discuss this announcement and related activities. Interested parties may access the webcast here. A webcast replay will be available for a limited time at the same address. About Ionis Pharmaceuticals, Inc. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing the standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company. To learn more about Ionis visit www.ionispharma.com or follow us on Twitter @ionispharma. Ionis' Forward-looking Statement This press release includes forward-looking statements regarding Ionis' business, financial guidance and the therapeutic and commercial potential of SPINRAZA (nusinersen), TEGSEDI (inotersen), WAYLIVRA (volanesorsen), eplontersen, olezarsen, donidalorsen, ION363, pelacarsen, tofersen, Ionis' technologies and Ionis' other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, including those related to the impact COVID-19 could have on our business, and including those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended December 31, 2021, and most recent Form 10-Q, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company. In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our" and "us" all refer to Ionis Pharmaceuticals and its subsidiaries. Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc. Akcea Therapeutics® is a registered trademark of Akcea Therapeutics, Inc. TEGSEDI® is a registered trademark of Akcea Therapeutics, Inc. WAYLIVRA® is a registered trademark of Akcea Therapeutics, Inc. SPINRAZA® is a registered trademark of Biogen. Reconciliation of GAAP to Non-GAAP Basis As illustrated in the Selected Financial Information in this press release, non-GAAP operating expenses, non-GAAP loss from operations, and non-GAAP net loss were adjusted from GAAP to exclude compensation expense related to equity awards and costs related to the Akcea merger and restructured commercial operations and the related tax effects. Compensation expense related to equity awards are non-cash. Costs related to the Akcea merger and restructured commercial operations included: severance costs, retention costs and other costs related to commercial operations. Ionis has regularly reported non-GAAP measures for operating results as non-GAAP results. These measures are provided as supplementary information and are not a substitute for financial measures calculated in accordance with GAAP. Ionis reports these non-GAAP results to better enable financial statement users to assess and compare its historical performance and project its future operating results and cash flows. Further, the presentation of Ionis' non-GAAP results is consistent with how Ionis' management internally evaluates the performance of its operations. Ionis' financial results for the first half of 2022 reflected the cost-sharing provisions related to its collaboration with AstraZeneca to develop and commercialize eplontersen for the treatment of ATTR. Under the terms of the collaboration agreement, AstraZeneca is paying 55 percent of the costs associated with the ongoing global Phase 3 development program. Because Ionis is leading and conducting the Phase 3 development program, Ionis is recognizing the 55 percent of cost-share funding AstraZeneca is responsible for, net of Ionis' share of AstraZeneca's development expenses, as R&D revenue in the same period Ionis incurs the related development expenses. In the first half of 2022, Ionis earned $37 million in joint development revenue under this collaboration. Because AstraZeneca is responsible for the majority of the medical affairs and commercial costs in the U.S. and all costs associated with bringing eplontersen to market outside the U.S., Ionis is recognizing cost-share funding it receives from AstraZeneca related to these activities as a reduction of its medical affairs (R&D expenses) and commercialization expenses (SG&A expenses). In the first half of 2022, Ionis recognized $0.8 million and $0.7 million of medical affairs expenses and commercialization expenses for eplontersen, respectively, net of cost-share funding from AstraZeneca. Ionis expects its medical affairs and commercialization expenses to increase as this collaboration progresses. View original content to download multimedia: SOURCE Ionis Pharmaceuticals, Inc.
https://www.wjhg.com/prnewswire/2022/08/09/ionis-reports-second-quarter-financial-results-recent-business-achievements/
2022-08-09T12:05:59Z
https://www.wjhg.com/prnewswire/2022/08/09/ionis-reports-second-quarter-financial-results-recent-business-achievements/
true
13
Witness: Teen going 100 mph in Leesburg crashed Jaguar into SUV, Northgate Animal Clinic LEESBURG — A Jaguar estimated to be traveling more than 100 mph slammed into a Cadillac Escalade at the intersection of Martin Luther King Drive and U.S. Highway 441/27 Monday evening, causing an explosion of car parts and the speeding car to flip onto the side of a building several feet away. It also broke a wooden power pole. The young man in the car was pulled from the wreckage and airlifted to Ocala Regional Medical Center, according to authorities on the scene. Ken Hutcheson, whose business, Champion rentals, sits on the busy corner leading to Wal-Mart, described the driver as an 18-year-old Spanish-speaking youth, who was bleeding profusely and kept repeating, “my papa’s car.” “I pulled him out of the car,” Hutcheson said. FHP:Lady Lake pedestrian killed in early Monday crash A pending death investigation:Leesburg PD investigating shooting death of 37-year-old woman, seeking tips from public In the news this week:Lake County School District improving crisis response system for new school year The crash, which happened around 6:25 p.m. Monday, was caught on Hutcheson's store’s surveillance camera. It shows the late-model SUV turning left to head north on U.S. 441/27 when it is suddenly struck by the southbound silver car. Then, there is an explosion, a massive smoke-filled cloud and car parts flying everywhere. “I could hear the Jaguar accelerating before the crash,” he said. One wheel landed in from of Hutcheson’s store, another was embedded in the side of Northlake Animal Clinic where the car finally came to rest leaning up against the front of the building. A spring from the front-end, along with other parts, ended up in the Wells Fargo bank parking lot, probably about 50 yards away. Hutcheson said he didn't smell any alcohol on the driver, but he was not wearing a seatbelt. He said the man and woman in the Cadillac did not appear to be hurt, but that he told them they needed to go to hospital to be evaluated. The collision deployed the air bags in their car. Leesburg Fire, Lake EMS, Leesburg Police, the Lake County Sheriff’s Office and the Florida Highway Patrol responded to the call. Authorities shut down one southbound lane following the crash. It was still closed around 9 p.m. A Florida Highway Patrol officer, who viewed the surveillance video, declined to comment on the accident, saying he was not authorized to speak to the press. Further details from authorities were not available Monday night. Hutcheson said there has been 67 crashes at the intersection since he has been in business at that corner, “four very violent.” He blames a blinking yellow turn light for causing some of the problems. “They see that, and they think they should go,” Hutcheson said.
https://www.dailycommercial.com/story/news/accident/2022/08/08/teen-airlifted-after-crashing-into-suv-northlake-animal-hospital-leesburg/10272481002/
2022-08-09T12:07:06Z
https://www.dailycommercial.com/story/news/accident/2022/08/08/teen-airlifted-after-crashing-into-suv-northlake-animal-hospital-leesburg/10272481002/
true
1
ATLANTA, Aug. 9, 2022 /PRNewswire/ -- On August 1, 2022, Cloud 9 Software, the leading provider of cloud-based practice management systems for orthodontists, pediatric dentists, and dental/orthodontic service organizations, acquired ToothFairy LP, a revolutionary Customer Experience Management (CXM) software designed for the orthodontic industry. ToothFairy helps orthodontists optimize their sales pipeline and maximize returns by leveraging the personal insights of potential patients and best practices from other industries. ToothFairy is the culmination of years of research and applying High-Reliability Organizational principles to orthodontic practice management. ToothFairy solves the five biggest problems facing orthodontists today: (1) losing patients to competition, (2) hiring and retaining talent, (3) winning new patients, (4) patient recalls falling through the cracks, and (5) leading and motivating teams. Trude Henderson, founder of ToothFairy, has also joined Cloud 9 in the role of Director, Practice Growth Strategy. Says Henderson, "We are thrilled to complete our partnership with Cloud 9, a company that shares our commitment to providing customers with the modern solutions they need to help improve their competitive advantage, accelerate sales velocity, and better serve patients, thus enabling them to retain existing customers for generations to come and win new ones—sooner." Mike Ressel, CEO of Cloud 9 Software, expressed his enthusiasm for the acquisition. "The acquisition of ToothFairy represents Cloud 9's on-going commitment to being the strategic platform of choice for practice growth and optimization. Enabling more starts and retaining talented staff have never been more critical to our customers' success. We are delighted to extend ToothFairy's game-changing capabilities to our valued customers." Cloud 9 customers will be able to add the new service to take advantage of the revolutionary CXM tools that enable practices to shorten the learning curve for new treatment coordinators, increase sales velocity, remove pipeline roadblocks, and prevent lost sale opportunities. The proprietary algorithm zeroes in on consumer buying motivations, differentiates "hot vs. cold" leads, and helps staff overcome objections with real-time coaching, scripting, and call to action buttons. Current users of ToothFairy have called the Recall Fall Protection™ system "the most robust and easy-to-use in the industry." Cloud 9 Software is a browser-based practice management platform for orthodontics, pediatric dentistry, Orthodontic Service Organizations, and Dental Service Organizations. Headquartered in Roswell, Georgia, Cloud 9 currently serves more than 2,000 locations with millions of patients combined. Discover more at www.cloud9.software. View original content to download multimedia: SOURCE Cloud 9 Software
https://www.wmbfnews.com/prnewswire/2022/08/09/cloud-9-software-acquires-game-changing-customer-experience-management-software-company/
2022-08-09T12:07:09Z
https://www.wmbfnews.com/prnewswire/2022/08/09/cloud-9-software-acquires-game-changing-customer-experience-management-software-company/
true
11
Amid rising inflation, interest rates and recession worries, money is getting tighter for many folks — and probably for you. Yet there may be charitable organizations you want to support, friends or family asking for financial help and things you want to buy for yourself. It’s possible to do these things even on a limited budget. But if you want to be responsible with your money, you have to know where to draw the line. When is it OK to put your own interests first? Use these criteria as guidance. WHEN YOUR FINANCES ARE AT RISK Think carefully before spending any amount of money on somebody else, whether that’s $20 or $2,000. Will it jeopardize your ability to pay bills or save for emergencies? Picking up the lunch tab for a friend or helping put your kid through college shouldn’t come at the cost of your own expenses and goals. A crucial part of this assessment: Assume you’ll never get the money back. There’s no guarantee your loved ones will repay you, no matter how well-intentioned they may be. “If you can’t afford to give it as a gift with no expectations on your end, then you can’t afford to help,” says Lacy Rogers, a certified financial planner in Fort Worth, Texas. Saving toward a “giving budget” in a designated account can create a clear separation for your spending, says Valerie Rivera, a Chicago-based CFP. If you don’t have enough funds in the account, that signals that you can’t spare the money. YOU FEEL PRESSURED TO PAY You’re not required to hand out money even if you have the means to be generous. You have the right to say no when you feel stressed or uncomfortable. Don’t let others talk you into something you’ll regret. Saying no can be challenging, especially when dealing with family or a close-knit community. Senses of guilt and obligation often cloud judgment. Your mother raised you, so the least you can do is pay her credit card debt, right? Not if it enables her to repeatedly overspend and turn to you for money. A lot of people who are the first in their families to come to this country or go to college “can really quickly become other people’s financial safety nets,” Rivera says. That’s a heavy burden to bear. Having conversations about finances with loved ones early and often helps set expectations. “It’s totally OK to reestablish or establish for the first time what money looks like in discussion with friends, in discussion with family,” says Kate Mielitz, an accredited financial counselor, or AFC, in Tumwater, Washington. Take time to process each money request that comes your way. Consider passing if you’re concerned with getting taken advantage of or supporting harmful financial behavior. YOU CAN HELP IN OTHER WAYS Supporting the people you care about doesn’t always have to cost money. Your time, skills and knowledge are valuable too. Say you have an elderly neighbor you used to purchase groceries for. “Maybe you can’t buy their groceries for them anymore but you can help them out with the yardwork, and maybe that eases the burden on them in a different way,” Rogers says. If you’re unable to pitch in personally, point your loved ones in the direction of those who can. “Familiarize yourself or help your friends and family familiarize themselves with resources in the area — if that’s a food bank, if that is secondhand clothing, if that is job services or resume help that’s in the community — to help them move forward and get a stronger foot up,” Mielitz says. Visiting 211.org is one way to find assistance with basic necessities like paying utility bills or accessing food. For people who want help managing their money, Mielitz recommends setting up a free virtual appointment with an AFC through the Association for Financial Counseling & Planning Education. YOU’VE SET ASIDE MONEY TO TREAT YOURSELF Taking care of your needs and goals (and giving to others) is important. But everyone deserves a little fun, too. “We’re human and we need balance. We can’t only save for later and not enjoy life today,” Rivera says. If you have discretionary money, don’t spend it all on others. Leave room for self-care, entertainment or whatever brings you joy. “A lot of times, we use money to find ways to enhance our mood. Whether that is dining out or going out for a drink with a friend or buying a book,” Mielitz says. “But you’ve got to put together a spending plan and know what you have access to, because there are times when we don’t have the money and we spend it anyway.” Regularly setting aside funds or shuffling expenses around can give you the flexibility to splurge on yourself without hurting your finances. If you can’t find extra money, make use of resources such as the free session with an AFC. An expert can help guide your dollars in the right direction. “Life in general is a series of trade-offs,” Rivera says. “So it’s picking and choosing, what really is going to add value to your life?” _________________________________________ This column was provided to The Associated Press by the personal finance website NerdWallet. Lauren Schwahn is a writer at NerdWallet. Email: lschwahn@nerdwallet.com. Twitter: @lauren_schwahn. RELATED LINKS: NerdWallet: Budgeting 101: How to budget money 211: Essential community resources Association for Financial Counseling & Planning Education: Find an accredited financial counselor
https://www.greenwichtime.com/news/article/Millennial-Money-When-is-it-OK-to-be-selfish-17361093.php
2022-08-09T12:07:22Z
https://www.greenwichtime.com/news/article/Millennial-Money-When-is-it-OK-to-be-selfish-17361093.php
true
17
Tom Daley’s new documentary about gay rights in the Commonwealth airs on BBC 1 tonight. Illegal to Be Me details how being gay is still criminalised in 35 of the 56 countries competing in the 2022 games - and seven even have the death penalty. The Olympic gold medallist diver will speak about his own experiences after coming out in 2013, as well as talking to athletes who feel forced to keep their sexuality a secret. The now 28-year-old announced his “whole world changed” when he met and fell in love with a man. That man was American screenwriter and director Dustin Lance Black, who at 48 is 20 years his senior. Fast forward nearly 10 years and the couple are now married and have a four-year-old son called Robbie. Here we look back on their relationship so far, from how they met to plans to have more children together.... Love at first sight Tom met Dustin at a party in 2013 and described their meeting as “love at first sight”. The Olympian admitted it was him who made the first move - despite being “terrified” as he had only just come to terms with his sexuality. At the time he had “no idea” who Dustin was, but felt the chemistry between them immediately. When Dustin – who won an Oscar for the film Milk starring Sean Penn - said he had to go home and write a script, Tom typed his number in his phone along with a wink emoji face. The pair began dating after Dustin texted him the next day. Speaking about their whirlwind romance, Tom told The Guardian : “It was a real love at first sight thing. “The first night I took him to meet my friends [eight weeks after meeting] and said: ‘This is my boyfriend’. The next night we went on our first date. The next night, after a couple of lychee martinis, he told me he loved me. “He extended his trip. We were already talking about babies and weddings – that was in the first week.” He said yes! On October 2, 2015 after dating for two years, Tom announced that he and Dustin were engaged. The couple revealed the happy news by registering it in The Times newspaper. The statement, in the Births, Marriages and Death section, read: "The engagement is announced between Tom, son of Robert and Debra Daley of Plymouth, and Lance, son of Jeff Bisch of Philadelphia and Anne Bisch of Lake Providence." Tom shared the post on social media, captioning it with the hashtags: #HeSaidYes #ISaidYes.” The age gap Although there is a 20-year age gap between Tom and Dustin, it’s never seemed to be an issue. Never mind the fact that Justin – who is nearly 50 – looks a lot younger than he is. Tom says he barely notices it, and said if anything it’s Dustin who acts younger than him most of the time. He confessed: “If anything, Lance [the name Dustin goes by] is very much the big kid in the house. I consider myself to be an old soul, hence I have nearly 200 houseplants – and I knit.” His family are also relaxed about the age difference, with Tom’s mum Debbie saying “age is just a number”. “Everyone gets on really well with him [Dustin] – even though he is American – but there we go,” she told The Telegraph. Cheating rumours Before they got married, Tom and Dustin secretly split in 2015 for seven months. During their temporary break – which was blamed on hectic work schedules – Tom indulged in a sexy snapchat with a Liverpool-based man. Although he never physically cheated and the couple were separated at the time, Dustin said the break made their relationship even stronger when they got back together. He said: “Tom and I talked about anything and everything that went on. That’s the secret to how we are so close and can survive tough times.” With their relationship firmly back on, Tom said nothing would ever happen now he’s with Dustin. “This will absolutely never happen again now that we’re getting married. The date is set and we’re raring and ready to go for that wedding now.” Their big day Tom and Dustin tied the knot on May 6, 2017 in a romantic ceremony at Bovey Castle in Devon. Two days after the wedding the couple took to social media – while on their honeymoon – to reveal they had walked down the aisle. Both wore Burberry suits for the occasion, with Dustin in navy and Tom in a maroon colour. Sharing a snap on Instagram, Tom wrote: “On 6th May 2017, I married the love of my life @dlanceblack. “We shared the day with 120 of our closest friends and family, from Texarkana to Plymouth! Thank you to everyone who made this weekend the most special weekend of our lives.” Baby news Tom and Dustin have always been open about the fact they wanted children. On Valentine’s Day 2018 they announced the happy news they were to become parents by sharing a photo of a baby scan. The couple had a baby via an American surrogate, who they still remain close with. Their son Robert Ray Black-Daley was born a few weeks later on June 27, 2018 and is now four years old. In an interview with The Times Tom revealed both he and Dustin had provided sperm to fertilise the donor eggs – but they did not wish to know who was the biological father to their son. Robert – or Robbie as he is known – was named in memory of Tom’s father, who passed away from a brain tumour in 2011. Paying tribute to his dad, Tom tweeted: “If I could be half the dad my Dad was to me then that would be my best achievement! I love you!" More kids in the future Tom previously told the Mirror he wants an “army of kids”, so more children are definitely on the cards in the future. He said: “I’ve always been a family person so I’ve always wanted kids, and I know Lance does too. “I don’t know how many – an army of kids, a whole diving team. We’re both lucky to have supportive families and we want to share that with our own children.” But as they are a same-sex couple he admitted it is “not quite as easy as a bottle of wine and a good time”. “A lot of thought has to go into it – but absolutely, I’d love more kids,” he added. *Tom Daley: Illegal to Be Me airs at 9pm tonight on BBC 1 or catch up on the BBC iPlayer Do you have a story to sell? Get in touch with us at webcelebs@trinitymirror.com or call us direct 0207 29 33033.
https://www.mirror.co.uk/3am/celebrity-news/tom-daley-dustin-lance-blacks-27694294
2022-08-09T12:09:47Z
https://www.mirror.co.uk/3am/celebrity-news/tom-daley-dustin-lance-blacks-27694294
true
1
Snap plans to lay off employees Snap Inc is in early stages of planning layoffs, the Verge reported on Monday, citing people familiar with the plans. The scope of the job cuts is currently unclear as managers are still planning it for their teams, the report said, adding that the Snapchat-owner has more than 6,000 employees. Snap declined to comment when contacted by Reuters. The development comes as technology companies, crypto exchanges and financial firms cut jobs and slow hiring as global economic growth slows due to higher interest rates, red-hot inflation and an energy crisis in Europe. Facebook-owner Meta Platforms Inc cut plans to hire engineers by at least 30% this year, CEO Mark Zuckerberg had told employees in June, and he warned them to brace for a deep economic downturn. Snap CEO Evan Spiegel also told employees in a memo in May that the company will slow hiring for this year and laid out a broad slate of problems. Last month, the company painted a grim picture of the effects of a weakening economy on social media and declined to make a forecast in "incredibly challenging" conditions, sending its shares down 25%.
https://www.tbsnews.net/world/global-economy/snap-plans-lay-employees-474194
2022-08-09T12:11:06Z
https://www.tbsnews.net/world/global-economy/snap-plans-lay-employees-474194
true
15
23-time Grand Slam winner Serena Williams began her US Open swing with a straight-sets win against World No. 57 Nuria Parrizas-Diaz in the first round of the National Bank Open on Monday. With this victory, she has surpassed Chris Evert (34) to hold the record for most wins (35) at the Canadian Open in the Open Era. Arantxa Sanchez (32), Monica Seles (31) and Helena Sukova (28) complete the top five winners list at the Masters 1000 event. Williams, a three-time winner, has often referred to the Canadian Open as one of her favorite WTA tournaments. After winning her first singles match in more than a year, Williams will be eager to pick up more wins ahead of the US Open. "It's great to be back in Toronto, I didn't know if I would be able to play here again," Williams said during her on-court interview. "This being one of my favorite stops on tour, I was really happy to be here again. Thank you everyone.I love you." "I love playing though, it's amazing but I can't do this forever so sometimes you just want to try your best to enjoy the moments and do the best that you can," quoted Williams to ESPN. Serena Williams' return to professional tennis Serena Williams was absent from the WTA tour for more than a year after sustaining a hamstring injury at Wimbledon last year. She made her comeback at Eastbourne this year, playing in the doubles alongside Ons Jabeur. The duo reached the semifinals but had to pull out after Jabeur suffered a knee injury. Williams returned to Wimbledon for her first singles match, where she faced Harmony Tan of France in the first round. Despite giving it her best, she fell short against the Frenchwoman and made an early exit. She fared much better in her first-round match at the Canadian Open, hitting some deep forehands and crispy volleys to dominate over her opponent. With the year's final Major scheduled to begin on August 29, the 40-year-old will be eager to regain some form before heading to New York.
https://www.sportskeeda.com/tennis/news-former-world-no-1-serena-williams-now-female-player-register-35-win-canadian-open
2022-08-09T12:11:11Z
https://www.sportskeeda.com/tennis/news-former-world-no-1-serena-williams-now-female-player-register-35-win-canadian-open
true
1
RIO VISTA, Calif. – Charlie Hamilton hasn't irrigated his vineyards with water from the Sacramento River since early May, even though it flows just yards from his crop. Nearby to the south, the industrial Bay Area city of Antioch has supplied its people with water from the San Joaquin River for just 32 days this year, compared to roughly 128 days by this time in a wet year. They may be close by, but these two rivers, central arms of California's water system, have become too salty to use in some places as the state's punishing drought drags on. In dry winters like the one California just had, less fresh water flows down from the mountains into the Sacramento River, the state's largest. That allows saltier water from Pacific Ocean tides to push farther into the state's main water hub, known as the Delta. It helps supply water to two-thirds of the state's 39 million people and to farms that grow fruits and vegetables for the whole nation, playing a key but sometimes underappreciated role in the state's economy. A drought that scientists say is part of the U.S. West's driest period in 1,200 years plus sea level rise are exposing the fragility of that system, forcing state water managers, cities, and farmers to look for new ways to stabilize their supply of fresh water. The Delta's challenges offer a harbinger of the risks to come for critical water supplies elsewhere in the nation amid a changing climate. Planners and farmers are coming at the problem of saltwater intrusion with a desalination plant, an artificial rock barrier and groundwater pumps. Those who can't engineer their way out of the problem are left with a fervent hope that things will change. “We just try to hang on and hope the water quality gets better," said Bobby Costa, a farmer who has seen his cucumber yields go down by 25% this year compared to wetter years. The Delta is the largest estuary on the west coast of the Americas. It's home to endangered species such as chinook salmon and Delta smelt that require certain water flows, temperatures and salt mixes, as well as hundreds of square miles of farmland and millions of people who live, work and recreate in the region. Other estuaries such as the Chesapeake Bay and within the Everglades don't play as critical a role in directly supplying water for drinking and farming. But those estuaries are also at risk of creeping salt, causing problems for ecosystems, groundwater supplies and other needs. Giant pumping systems built more than a half a century ago send Delta water south to major urban centers like Los Angeles and huge farming operations. The farther east the salt moves, the more at risk that water system becomes. Brackish water that creeps into the system isn’t as salty as ocean water, but it's salty enough to render it undrinkable for some crops and for people. “The fallout of losing control of the Delta is very serious,” said Jacob McQuirk, principal engineer for the state’s Department of Water Resources. Last year, the state hauled 112,000 tons of rock and stacked it 30 feet (9 meters) deep in a key Delta river to stop salty water from getting too close to the pumps. It was the second time in the past decade the barrier was needed; the Department of Water Resources first installed it during the last drought in 2015. It was supposed to be only temporary, but plans to remove the barrier last fall were scrapped due to dry conditions, though a notch was cut to allow fish to swim through. Officials still hope to take it out this November. The state has asked the federal government for permission to build two more barriers further north if the drought worsens, arguing it will be necessary to protect water supplies. In the longer term, the state wants to construct a massive tunnel that would move water around the Delta entirely, which officials say would make it easier to capture more during times of heavy rain and guard against the risks of this salt water intrusion. But advocates for the region worry it's just another solution that will leave the farmers, fish and people who rely on Delta water high and dry. While the barrier protects the pumps, it does little to help some interests within the Delta who rely on fresh water before it heads south. Take Hamilton, who leases about 50 acres of vineyards to grow wine grapes along the Sacramento River. The land belongs to Al Medvitz, who farms alfalfa and other crops on more than five square miles of land. The water they draw from the river has always been tidally influenced, and they've learned how to pump from it when the tides are out and the salt content low. But since early May, Hamilton hasn't been able to pull out any water at all, even during low tides, because it's too salty for his grapes. If he continued to use it, first the edges of the leaves on the vine would begin to burn and crinkle, then fewer grapes would be able to grow on each bunch, eventually rendering the crop unusable. To avoid that, he taps groundwater from a well farther up the property and runs it through a ditch down to his drip irrigation lines, a process that takes longer. The owner's alfalfa, which is used to feed cows, can withstand higher salt levels, so for now it can still drink up the river water. The two men want approval from the state to build a small reservoir on the property to store fresh water for use in dry times. If they are forced to turn to salty water more and more, it will hurt the soil over time. Hamilton's goal, he said, is “to have a soil that my kids will be able to farm in." Others, like Costa, don't have as many options. He farms about four square miles (10 square kilometers) of land in the southern reach of the Delta. He gets water from several rivers in the Delta, delivered by an irrigation district through a ditch on his property. This year, the water’s higher salt content is evident, leaving white stains on the dirt in his fields and hurting his cucumber crop. He sells the cucumbers to a company that turns them into pickles for use at Subway and other stores. His yield is down about 25% this year, and more of the cucumbers he picks are crooked, making them harder to use for pickling. “If you don’t repulse salinity in the Delta, then the ocean slowly creeps in and at some point you get water that’s unusable and people are ruined,” said John Herrick, general counsel for the South Delta Water Agency, which is responsible for protecting the region's water supply. Meanwhile in Antioch, a city of 115,000 people, officials are investing in desalination. Last year, things were so bad the city couldn't pull water from the river at all. The plant will be the state's first inland desalination plant for brackish surface water, said John Samuelson, the city engineer and director of public works. Desalination plants are often controversial; earlier this year the state rejected a proposal in Orange County that would draw water from the ocean. But water in the Delta isn't as salty, so it takes less energy to make it fresh. Samuelson said other Bay Area cities are reaching out to Antioch to learn more about its effort as they consider their own options for stabilizing the water supply as climate risks grow. “We just know that this problem is going to continue to get worse in the future," Samuelson said. “We want to make sure that we are being forward thinking and solving the problem today." ___ The Associated Press receives support from the Walton Family Foundation for coverage of water and environmental policy. The AP is solely responsible for all content. For all of AP’s environmental coverage, visit https://apnews.com/hub/climate-and-environment
https://www.click2houston.com/business/2022/08/08/in-dry-california-salty-water-creeps-into-key-waterways/
2022-08-09T12:11:29Z
https://www.click2houston.com/business/2022/08/08/in-dry-california-salty-water-creeps-into-key-waterways/
true
44
“ The new report titled Global Automotive Piston Market by Global Market Vision provides an in-depth analysis of the global Automotive Piston Market evaluating the market based on historical and forecast market data, demand, application details, price trends, and company shares of the leading industries by geography. The research examines the current industry developments and their implications for the broader market. It also analyses the market using the SWOT and Porter’s Five Forces models, as well as assessing market dynamics and key demand and price indicators. The study provides data on the most exact revenue estimates for the complete market and its segments to aid industry leaders and new participants in this market. The purpose of this study is to help stakeholders better understand the competitive landscape and design suitable go-to-market strategies. The market size, features, and growth of the Automotive Piston Market industry are segmented by type, application, and consumption area in this study. Furthermore, key sections of the Global Automotive Piston Market are evaluated based on their performance, such as cost of production, dispatch, application, volume of usage, and arrangement. Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://globalmarketvision.com/sample_request/27674 Key Players Mentioned in the Global Automotive Piston Market Research Report: Mahle, KSPG, Federal-Mogul, Aisin Seiki, TIK Piston Taiwan, Menon Piston, Wiseco, Shandong Binzhou Bohai Piston. Global Automotive Piston Market Segmentation: Market Segmentation: By Type Steel Piston Aluminum Piston Market Segmentation: By Application Commercial Vehicle Passenger Vehicle This Automotive Piston market report assists a number of investors, shareholders as well as enterprises in understanding the tough areas of marketing ideas, technical development, key issues, and systematic analysis in order to accomplish long-term competitive gain in the industry. It goes on to talk about basic market facets along with market drivers, restraints, existing problems, forthcoming opportunities, and forecasts. This Automotive Piston market survey depicts a few exact customer insights in order to build technology strategies to make investment useful. It makes use of both primary and secondary methods to offer wide-ranging industry data to help out you in making business choices and introducing new items to the market. The base of geography, the world market of Automotive Piston has segmented as follows: - North America includes the United States, Canada, and Mexico - Europe includes Germany, France, UK, Italy, Spain - South America includes Colombia, Argentina, Nigeria, and Chile - The Asia Pacific includes Japan, China, Korea, India, Saudi Arabia, and Southeast Asia The Automotive Piston report analyses various critical constraints, such as item price, production capacity, profit & loss statistics, and global market-influencing transportation & delivery channels. It also includes examining such important elements such as Automotive Piston market demands, trends, and product developments, various organizations, and global market effect processes. Premium Report offers: - Assessments of market share for the regional and national segments. - A description of the business, including its goals, finances, and most recent advancements. - In addition to a comprehensive analysis of market share, the report contains data on significant drivers, restraints, and opportunities. - The market power of consumers and suppliers is demonstrated via Porter’s five forces study. Table of Content (TOC): Chapter 1: Introduction and Overview Chapter 2: Industry Cost Structure and Economic Impact Chapter 3: Rising Trends and New Technologies with Major key players Chapter 4: Global Automotive Piston Market Analysis, Trends, Growth Facto Chapter 5: Automotive Piston Market Application and Business with Potential Analysis Chapter 6: Global Automotive Piston Market Segment, Type, Application Chapter 7: Global Automotive Piston Market Analysis (by Application, Type, End User) Chapter 8: Major Key Vendors Analysis of Automotive Piston Market Chapter 9: Development Trend of Analysis Chapter 10: Conclusion Conclusion: At the end of Automotive Piston Market report, all the findings and estimation are given. It also includes major drivers, and opportunities along with regional analysis. Segment analysis is also providing in terms of type and application both. Access the full Research Report @ https://globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=27674 If you have any special requirements, please let us know and we will offer you the report at a customized price. About Global Market Vision Global Market Vision consists of an ambitious team of young, experienced people who focus on the details and provide the information as per customer’s needs. Information is vital in the business world, and we specialize in disseminating it. Our experts not only have in-depth expertise, but can also create a comprehensive report to help you develop your own business. With our reports, you can make important tactical business decisions with the certainty that they are based on accurate and well-founded information. Our experts can dispel any concerns or doubts about our accuracy and help you differentiate between reliable and less reliable reports, reducing the risk of making decisions. We can make your decision-making process more precise and increase the probability of success of your goals. Contact Us Sarah Ivans | Business Development Phone: +1-3105055739 Email: [email protected] Global Market Vision Website: www.globalmarketvision.com
https://thenelsonpost.ca/news/380736/automotive-piston-market-report-2022-analysis-key-indicators-forecast-2030-mahle-kspg-federal-mogul-aisin-seiki/
2022-08-09T12:12:11Z
https://thenelsonpost.ca/news/380736/automotive-piston-market-report-2022-analysis-key-indicators-forecast-2030-mahle-kspg-federal-mogul-aisin-seiki/
false
13
A little-known 20p coin hack can help drivers slash their fuel costs within minutes. Motorists struggling with high petrol and diesel prices are being urged to use the coin trick every month to help slash your fuel consumption levels and stay safe on the road. Fuel prices hit their highest-ever levels earlier this summer as the UK’s cost-of-living crisis worsened. But major retailers are failing to lower petrol prices in line with wholesale costs of unleaded petrol dropping over the past two months, the RAC said last week. In some areas fuel prices seem to be slowly dropping but they are still at incredibly high levels, averaging 181.3p for petrol and 191.1p foe diesel today (August 9). READ MORE: Get £5 off petrol and diesel at all UK forecourts with this new deal Experts at KwikFit are recommending one simple fuel-saving message that could help you slash your fuel bills, and all it takes is checking your tyres. This is because using underinflated or unsuitable tyres can add 20 per cent to a car’s fuel consumption. Tyres typically lose air naturally, at a rate of up to two PSI (pounds per square inch) every month. Because of this, drivers are urged to check their tyre pressure regularly, as it can help preserve fuel. Ensuring tyres are topped up not only prolongs the life of the tread, but also improves fuel efficiency as there is less rolling resistance on the road. If your tyres are even slightly distorted due to incorrect tyre pressure, drivers will be using more fuel to keep their cars running smoothly. This is because of the added friction while driving that comes from a misshapen tyre. Drivers can check their tyre treads very easily with a 20p coin, the Express reports. Current UK law states that tyre tread on cars must be a minimum of 1.6mm across the central three-quarters of the tread, around its entire circumference. Drivers should place a 20p coin into the main tread grooves of the tyre. If the outer band of the 20p coin is obscured when it is inserted, then the tread is above the legal limit. If the outer band of the coin is visible, then the tyres may be unsafe and should be checked immediately by a qualified tyre professional. When taking the test, drivers need to remember to check at least three locations around each tyre. Since the test is so quick and easy, motorists are urged to check their tyres at least once a month. All new tyres purchased in the UK come with an EU Tyre Label, which is there to help drivers make an informed choice when choosing a new tyre. Tyres are rated in three categories: fuel efficiency, wet grip and noise. Fuel efficiency is rated on a scale from A to F, with an A-rating being the best result possible. These tyres require less energy to roll, and therefore burn less fuel. So, if motorists want new tyres with good fuel economy, Kwik Fit advises people to look to the EU Tyre Label for guidance. READ NEXT: - Ofgem energy price cap to hit £4,200 a year after Christmas and New Year - DWP singles out claimants who may be due thousands in back pay - Blackpool Pleasure Beach visitors can claim £28 ice skating show tickets for free - Iceland giving pensioners free £30 voucher to help them buy food - Tesco unveils Christmas food menu with weird and wonderful treats
https://www.lancs.live/news/cost-of-living/drivers-urged-simple-20p-check-24709415
2022-08-09T12:17:00Z
https://www.lancs.live/news/cost-of-living/drivers-urged-simple-20p-check-24709415
false
1
CBS News New York: Free 24/7 News CBS New York App CBSNews.com Links & Numbers Community Journalism #BetterTogether CBS+ News All News NY News NJ News CT News LI News U.S. World Health Business Entertainment Politics Tech Weather First Alert Weather Radars & Maps CBS2 Weather Map CBS2 Weather Watchers First Alert Weather 101 Sports All Sports Giants Yankees Knicks Rangers Islanders CBS Sports Live Jets Mets Nets Devils Odds Video More Station Info WCBS-TV WLNY-TV Contact Us Advertise Contests & Promotions Galleries Links & Numbers Download the App Log In Search Search Login Watch CBS News Trump family reacts to Mar-a-Lago search Former President Donald Trump and his family are speaking out after FBI agents searched his Mar-a-Lago home. CBS2's Elijah Westbrook has the latest. View CBS News In CBS News App Open Chrome Safari Continue Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
https://www.cbsnews.com/newyork/video/trump-family-reacts-to-mar-a-lago-search/
2022-08-09T12:17:42Z
https://www.cbsnews.com/newyork/video/trump-family-reacts-to-mar-a-lago-search/
false
null
The PGA Tour asked a federal judge in San Francisco to deny the appeal of three suspended players who joined Saudi-backed LIV Golf and now want to compete in the tour's lucrative postseason, arguing the players knew the consequences two months ago. Talor Gooch, Matt Jones and Hudson Swafford are seeking a temporary restraining order. They are among 10 players who filed an antitrust lawsuit against the PGA Tour last week. The hearing is scheduled for 1 p.m. PDT Tuesday in San Jose, California, two days before the first of three FedEx Cup playoff events in the chase for the $18 million top prize. The FedEx St. Jude Championship in Memphis, Tennessee, has a $15 million purse, and the top 70 players advance to the second postseason event in Wilmington, Delaware. Gooch (No. 20), Jones (No. 65) and Swafford (No. 67) are among nine players who have joined LIV Golf and finished the regular season among the top 125 in the FedEx Cup standings. The other six who joined LIV Golf are not asking to play in the tour's postseason. In a court filing Monday to oppose the temporary restraining order, the tour argued antitrust laws do not allow the three players “to have their cake and eat it, too.” Gooch, Swafford and Jones used the same phrase in separate, legal-heavy letters to tour officials last month in protesting their suspensions and claiming the regulations were onerous and kept them from playing elsewhere. “I am a free agent and independent contractor. The Tour cannot have its cake and eat it too by trying to control me as one might an employee, while not providing me the rights and benefits an employee would receive,” each letter said. The PGA Tour argued in its opposing motion, “Despite knowing full well that they would breach TOUR Regulations and be suspended for doing so, Plaintiffs have joined competing golf league LIV Golf, which has paid them tens and hundreds of millions of dollars in guaranteed money supplied by Saudi Arabia’s sovereign wealth fund.” LIV Golf CEO Greg Norman said in a statement, “I believe players have the right to play when and where they choose so their talents can take them as far and high as possible.” “I believe all players — whether they choose to play with LIV or the PGA Tour — understand and appreciate the purpose and importance of the players’ legal actions, across the globe,” Norman said. "The PGA Tour is trying to cast this as ‘us’ against ‘them.’ The players know better.” The three players were not among the highest-sought players for Norman's rival league, though they were among the initial group of players who signed with LIV Golf. Gooch was the only one among the top 50 in the world, mainly from his only PGA Tour win last November. “Plaintiffs have waited nearly two months to seek relief from the Court, fabricating an ‘emergency’ they now maintain requires immediate action,” the filing said. “It doesn't.” The tour contends player knew they would be ineligible for the FedEx Cup playoffs “when they accepted millions from LIV to breach their agreements” with the tour. Players were not suspended until they actually teed off in a LIV Golf event. The LIV Golf events, with a 48-man field, consist of 54 holes and offer $25 million in total prize money for each event. Seventeen players already have earned $1 million or more in three or fewer events. Five more events remain on this year's schedule, and LIV Golf already has announced a 14-tournament schedule for 2023. The next LIV event does not start until after the PGA Tour's season ends at East Lake in Atlanta with the FedEx Cup, which pays $18 million to the champion. Even though LIV Golf players have been suspended, they remain eligible for the FedEx Cup bonus package. Anyone finishing in the top 125 gets $120,000. Those who finish inside the top 150, such as Pat Perez and Paul Casey, would get $85,000. Dustin Johnson, Patrick Reed and Sergio Garcia are among LIV Golf players who chose to resign their PGA Tour membership. Reed is playing two Asian Tour-International Series tournaments this month. The lawsuit was filed Aug. 3 by 11 players. The manager for Carlos Ortiz told The Associated Press that Ortiz is no longer part of the lawsuit, though it has not been reflected in court documents yet. “Carlos does not want to be involved in any legal battles,” his manager, Carlos Rodriguez, said in a text message. “He is thankful for the opportunity he had to play on the PGA Tour and Korn Ferry Tour the last few years.” Ortiz in two LIV events has made nearly $3.5 million, about 44% of his career PGA Tour earnings from 160 tournaments. The field for Memphis currently is at 122 players from the 125 who are eligible and in good standing. Three players chose not to compete because of injury or scheduling. ___ More AP golf: https://apnews.com/hub/golf and https://twitter.com/AP_Sports
https://www.click2houston.com/sports/2022/08/08/pga-tour-says-players-knew-consequences-of-joining-liv-golf/
2022-08-09T12:19:35Z
https://www.click2houston.com/sports/2022/08/08/pga-tour-says-players-knew-consequences-of-joining-liv-golf/
true
41
Aldi issues urgent recall of summer Specialbuy over injury risk A MAJOR high-street chain has issued an urgent recall on a product in its outdoor furniture range. Aldi has recalled its portable hammocks due to "risk of injury" to customers. The retail giant has released a statement advising customers who bought a particular outdoor hammock to return the Specialbuy item to stores immediately. The firm said: "We are recalling this product due to a design defect that may cause the seam to split. "Customers are asked to return this product to their nearest store, where a full refund will be given. "We apologise that this product did not meet our normal high standards and thank you for your co-operation." If you're not sure whether this concerns your purchase, there should be a product code on the receipt - 816216. If you can't find the receipt, we'd advise taking it into your nearest store where a member of staff will clarify. Customers who bought this product should contact Customer Service on 0800 042 0800. The latest recall follows a previous one earlier this year, when Aldi asked customers to return a number of defective garden furniture which carried a fire risk. Most read in Money What are my rights to a refund? If you're returning a recalled product, your rights to getting a refund depends on whether the fault makes the product unsafe. Sometimes the business will repair the product, for example by fitting a new part. But this should be done for you. If a fault makes a product unsafe to use — and it's difficult to correct the fault — the Consumer Guarantees Act says you might have the right to reject the product and claim a replacement or a refund. You can read more about your rights concerning a recalled product in our guide.
https://www.thesun.co.uk/money/19459435/aldi-issues-urgent-recall-of-summer-specialbuy/
2022-08-09T12:20:00Z
https://www.thesun.co.uk/money/19459435/aldi-issues-urgent-recall-of-summer-specialbuy/
true
2
- Click here for contact information on Greater Cleveland Food Bank Nourishing Beginnings program enrollment - Click here to vote for the name of the baby rhino at Cleveland Metroparks Zoo - Click here to sign up to donate blood. - Click here for more on Stuff the Bus - Click here for more on the Beavers family fundraiser - Click here to register for the Fox 8 Fox Trot and a chance to win eight tickets to see Bruce Springsteen and the E Street Band - Click here for more on the 2022 Buddy Walk - Click here for more on Allie LaForce and Joe Smith’s fundraiser to fight Huntington’s Disease - Click here for more on the Asian Lantern Festival - Click here to get weather alerts sent right to your inbox - Click here to sign up for the Fox 8 Recall Report & Safety Alerts Newsletter - Click here to sign up for the FOX 8 Daily News Newsletter - Click here to sign up for the Dining & Delicious Eats FOX 8 Newsletter - Click here to sign up for the Orange & Brown FOX 8 Newsletter to get updates on the Browns - Click here to donate to the Greater Cleveland Food Bank - Click here to track the cheapest gas prices in your area - Click here to find a blood drive near you - Click here for information on reporting power outages - Click here to find a location to get vaccinated - Click here for resources to assist victims of domestic violence - Click here for Ohio zip codes with the highest number of sex offenders - Click here to check on unclaimed funds - Click here to tell us why you want a SKYFOX flyover - Click here to sign up for the FOX 8 newsletter and download the FOX 8 News app - Click here for Playhouse Square ticket info - Click here to submit your “Dig This” questions for AJ Petitti of Petitti Garden Centers - Click here for more on suicide prevention - Click here for information on Cuyahoga County health, housing resources - Click here to make a submission for Cleveland’s Own - Click here to share your child’s work of art - Click here for more on the Best Community Resource Center - Click here for Ohio Means Jobs - Click here for more on Voices of Unity - Click here for more on the Urban League of Greater Cleveland - Click here for information on sending tips on unsolved murders in Rocky River Reservation - Click here to nominate your favorite school for a chance to be a Cool School - Click here for Crime Stoppers information - Click here to send a news tip to the FOX 8 I-Team - Click here for a link to the sex offender registry
https://fox8.com/news/seen-on-tv/seen-on-tv-8-9-22/
2022-08-09T12:26:06Z
https://fox8.com/news/seen-on-tv/seen-on-tv-8-9-22/
false
55
3 dead in shooting at Florida Narcotics Anonymous meeting EDGEWATER, Fla. (AP) — Three people are dead following a shooting and hostage situation at Narcotics Anonymous meeting in Florida, police said. Officers responded to a report that a man was shot and a woman was being held hostage Monday night in Edgewater, which is near Daytona Beach. The other people at the meeting were able escape the offices of Be The Bridge, a nonprofit organization that helps the homeless and others get a fresh start in life. Edgewater police said in a Facebook post that investigators believe it appeared to involve a domestic dispute. Officers sought to make contact with the suspect to negotiate before a SWAT team breached the building and found the gunman and the two others dead inside, the post said. No additional details were immediately available. Copyright 2022 The Associated Press. All rights reserved.
https://www.kjct8.com/2022/08/09/3-dead-shooting-florida-narcotics-anonymous-meeting/
2022-08-09T12:28:11Z
https://www.kjct8.com/2022/08/09/3-dead-shooting-florida-narcotics-anonymous-meeting/
false
null
Dear Savvy Senior, What tips can you recommend for choosing a good active adult housing community? My husband and I, who recently retired, are planning to relocate to an area closer to our grandkids and are interested in buying a house in an age-restricted 55-plus housing community. Active Retirees Dear Active, If you’re contemplating moving into an age-restricted community, finding one that’s right for you takes some legwork. While active adult communities generally offer the opportunity for a lower-maintenance lifestyle around similar aged people, they vary enormously. Here’s what you should know. Today’s active adult communities come in all shapes, sizes and price ranges, ranging from small city-based apartment complexes, to single-family homes, to sprawling resort-style locations situated on a gated golf course. Most are owned by their occupants, but a growing number are rentals. Typically, at least one occupant of each property must be at least 55. It’s also important to understand that 55-plus active adult communities are not the same as retirement or independent living communities, which are primarily designed for older seniors in their 70s and 80s. Active adult communities do not typically include meals or have a central dining area, but many of them do offer a range of recreational amenities and activities. To help you locate and research active adult communities in the areas you’re interested in, the best resource is 55places.com. This is a comprehensive website that provides ratings, reviews and information on activities and amenities for thousands of communities across the country. Once you find a few you like, here are some questions to ask yourself that can help you choose: What’s our budget? To help you choose the right active adult community you’ll first need to determine what you can afford. Consider the home’s purchase price, whether you’ll need a mortgage, how much the property taxes and insurance are, and how much the homeowners’ association or community fees are. These fees, which typically run a few hundred dollars per month, go toward lawn care and possibly snow removal, as well as community areas like a clubhouse or pool. However, some communities may require additional memberships or fees for golf, tennis, classes, or other activities. You also need to consider the area’s cost of living for other things like food, utilities, transportation, health care and taxes. Numbeo.com and BestPlaces.net offer tools to compare the cost from your current location to where you would like to move. And Kiplinger’s has a tax guide for retirees at Kiplinger.com/links/retireetaxmap that lets you find and compare taxes state-by-state. How active is the community? Some communities provide fitness facilities, swimming pools, tennis courts and more, along with dozens of organized activities, classes and social events. Other communities are much simpler and more laid back with very limited amenities and structured activities. You’ll want to choose a community that has the types of people, facilities, activities and vibe that appeals to you. Will we like the surrounding area? Will the area around your prospective community serve your needs now and in the future? Ideally, this means having easy access to good doctors and hospitals, and a local airport if you plan to travel much. You’ll also want to research how far you’ll be from essential services like grocery stores, banks and pharmacies, as well as dining, shopping, and recreational attractions. Schedule a Visit Once you’ve narrowed your choices, call to make an appointment and visit them. Be sure to allow plenty of time at each community and, if possible, go back to your favorites more than once. Also be sure to ask questions while you are visiting, particularly about the community rules. Some developments will let you stay overnight in a model home for a few nights to get a feel of what it would be like to live there. While you are there, try the amenities and activities, and speak with as many residents as you can.
https://www.ottumwacourier.com/news/savvy_senior/how-to-choose-a-55-plus-active-adult-community/article_4ad55024-11a7-11ed-bea3-3be94e66d884.html
2022-08-09T12:35:04Z
https://www.ottumwacourier.com/news/savvy_senior/how-to-choose-a-55-plus-active-adult-community/article_4ad55024-11a7-11ed-bea3-3be94e66d884.html
false
16
CLEVELAND (AP) _ TransDigm Group Inc. (TDG) on Tuesday reported fiscal third-quarter earnings of $238 million. On a per-share basis, the Cleveland-based company said it had net income of $4.10. Earnings, adjusted for one-time gains and costs, came to $4.85 per share. The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $4.46 per share. The aircraft components maker posted revenue of $1.4 billion in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $1.43 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TDG at https://www.zacks.com/ap/TDG
https://www.michigansthumb.com/business/article/TransDigm-Fiscal-Q3-Earnings-Snapshot-17361150.php
2022-08-09T12:35:35Z
https://www.michigansthumb.com/business/article/TransDigm-Fiscal-Q3-Earnings-Snapshot-17361150.php
false
null
JOHNS CREEK, Ga. (AP) _ Ebix Inc. (EBIX) on Tuesday reported second-quarter earnings of $19.3 million. On a per-share basis, the Johns Creek, Georgia-based company said it had net income of 63 cents. Earnings, adjusted for non-recurring costs, were 75 cents per share. The supplier of software and e-commerce services to the insurance industry posted revenue of $250.8 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBIX at https://www.zacks.com/ap/EBIX
https://www.thehour.com/business/article/Ebix-Q2-Earnings-Snapshot-17361158.php
2022-08-09T12:35:47Z
https://www.thehour.com/business/article/Ebix-Q2-Earnings-Snapshot-17361158.php
true
null
Big 5 Sporting Goods (BGFV) Gains 18.01% on August 8 Equities Staff Follow |Big 5 Sporting Goods Corp (NASDAQ: BGFV) shares moved 18.01%, or $1.985 per share, as on 11:49:08 est today. Since opening at $11.18, 561,146 shares of Big 5 Sporting Goods have traded hands and the stock has ranged between $13.09 and $11.13. Already this year the company is down 41.14%. Big 5 Sporting Goods expects its next earnings on 2022-11-01. For technical charts, analysis, and more on Big 5 Sporting Goods visit the company profile. About Big 5 Sporting Goods Corp Big 5 is a leading sporting goods retailer in the western United States, operating 430 stores under the 'Big 5 Sporting Goods' name as of the fiscal quarter ended January 3, 2021. Big 5 provides a full-line product offering in a traditional sporting goods store format that averages 11,000 square feet. Big 5's product mix includes athletic shoes, apparel and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, home recreation, tennis, golf, and winter and summer recreation. To get more information on Big 5 Sporting Goods Corp and to follow the company's latest updates, you can visit the company's profile page here: Big 5 Sporting Goods Corp's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info. Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis. DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
https://www.equities.com/news/big-5-sporting-goods-bgfv-gains-18-01-on-august-8
2022-08-09T12:36:12Z
https://www.equities.com/news/big-5-sporting-goods-bgfv-gains-18-01-on-august-8
true
22710
Love has no boundaries, and a couple from Assam are living proof of this proverb. Although some people may have gone to extraordinary lengths for love, this incident is rather strange. A 15-year-old Assamese girl did something really strange and unconventional to prove her love. She injected herself with her lover's HIV+ blood using a syringe. The incident happened in the Sualkuchi district of Assam. Reportedly, the ‘insane’ lovers met on social media. The report also suggests the girl made a few attempts to run away with the boy, but she was brought home by her parents. Netizens were taken aback by this incident and expressed shock over it. Netizens react Twitter users are reacting to the incident as the news is making rounds on the internet. One user wrote, "true love (sic)." While another user tweeted in jest, "The youth of the nation." The third user commented, "God forgive them." Netizens were shocked by the incident, few expressed their surprise, while others made jibes, mocking the couple. About HIV The human immunodeficiency virus (HIV) is a virus that targets immune system cells, leaving an individual more susceptible to various illnesses and infections. It is shared by sharing injection equipment or through direct contact with the body fluids of an infected individual, most frequently during unprotected intercourse (sex without the use of a condom or HIV medication to prevent or treat HIV). HIV can cause AIDS if not properly treated (acquired immunodeficiency syndrome). According to reports, doctors are currently observing the girl while her lover has been taken into custody by Hajo police. The girl's family also brought proceedings against her lover. The 15-year-old girl's strange method of expressing her love undoubtedly spoke volumes about the lengths to which love can drive individuals. It has also highlighted how teenagers act in any way without considering the consequences. DON'T MISS Burger King emails blank order receipts to everyone, confused customers react As CWG ends, enthusiastic Indians welcome champions with dhol, nagada and garlands
https://www.indiatvnews.com/trending/news/assam-girl-injects-herself-with-boyfriends-hiv-blood-to-prove-her-love-netizens-mock-the-youth-of-nation-viral-2022-08-09-798637
2022-08-09T12:36:18Z
https://www.indiatvnews.com/trending/news/assam-girl-injects-herself-with-boyfriends-hiv-blood-to-prove-her-love-netizens-mock-the-youth-of-nation-viral-2022-08-09-798637
true
1
Investors include Acequia Capital, Possible Ventures, E2MC, HCVC and Lockheed Martin Ventures Deals Inked with Key Partners including OHB Hellas, Ananth Technologies, Phantom Space Corporation and Morpheus Space LOS ALTOS, Calif., Aug. 9, 2022 /PRNewswire/ -- Antaris, the software platform provider for space, announced the company has closed a $4.2 million seed round of funding led by Acequia Capital and Possible Ventures. The round also includes investment from leading space tech investors Lockheed Martin Ventures, HCVC, E2MC and Ananth Technologies. "We created Antaris to make space easy," said Tom Barton, Co-Founder and CEO of Antaris. "Our platform dramatically simplifies the way satellites are designed, built and operated, and we're excited to accelerate our development efforts with this new funding round. For too long, the ability to deploy payloads into space has been hampered by extraordinarily high costs, supply chain constraints and lack of vendor interoperability. We intend to change all that." Funding will primarily be used to onboard new talent and accelerate development of the Antaris Open Space platform, which includes modular satellite design tools, True Twin™ virtual satellites, integration with verified manufacturing partners and interfaces to a comprehensive suite of mission control solutions. "Antaris is aiming to streamline how we build and manage satellites in low Earth orbit," said Chris Moran, vice president and general manager of Lockheed Martin Ventures. "We invested in Antaris because we believe in their mission of bridging space and cloud technology, and simplifying operational management throughout a satellite's lifecycle." Antaris is suited to a wide range of missions, including communications, imaging, climate study, military intelligence and academic research. The company has inked preliminary deals with key industry players including Ananth Technologies Limited, OHB Hellas, Phantom Space Corporation, Morpheus Space, ZES and Aphelion Aerospace. The first Antaris satellite, known as Janus I, is scheduled to launch in late Q3. "The launch of Janus I in the coming months will be a key milestone for Antaris and our valued partners," said Karthik Govindhasamy, Co-Founder and Chief Technology Officer of Antaris. "We are fundamentally revolutionizing access to satellite technology, and it all revolves around our unique approach to the end-to-end software solution for all aspects of the satellite lifecycle." Antaris founders previously served in key leadership roles at satellite disruptor Planet Labs and were part of the team that launched the largest commercial imaging constellation ever flown. About Antaris Antaris, the software platform provider for space, exists to make space easy. We dramatically simplify the design, simulation, manufacturing and operation of satellites, giving customers the flexibility and security to ensure mission success. Antaris brings New Space thinking to an Old Space world, solving the most pressing challenges for our industry to improve time-to-orbit and reduce cost. Learn more at www.antaris.space About Lockheed Martin Ventures Lockheed Martin Ventures makes strategic investments in companies that are developing cutting edge technologies in core businesses and new markets important to Lockheed Martin. More than a source of capital, Lockheed Martin Ventures provides portfolio companies with access to our world-class engineering talent, state-of-the-art technologies, and research and access to the company's international business relationships and supply chain. Learn more at www.lockheedmartinventures.com View original content to download multimedia: SOURCE Antaris
https://www.whsv.com/prnewswire/2022/08/09/satellite-software-innovator-antaris-announces-close-42-million-seed-funding-round-accelerate-development-software-solutions-space/
2022-08-09T12:37:37Z
https://www.whsv.com/prnewswire/2022/08/09/satellite-software-innovator-antaris-announces-close-42-million-seed-funding-round-accelerate-development-software-solutions-space/
true
12
BEIJING, Aug. 9, 2022 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) (the "Company") today announced that the consortium led by the Company's subsidiary REIT Ecological Technology Co., Ltd. ("REIT Eco") has won the bid for the Longxi County Comprehensive Land Management and Logistics Zone (Yangjia River Band) EOD Project, an ecological oriented development project in Longxi County, Gansu Province, China(the "EOD Project"). Pursuant to the bidding documents, the EOD Project involves a total investment of RMB1.318 billion (approximately $195.02 million). REIT Eco and Hainan Shiyuan Tongda Private Equity Fund Management Co., Ltd. will jointly establish a project company in Longxi County, which will be responsible for the investment and financing, project management and operation, and other work required to complete the EOD Project. ReTo and the other shareholder of the project company are expected to receive an annualized return of 12% on their total investment at the end of the three year term of the EOD project. The EOD Project mainly consists of three parts. First part includes land reclamation and supporting rural road construction, which involves a total of ten sub-projects that span 60,000 mu (approximately 9,884 acres) of land across the Longxi County. The second part involves land acquisition for the Logistics Zone (Yangjia River Band). The third part includes work on land development and municipal infrastructure construction that ensure water and electricity supply, road and communication establishment as well as drainage and other needed land leveling works. Mr. Hengfang Li, Chairman and CEO of the Company commented, "The Company has been working for many years in the fields of comprehensive land management, soil remediation, mine ecological restoration, solid waste utilization, sewage treatment and domestic waste treatment. With our business growth, the Company strives to become a provider of leading intelligent environmental and ecological solutions and operation services in China." About ReTo Eco-Solutions, Inc. Founded in 1999, ReTo Eco-Solutions, Inc., through its proprietary technologies, systems and solutions, is striving to bring clean water and fertile soil to communities worldwide. The Company offers a full range of products and services, ranging from the production of environmentally-friendly construction materials, environmental protection equipment, and manufacturing equipment used to produce environmentally-friendly construction materials, to project consulting, design, and installation for the improvement of ecological environments, such as ecological soil restoration through solid waste treatment. Through its subsidiary Hainan REIT Mingde Investment Holding Co., Ltd. and Hainan Yile IoT Technology Co., Ltd., a high-tech enterprise in Hainan Province, the Company provides roadside assistance services to drivers within Hainan Province through its network of tow providers, automotive repair services and other service providers, and is also engaged in the design, development and sales of customized software solutions. For more information, please visit: http://en.retoeco.com. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development such as the implementation of the EOD Project, including its anticipated investment amount and return; product and service demand and acceptance; changes in technology; economic conditions; the growth of the construction industry in China; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission (the "SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. For more information, please contact: ReTo Eco-Solutions, Inc. Angela Hu Beijing Phone: +86-010-64827328 ir@retoeco.com or 310@reit.cc View original content: SOURCE ReTo Eco-Solutions, Inc.
https://www.alaskasnewssource.com/prnewswire/2022/08/09/subsidiary-reto-eco-solutions-wins-bid-develop-rmb1318-billion-eod-project/
2022-08-09T12:38:16Z
https://www.alaskasnewssource.com/prnewswire/2022/08/09/subsidiary-reto-eco-solutions-wins-bid-develop-rmb1318-billion-eod-project/
false
11
Ukraine: Shelling hits town near Russian-held nuclear plant KYIV, Ukraine (AP) — At least three Ukrainian civilians were killed and 23 others were wounded by Russian shelling in 24 hours, including an attack not far from a Russian-occupied nuclear power plant, the office of Ukraine’s president reported Tuesday. The Russians fired over 120 rockets from Grad multiple rocket launchers at the southern town of Nikopol, which is across the Dnieper River from the Zaporizhzhia Nuclear Power Plant, Dnipropetrovsk Gov. Valentyn Reznichenko said. Several apartment buildings and industrial facilities were damaged, he said. Ukraine and Russia accused each other in recent days of shelling the nuclear plant, which is the largest one in Europe, and increasing the risks of a nuclear accident. In his nightly video address, Ukrainian President Volodymyr Zelenskyy invoked the 1986 disaster at the Chernobyl nuclear plant in Ukraine, which at the time was a Soviet republic. He called for new sanctions against Russia “for creating the threat” of another nuclear disaster. “We are actively informing the world about Russian nuclear blackmail - about the shelling and mining of the Zaporizhzhia NPP facilities,” Zelenskyy said. “Russia will not pay attention to words and concerns. ... The Chernobyl disaster is an explosion in one reactor; the Zaporizhzhia NPP is six power units.” The Kremlin claimed Monday that Ukraine’s military was attacking the plant and urged Western powers to force Kyiv to stop the activity. A Russian-installed official in the partially occupied Zaporizhzhia region said an air defense system at the plant would be reinforced in the aftermath of last week’s shelling. Evgeny Balitsky, the head of the Kremlin-backed administration, told Russian state TV Tuesday that power lines and damaged blocks of the plant were restored. “The plant is operating normally, but, of course, with an increased degree of security,” Balitsky said. A Ukrainian counteroffensive and Russian defensive actions in occupied areas has increasingly drawn firepower to southern Ukraine. After failing to capture Ukraine’s capital, Kyiv, early in the war, the Russian military focused its strength on trying to seize all of the country’s eastern Donbas region. Pro-Moscow separatists have fought Ukrainian forces in the region for eight years and control some territory as self-proclaimed republics. GRAPHIC WARNING: Videos included in this story may have disturbing content. The British Defense Ministry said Tuesday that Russian forces had made the most progress in the past month in moving toward the town of Bakhmut - an advance limited to about 10 kilometers (6.2 miles). “In other Donbas sectors where Russia was attempting to break through, its forces have not gained more than 3 km during this 30-day period; almost certainly significantly less than planned,” the U.K. ministry said. However, the ministry cautioned that despite the attention required in southern Ukraine, Russia had maintained attacks on Ukrainian positions in the east. The governor of eastern Ukraine’s Donetsk province, Pavlo Kyrylenko, said the Russians were trying to press their offensive in several areas. Kharkiv, the country’s second-largest city, came under the Russian shelling four times over the past 24 hours, and some city infrastructure was damaged. ___ This version has been corrected to show the pro-Moscow separatists are fighting Ukrainian forces, not the Russians. ___ Follow AP’s coverage of the war in Ukraine at https://apnews.com/hub/russia-ukraine Copyright 2022 The Associated Press. All rights reserved.
https://www.knoe.com/2022/08/09/ukraine-shelling-hits-town-near-russian-held-nuclear-plant/
2022-08-09T12:40:55Z
https://www.knoe.com/2022/08/09/ukraine-shelling-hits-town-near-russian-held-nuclear-plant/
true
26
Arajet, the Dominican Republic’s low-cost airline, announced that it will begin operations in Costa Rica. This company offers direct connections from Costa Rica to destinations in Latin America, the Caribbean, and the United States. The company has started selling tickets for direct, short, and convenient flights beginning in October. The company expects to fly five times a week and intends to offer rates 30% to 60% lower than the market average. Moreover, the company invested $3 billion in purchasing Boeing 737 MAX aircrafts. Each plane has a capacity of 185 passengers. These airplanes are equipped with environmentally sustainable features and the latest technology. Arajet will commence commercial activities with five units and expects to increase its capacity to 20 units. “I encourage Ticos to keep an eye out for the next plane ticket sale, so they can try our service and support us. We want to democratize flights; we don’t want them to be for the rich only,” said Victor Pacheco, president of Arajet. Some available destinations include the Dominican Republic, the United States, Cuba, Colombia, Puerto Rico, Costa Rica, St. Maarten, Curaçao, Mexico, Panama, Aruba, Guadeloupe, Guatemala, Peru, Haiti, Trinidad & Tobago, Canada, El Salvador, and Jamaica. “This airline came to create a new travel opportunity for those for whom it is very pricey to travel,” added Pacheco. As confirmed by the airline’s president, the company is finalizing the permits to operate in the country. This is great news for travelers, as they will have a wider choice of airlines and routes. It will also be an excellent alternative for travel to Latin America and the Caribbean, with reasonably low costs. Further details on prices, routes, flight schedules, and airline policies can be found at https://www.arajet.com.
https://ticotimes.net/2022/08/09/low-cost-airline-arajet-announces-operations-in-costa-rica
2022-08-09T12:41:51Z
https://ticotimes.net/2022/08/09/low-cost-airline-arajet-announces-operations-in-costa-rica
false
1
BEIJING, Aug. 9, 2022 /PRNewswire/ -- VNET Group, Inc. (NASDAQ: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral Internet data center services provider in China, today announced that its board of directors (the "Board") has appointed Mr. Changqing Ye as a new director of the Company and a member of the audit committee of the Board, effective August 9, 2022. The Board has reviewed the independence of Mr. Ye and determined that he satisfies the "independence" requirements under Rule 10A-3 of the United States Exchange Act of 1934 and Rule 5605 of the Nasdaq Stock Market Rules. Mr. Changqing Ye has served as an independent director of Baozun Inc. (a company listed on Nasdaq) since May 2016 and Niu Technologies (a company listed on Nasdaq) since October 2018. Mr. Ye has also served as an independent non-executive director of Luzhou Bank Co., Ltd. (a company listed on the Hong Kong Stock Exchange) since December 2018, Ascentage Pharma Group International (a company listed on the Hong Kong Stock Exchange) since June 2019, Jinxin Fertility Group Limited (a company listed on the Hong Kong Stock Exchange) since June 2019 and Hygeia Healthcare Holdings Co., Limited (a company listed on the Hong Kong Stock Exchange) since September 2019. From February 2011 to December 2015, Mr. Ye served as an investment committee member, group chief financial officer and a managing director of CITICPE Group. Prior to that, Mr. Ye worked at PricewaterhouseCoopers Zhong Tian LLP from April 1993 to January 2011. Mr. Ye received a bachelor's degree in journalism from Huazhong University of Science and Technology in China and a master's degree in business administration from Warwick University in the United Kingdom. Mr. Ye is a certified public accountant in China. In addition, the Company announced the following changes to the committees of the Board: - The Board appointed Mr. Sheng Chen as a member of the compensation committee of the Board and a member of the nominating and corporate governance committee of the Board. - The Board also approved that Mr. Kenneth Chung-Hou Tai will no longer serve as a member of the audit committee of the Board and Mr. Erhfei Liu will no longer serve as a member of the compensation committee of the Board. Both Mr. Kenneth Chung-Hou Tai and Mr. Erhfei Liu will continue serving as directors of the Company. - These changes to the committees of the Board became effective August 9, 2022. The following table sets forth the composition of the committees of the Board immediately following the appointment of the new director and the changes to the committee members. About VNET VNET Group, Inc. is a leading carrier- and cloud-neutral Internet data center services provider in China. VNET provides hosting and related services, including IDC services, cloud services, and business VPN services to improve the reliability, security, and speed of its customers' internet infrastructure. Customers may locate their servers and equipment in VNET's data centers and connect to China's internet backbone. VNET operates in more than 30 cities throughout China, servicing a diversified and loyal base of over 6,500 hosting and related enterprise customers that span numerous industries ranging from internet companies to government entities and blue-chip enterprises to small- to mid-sized enterprises. Safe Harbor Statement This announcement contains forward-looking statements. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "target," "believes," "estimates" and similar statements. Among other things, quotations from management in this announcement as well as VNET's strategic and operational plans contain forward-looking statements. VNET may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about VNET's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: VNET's goals and strategies; VNET's future business development and expansion plans; the expected growth of the data center and cloud services market; expectations regarding demand for, and market acceptance of, VNET's services; VNET's expectations regarding maintaining and strengthening its relationships with customers; VNET's plans to invest in research and development to enhance and complement its solution and service offerings; international trade policies, protectionist policies and other policies that could place restrictions on economic and commercial activity; and general economic and business conditions in the regions where VNET provides solutions and services. Further information regarding these and other risks is included in VNET's reports filed with, or furnished to, the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of this press release, and VNET undertakes no duty to update such information, except as required under applicable law. Investor Relations Contact: Xinyuan Liu Tel: +86 10 8456 2121 Email: ir@vnet.com View original content: SOURCE VNET Group, Inc.
https://www.newschannel10.com/prnewswire/2022/08/09/vnet-announces-changes-board-committees-composition/
2022-08-09T12:44:20Z
https://www.newschannel10.com/prnewswire/2022/08/09/vnet-announces-changes-board-committees-composition/
true
12
Carolina Panthers coach Matt Rhule is playing his cards close to the vest, but let me spell out exactly what I’m seeing at the team’s training camp in Spartanburg: There’s no doubt Baker Mayfield is winning this quarterback competition. Mayfield hasn’t looked great by any means, but he’s been good enough to be better than Sam Darnold. Rhule said Saturday that he probably wouldn’t announce the winner of the QB competition until sometime after the New England preseason game Aug. 19. But it looks to me like Mayfield has taken the lead and now just needs to not mess it up and not get hurt to be able to start in Week 1 vs. his old team, the Cleveland Browns, on Sept. 11 in Charlotte. The two QBs have been cordial with one another, trying to avoid the sort of drama that is inherent when a team doesn’t know who is going to play its most important position with the season opener a month away. “It’s not about trying to stab one another in the back,” Mayfield said Monday of the QB competition. “It’s about elevating, because the franchise and the team go as the QB room goes.” Neither QB could move the ball worth a darn in two-minute drill simulations Monday against Carolina’s defense, which is clearly ahead of the offense at this point. The difference was more about who made the big mistake, and that was Darnold. After getting behind the chains due to a penalty, he misread a coverage, threw into a crowded area and got intercepted by Sean Chandler. It was a depressingly familiar sight to watch Darnold do this, so much so that 45 seconds before it happened, I turned to the two guys next to me watching practice and said: “I feel a Darnold interception coming on.” That wasn’t a hard prediction to make, because those were too often the exact situations in which Darnold threw picks last year (he had nine TD passes but 13 interceptions in 2021, going 4-7 as a starter). Sometimes, Darnold looks better than he was in 2021, but a lot of the time he doesn’t. Mayfield completes more balls downfield than Darnold and he’s picking up the offense fast enough that Darnold’s six-month advantage in learning new offensive coordinator Ben McAdoo’s playbook is starting to evaporate. “He’s definitely improving,” Rhule said of Mayfield Monday, “as he gets more and more of a feel for what he can do at the line of scrimmage… What he’s done in 10 days (of training camp practice) is pretty impressive. He’s making really good jumps.” Mayfield also gets more balls batted down at the line of scrimmage than Darnold does, owing in part to Darnold’s height advantage (officially two inches, but it looks more like four to me). And you’d want Darnold on the quarterback sneak before you’d want Mayfield. But the QB’s main job is throwing to open receivers, and Mayfield looks better at that. He’s learning his top guys now in DJ Moore and Robbie Anderson. “DJ’s a guy (who you) just give him a chance,” Mayfield said. “He’s a contested-catch guy, real physical at the top of his routes… Robbie… just being able to separate with his speed and trusting that he’s going to run by people. The cliched thing of, ‘if he’s even, he’s leavin’ — that’s true of Robbie.” As for rookie Matt Corral: he can throw, which is no surprise. But he needs more seasoning, and right now is going to be this team’s No. 3 QB, with P.J. Walker the odd man out unless someone gets hurt. Maybe I’m wrong, Rhule runs a double reverse and Darnold will end up starting. I do think he will be on the roster regardless. I don’t set any stock on the latest Darnold trade rumor, simply because the team that already was willing to offer a major ransom for Darnold already employs him (looking at you, Panthers). “I’m just gonna continue to do me and do what I can to put myself in a good position,” Darnold said Monday. At some point, both of them are going to play during the regular season. I don’t think either of these QBs are durable enough, nor their revamped offensive line quite good enough, to start all 17 games. But the guy who starts Week 1? Looks like Baker all the way to me.
https://www.thehamdenjournal.com/world/even-though-panthers-coach-matt-rhule-wont-say-it-one-qb-clearly-looks-better-so-far/292556/
2022-08-09T12:44:37Z
https://www.thehamdenjournal.com/world/even-though-panthers-coach-matt-rhule-wont-say-it-one-qb-clearly-looks-better-so-far/292556/
true
3
Early Trading Has Kodiak (KOD) Climbing for August 8 Equities Staff Follow |Shares of Kodiak Sciences Inc (NASDAQ:KOD) are on the move in pre-market trading for August 8. Ahead of the market's open, Kodiak stock is up 30.19% from the previous session’s close. Kodiak gained $0.58 in the last session and aims for another gain today. For technical charts, analysis, and more on Kodiak visit the company profile. Pre-market prices and movements as of 08:32:10 est. About Kodiak Sciences Inc Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Its ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's lead product candidate, KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development including KSI-501, its bispecific anti-IL-6/VEGF biopolymer conjugate for the treatment of neovascular retinal diseases with an inflammatory component, and the company is expanding its early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA. To get more information on Kodiak Sciences Inc and to follow the company's latest updates, you can visit the company's profile page here: Kodiak Sciences Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info. Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis. DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
https://www.equities.com/news/early-trading-has-kodiak-kod-climbing-for-august-8
2022-08-09T12:46:06Z
https://www.equities.com/news/early-trading-has-kodiak-kod-climbing-for-august-8
true
13
Nobelpharma Will Also Have an Exhibit at the Conference BETHESDA, Md., Aug. 9, 2022 /PRNewswire/ -- Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, today announced that data from a scientific poster on a survey of caregivers and individuals with tuberous sclerosis complex (TSC) will be presented at the Masters of Pediatric Dermatology Conference August 11-12, 2022 in Miami, Florida. In addition to the scientific poster, the company will have Nobelpharma exhibit space at the meeting. "Characterization of facial angiofibroma and understanding its management in the US may help to provide meaningful treatment options and support for this rare disease," said Yoshiki Kida, President and CEO of Nobelpharma America. "We are excited to share this data from the Natural History database with the clinicians who are often on the front lines of caring for people who live with TSC." Details of Poster Presentation: Title: Factors Associated with Facial Angiofibroma Related to Tuberous Sclerosis Complex and use of Topical mTOR Inhibitor in the United States: A Retrospective Analysis of the Natural History Database Presenter: Sreedevi Boggarapu, PhD, CMPP, Director, Scientific Publications at Nobelpharma America, or a Medical Affairs colleague will be onsite during official breaks: Thursday, August 11th - 9:30am-10:00am - 11:30am – 12:00pm - 12:45pm-1:15pm - 3:00pm – 3:30pm Friday, August 12th - 9:00am – 9:15am - 11:30am – 12:00pm - 12:45pm – 1:15pm - 2:45pm – 3:00pm Nobelpharma will also have exhibit space at the Masters of Pediatric Dermatology Conference, where the company will display medical information on facial angiofibroma due to TSC. For more information and to register for the 30th Annual Masters of Pediatric Dermatology Conference, visit https://www.livderm.org/masters-of-pediatric-dermatology-2022/. About Tuberous Sclerosis Complex (TSC): TSC is a rare genetic disease that affects approximately one in 6,000 live births. Nearly one million people worldwide are estimated to have TSC, with approximately 50,000 in the United States. TSC causes non-cancerous tumors, or hamartomas, to form in vital organs including the skin. TSC may also cause facial angiofibromas, which are pink or red bumps usually located on the cheeks, nose, and chin that may cause bleeding, itching, redness, and significant disfiguration without treatment. Many individuals with TSC also present with autism, epilepsy, and other neuropsychiatric disorders. About Nobelpharma America Nobelpharma America, LLC (NPA) is focused on the commercialization of pharmaceuticals and medical devices that expand treatment options for people with rare diseases. In 2019, NPA became the first wholly owned global subsidiary of Nobelpharma Co., Ltd., which is based in Tokyo. The company, which is named after Alfred Nobel, remains committed to honoring his innovative and scientific legacy by developing treatments for diseases that often go overlooked because of the small number of individuals affected. For more information visit nobelpharma-us.com. View original content to download multimedia: SOURCE Nobelpharma America
https://www.kltv.com/prnewswire/2022/08/09/nobelpharma-america-presents-findings-natural-history-database-tsc-alliance-characterization-facial-angiofibroma-use-topical-rapamycin-people-with-tuberous-sclerosis-complex-us-30th-annual-masters-pediatric-dermatology-conference/
2022-08-09T12:47:03Z
https://www.kltv.com/prnewswire/2022/08/09/nobelpharma-america-presents-findings-natural-history-database-tsc-alliance-characterization-facial-angiofibroma-use-topical-rapamycin-people-with-tuberous-sclerosis-complex-us-30th-annual-masters-pediatric-dermatology-conference/
false
11
Elden Ring nerfs Bloodhound Step in latest patch ELDEN Ring is one of the most popular games of 2022, and developer FromSoftware has released another patch to help balance the game. The most approachable Soulsbourne games to date, FromSoftware has worked endlessly to release updates which balance the weapons and builds in-game. This is so that players can feel justified in their choices, whatever they are, and do not feel like they have missed out by not picking up a particular weapon or spell. However, all things are not yet created equal. Here are the biggest changes which will affect how people play Elden Ring. Bloodhound Step nerfed The latest 1.06 patch has finally nerfed one of the most overpowered skills in the game, Bloodhound Step. As long as a player had FP - the game’s magic - they could use Bloodhound Step continuously allowing them to be practically invincible and move swiftly. Since the update, the more times you use Bloodhound Step in a row, the less distance and invulnerability you have. Quick Step will also see a reduction in performance, but you will also be able to chain it more quickly. Rivers of Blood nerfed This is not the first time Rivers of Blood has received a downgrade, but this time only the Corpse Piler skill is affected. Blood attacks have been weakened along with reduced bleed damage build-up. Most read in Tech However, when hit with the blade in close combat, the skill still deals a considerable amount of damage. New NPC for Varre's quest A few changes have been made to NPC quests with the biggest being to Varre’s questline. Previously, you had to invade someone else’s game in order to complete the quest. Now there is an NPC in-game which you can choose to fight instead. This is good for those who don’t pay for online console subscriptions. Summoning pool changes Thanks to the latest patch you will now be able to send summoning signs to summoning pools in multiple areas at once. This means you can now invade a much larger area and at greater distance. The change excludes Mohgwyn Palace, but should make multiplayer fights easier than before. Stars of Ruin-ed Fan favourite spell, Stars of Ruin, has received a significant nerf, in particular against multiplayer enemies. Target tracking has been reduced, meaning foes are more likely to be able to evade the attack. Greatsword, Curved Greatsword, and Great Hammer improvements Despite all the nerfs, a number of weapons are also being improved. Each of these weapon classes will receive a speed increase to guard counters, strong attacks, charge attacks, and rolls. You’ll also get to roll further with these weapons than ever before. Full patch notes can be read on Bandai Namco’s website. Written by Georgina Young on behalf of GLHF. All the latest Gaming tips and tricks Looking for tips and tricks across your favourite consoles and games? We have you covered... - All the video game releases in 2022 - Can you play PS4 games on PS5? - All of the Call of Duty games in order - Every Assassin's Creed game in order - All the GTA 5 mods and cheats - What are the Pokemon Go Eevee Evolutions? - Everything you need to know about Roblox - Who created Fortnite? - Most popular Roblox games - How to get free Robux - How many people play Fortnite? - Best PS4 games with free PS5 upgrades - Who is the highest-paid Twitch streamer? Get all of the latest PS5, Xbox and other video game news here
https://www.the-sun.com/tech/5961138/elden-ring-106-patch-notes/
2022-08-09T12:47:29Z
https://www.the-sun.com/tech/5961138/elden-ring-106-patch-notes/
false
4
Banco Santander S.A. bought a new stake in Universal Health Services, Inc. (NYSE:UHS – Get Rating) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,273 shares of the health services provider’s stock, valued at approximately $329,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in shares of Universal Health Services by 5.3% during the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 38,372 shares of the health services provider’s stock valued at $5,562,000 after purchasing an additional 1,915 shares in the last quarter. Sector Gamma AS boosted its position in shares of Universal Health Services by 4.9% during the 1st quarter. Sector Gamma AS now owns 47,467 shares of the health services provider’s stock valued at $6,880,000 after purchasing an additional 2,229 shares in the last quarter. AIA Group Ltd boosted its position in shares of Universal Health Services by 42.8% during the 1st quarter. AIA Group Ltd now owns 1,001 shares of the health services provider’s stock valued at $145,000 after purchasing an additional 300 shares in the last quarter. IFM Investors Pty Ltd boosted its position in shares of Universal Health Services by 9.8% during the 1st quarter. IFM Investors Pty Ltd now owns 11,313 shares of the health services provider’s stock valued at $1,640,000 after purchasing an additional 1,013 shares in the last quarter. Finally, 1ST Source Bank bought a new position in shares of Universal Health Services during the 1st quarter valued at about $216,000. Institutional investors own 89.41% of the company’s stock. Analysts Set New Price Targets Several research analysts have commented on UHS shares. Wells Fargo & Company decreased their target price on shares of Universal Health Services from $139.00 to $118.00 in a report on Thursday, April 28th. Barclays decreased their target price on shares of Universal Health Services from $133.00 to $115.00 in a report on Friday, July 29th. Royal Bank of Canada reduced their price target on shares of Universal Health Services from $149.00 to $130.00 in a research report on Wednesday, April 27th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Universal Health Services from $160.00 to $130.00 in a research report on Wednesday, July 27th. Finally, TheStreet lowered shares of Universal Health Services from a “b-” rating to a “c+” rating in a research report on Tuesday, June 21st. Five equities research analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $123.29. Universal Health Services Trading Down 0.2 % Universal Health Services (NYSE:UHS – Get Rating) last released its quarterly earnings results on Monday, July 25th. The health services provider reported $2.20 EPS for the quarter, beating analysts’ consensus estimates of $2.10 by $0.10. Universal Health Services had a net margin of 5.94% and a return on equity of 12.88%. The company had revenue of $3.32 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same quarter last year, the firm posted $3.76 earnings per share. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Equities analysts anticipate that Universal Health Services, Inc. will post 9.9 EPS for the current year. Universal Health Services Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 15th. Stockholders of record on Thursday, September 1st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Wednesday, August 31st. This represents a $0.80 annualized dividend and a dividend yield of 0.73%. Universal Health Services’s payout ratio is 8.15%. Universal Health Services Company Profile Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. Read More - Get a free copy of the StockNews.com research report on Universal Health Services (UHS) - Home Depot, Lowe’s On Track To Grow 2022 Earnings - Could Smaller be Better for Investors in Norwegian Cruise Lines? - Walmart Or Target: Which Is The Stronger Stock? - Volume Surges Spark Turnarounds for These 3 Stocks - Can Etsy Continue to Thrive After the Pandemic? Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
https://www.americanbankingnews.com/2022/08/09/banco-santander-s-a-buys-new-position-in-universal-health-services-inc-nyseuhs.html
2022-08-09T12:47:57Z
https://www.americanbankingnews.com/2022/08/09/banco-santander-s-a-buys-new-position-in-universal-health-services-inc-nyseuhs.html
true
1
BENTONVILLE, Ark., Aug. 9, 2022 /PRNewswire/ -- Retail SaaS company Movista expands its executive leadership team with C-Suite veterans Scot DeLancey, Chief Product Officer (CPO), and Madhu Kota, Chief Technology Officer (CTO). DeLancey and Kota will lead the product and technology teams respectively to drive innovation for Movista's industry-leading retail execution and mobile-first workforce management platform. As CPO, DeLancey will guide Movista's product vision and direction from ideation to execution, with responsibility for the product strategy, product management, product marketing, and UI/UX functions. With more than twenty-five years of experience in technology and product management across several industries, he will bring significant value to Movista's product evolution. "Product innovation boils down to one thing: solving customers' problems," DeLancey said. "I can't wait to help alleviate our clients' challenges and work cross-functionally to deliver the best product possible." As CTO, Kota will spearhead all aspects of technology including technology strategy, product engineering, and R&D functions, ensuring Movista has the foundation to meet customers' current and future needs. He brings with him more than twenty-five years of experience in information technology and product development across various industries, from e-commerce to FinTech. "My goal as Movista's CTO is to foster a culture of technology excellence," Kota noted. "Movista is at the cutting edge of retail software innovation. I'm looking forward to collaborating with others to build beautifully simple solutions to complex business problems." "The needs of retail teams grow more complex every day," said Movista co-founders Stan Zylowski, CEO, and April Seggebruch, Chief Strategy Officer. "Scot and Madhu are visionaries who will enable us to push the boundaries of our software and provide complete front door, store floor, and back door control for all retail stakeholders, backed by data-driven automation sets and advanced optimizations. Our goal is to empower our clients with the solutions they need to thrive in and out of retail stores." Movista is a global leader in retail execution and workforce management solutions. We believe the future of retail work is radically transparent and collaborative. As the world's first and only SaaS platform to enable collaboration between retailers, brands, service providers, and distributors, we are transforming the execution of all work and engagement by all teams in the retail ecosystem. Learn more at www.movista.com and connect with us on LinkedIn, Twitter, Facebook, and Instagram. View original content to download multimedia: SOURCE Movista
https://www.wcax.com/prnewswire/2022/08/09/movista-welcomes-two-product-veterans-leadership-team/
2022-08-09T12:48:51Z
https://www.wcax.com/prnewswire/2022/08/09/movista-welcomes-two-product-veterans-leadership-team/
false
11
It's been 20 long years since Brazil lifted the last of the country's five World Cups, so fittingly they have called upon the star of that tournament to help launch their kits for the 2022 World Cup. 2002 was Ronaldo's phoenix moment, rising from the flames of four injury-wrecked seasons to finish the tournament with the Golden Boot as top scorer GOAL loves the new kits nearly as much as we love O Fenomeno in wavey Air Max 90s. The Jaguar is an important symbol to the people of Brazil, and a subtle all-over jaguar pattern adorns the home kit. The Green and blue of the national flag are used for the sleeve cuffs and collar, and detailing on the collar shows the Brazil flag when left unbuttoned. The jaguar pattern is even more loud and proud on the away kit, which comes in the iconic brilliant blue colourway. Luminescent green bleeds into the blue on the sleeves to further reveal the patterning of the large cat, and both kits are made from 100% recycled plastic bottles. Brazil 2022 World Cup home and away kit price and how to buy We independently choose all products featured on our site. We may earn a commission when you purchase something through the links provided. The Brazil World Cup 2022 home and away kits will be available to pre-order from PRO: Direct Soccer.
https://www.goal.com/en-us/news/brazil-2022-world-cup-home-away-kit/blt8e866b5305e8e866
2022-08-09T12:48:53Z
https://www.goal.com/en-us/news/brazil-2022-world-cup-home-away-kit/blt8e866b5305e8e866
false
13
Mike Stringile Named International Sales Director DENVER, Aug. 9, 2022 /PRNewswire/ -- CryoMass Technologies Inc. (the "Company" or "CryoMass") (OTCQX: CRYM) welcomes Mike Stringile to lead its worldwide sales team as it prepares to launch its first commercial installation next month in Monterey, California. Mr. Stringile brings unsurpassed cannabis industry extraction knowledge and sales experience to CryoMass. Mike began his extraction career working in the oil and gas industry in Fort McMurray, Alberta, where he was immersed in the complex world of extracting hydrocarbons from oil sands. After spending more than seven years honing his technical knowledge of hydrocarbon extraction processes, Mike was given the opportunity to apply his extraction expertise to the burgeoning new cannabis industry. In November 2018, Mr. Stringile joined an upstart C02 extraction company based in Kelowna, British Columbia, called Vitalis Extraction Technologies. It didn't take long for Mike's expertise to pay off. Mike integrated his oil and gas industry knowledge into the design of their extractors, which resulted in the development of industry-leading C02 extractors for the cannabis industry. Simultaneously Mike built an ancillary sales department that did much more than sell extractors; it sold much-needed extraction knowledge and process integration expertise to cannabis companies. In the first 18 months, Mike's sales division generated more than $18 million in revenues for Vitalis. Then in March 2020, during the Covid lockdowns, Mr. Stringile co-founded AGMS Solutions Inc., which continues to provide a comprehensive suite of extraction-oriented consulting services to the cannabis industry. AGMS quickly developed a worldwide network of cannabis cultivators, extractors, and finished goods producers seeking to avail themselves of advanced and customized extraction solutions. CryoMass Director and CEO Christian Noël stated, "Having someone with both the technical extraction expertise and proven sales experience that Mr. Stringile possesses is extremely rare in today's cannabis industry. I am extremely confident that between Mike and our current Director of U.S. Sales, Steve Cimini, we have the perfect team to rapidly build an international sales and toll-partnering network that generates millions of dollars of revenues." Mr. Stringile, commenting on his appointment, stated, "I am extremely excited about the opportunity to lead the development and deployment of a robust international sales effort for CryoMass. I've seen just about everything there is to see when it comes to extraction technologies and when I understood what these guys were up to, I immediately thought of just one thing… this will change everything. And the beauty of this must-have technology is that it is patent-protected until 2038. I see this as a major game changer for the entire industry – globally." The common stock of CryoMass Technologies Inc. trades on the OTC QX market under the symbol CRYM. For further information, please contact the Company by email at investors@cryomass.com or by telephone at +1 833 256 2382. This press release is not an offer of securities, or a solicitation for purchase, subscription or sale of securities in the United States of America or in any other jurisdiction in which it would be unlawful to do so. This press release may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 that involve known and unknown risks, uncertainties and other factors, including risk factors identified in the Company's SEC filings, and which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, changes in the regulatory environment affecting the sale and use of cannabis or hemp products and of other, potential lines of businesses that the Company will consider entering at a given time, demand for the Company's products, internal funding and the financial condition of the Company, product roll-out, competition, our dependence upon our commercial partners, variations in the global commodities markets and other commercial matters involving the Company, its products and the markets in which the Company operates or seeks to enter, as well as general economic conditions. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Marijuana, as defined in the U.S. Controlled Substances Act, remains a Schedule I drug under the respective act, making it illegal under federal law in the U.S. to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the U.S. may form the basis for prosecution under applicable U.S. federal money laundering legislation. Please carefully review the Company's SEC filings with respect to related risk factor. View original content to download multimedia: SOURCE CryoMass Technologies Inc
https://www.wrdw.com/prnewswire/2022/08/09/cryomass-technologies-appoints-top-extractor-sales-veteran-lead-global-sales-just-ahead-california-product-launch/
2022-08-09T12:49:50Z
https://www.wrdw.com/prnewswire/2022/08/09/cryomass-technologies-appoints-top-extractor-sales-veteran-lead-global-sales-just-ahead-california-product-launch/
false
13
Seaport Res Ptn restated their neutral rating on shares of B&G Foods (NYSE:BGS – Get Rating) in a report released on Friday morning, PriceTargets.com reports. A number of other analysts also recently issued reports on the stock. StockNews.com raised shares of B&G Foods from a sell rating to a hold rating in a report on Friday. Piper Sandler upped their price target on shares of B&G Foods from $23.00 to $27.00 and gave the company a neutral rating in a research report on Tuesday, August 2nd. Finally, BMO Capital Markets decreased their price target on shares of B&G Foods from $29.00 to $21.00 and set a market perform rating for the company in a research report on Monday. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. Based on data from MarketBeat, the company has an average rating of Hold and an average price target of $24.67. B&G Foods Trading Up 2.0 % NYSE BGS opened at $23.91 on Friday. B&G Foods has a 1-year low of $21.05 and a 1-year high of $34.27. The company has a current ratio of 3.27, a quick ratio of 0.89 and a debt-to-equity ratio of 2.44. The company has a market capitalization of $1.71 billion, a PE ratio of 40.53 and a beta of 0.26. The firm’s fifty day simple moving average is $23.69 and its 200-day simple moving average is $26.27. B&G Foods Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Monday, October 31st. Stockholders of record on Friday, September 30th will be issued a dividend of $0.475 per share. This represents a $1.90 dividend on an annualized basis and a dividend yield of 7.95%. The ex-dividend date of this dividend is Thursday, September 29th. B&G Foods’s dividend payout ratio (DPR) is presently 322.03%. Hedge Funds Weigh In On B&G Foods Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Advisors Asset Management Inc. increased its holdings in B&G Foods by 5.8% in the 2nd quarter. Advisors Asset Management Inc. now owns 543,157 shares of the company’s stock worth $12,916,000 after acquiring an additional 29,990 shares in the last quarter. Baird Financial Group Inc. boosted its stake in B&G Foods by 10.5% during the second quarter. Baird Financial Group Inc. now owns 58,676 shares of the company’s stock worth $1,395,000 after buying an additional 5,576 shares during the period. Texas Permanent School Fund boosted its stake in shares of B&G Foods by 8.0% during the second quarter. Texas Permanent School Fund now owns 49,679 shares of the company’s stock valued at $1,181,000 after purchasing an additional 3,670 shares during the period. ING Groep NV boosted its stake in shares of B&G Foods by 19.8% during the second quarter. ING Groep NV now owns 38,677 shares of the company’s stock valued at $920,000 after purchasing an additional 6,389 shares during the period. Finally, State Board of Administration of Florida Retirement System boosted its stake in shares of B&G Foods by 29.8% during the second quarter. State Board of Administration of Florida Retirement System now owns 32,173 shares of the company’s stock valued at $765,000 after purchasing an additional 7,378 shares during the period. Institutional investors own 64.72% of the company’s stock. B&G Foods Company Profile B&G Foods, Inc manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico. The company's products include frozen and canned vegetables, vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, maple syrups, molasses, salad dressings, pizza crusts, Mexican-style sauces, dry soups, taco shells and kits, salsas, pickles, peppers, tomato-based products, baking powder and soda, corn starch, cookies and crackers, nut clusters, and other specialty products. See Also - Get a free copy of the StockNews.com research report on B&G Foods (BGS) - Home Depot, Lowe’s On Track To Grow 2022 Earnings - Could Smaller be Better for Investors in Norwegian Cruise Lines? - Walmart Or Target: Which Is The Stronger Stock? - Can Etsy Continue to Thrive After the Pandemic? - MarketBeat Podcast: Investing in What You Know Has Changed Receive News & Ratings for B&G Foods Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for B&G Foods and related companies with MarketBeat.com's FREE daily email newsletter.
https://www.americanbankingnews.com/2022/08/09/bg-foods-nysebgs-given-neutral-rating-at-seaport-res-ptn-2.html
2022-08-09T12:49:57Z
https://www.americanbankingnews.com/2022/08/09/bg-foods-nysebgs-given-neutral-rating-at-seaport-res-ptn-2.html
false
2
Most Read - Warmer, Still Sunny Tuesday - Rain Chance Late In The Week - Morning forecast: Partly sunny with high of 84 - Hot Friday - Soaking Rains This Weekend - More rain today, then cooler, then heat returns - Watch storm clouds roll in across the Twin Cities
https://m.startribune.com/morning-forecast-partly-sunny-with-high-of-84/600196836/
2022-08-09T12:51:59Z
https://m.startribune.com/morning-forecast-partly-sunny-with-high-of-84/600196836/
false
null
Announced achievement of THCV equity milestone Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), today announces its 2022 second quarter business results. "I am encouraged by the progress we are making to realign our business around our brands to become more efficient in our decision making and agile throughout our supply chain," said Mike Gorenstein, Chairman, President and CEO, Cronos. "Our supply chain transformation in Canada is going very well, with GrowCo achieving profitability in the year-to-date period, and the operational efficiencies we envisioned when we embarked on this initiative are starting to be realized. We are also refocusing the U.S. business to prioritize hero SKUs while leaning into adult-use product formats and concentrating on the direct-to-consumer channel. Although early in the repositioning of our U.S. business, we are confident the new strategy will improve our bottom-line while maintaining brand equity that we can leverage into cannabinoids beyond CBD, and in the U.S. THC market once regulations permit." "As we realign our business, we remain focused on what we know will drive differentiation: product development and long-term focused innovation. We continue to expand our borderless cannabinoid product portfolio with the recent launch of a CBN vape and gummy in select markets in Canada, and we achieved the THCV equity milestone in partnership with Ginkgo. Continuing to hit these productivity milestones fuels our innovation pipeline focused on creating borderless products with rare cannabinoids that amplify and differentiate the consumer experience. With a focus on utilizing rare cannabinoids, you have seen the success of our approach in the gummy category in Canada. We intend to apply this same strategy to win in other categories such as vapes and pre-rolls." Financial Results (i) Gross margin is defined as gross profit divided by net revenue. (ii) Net loss of $20.3 million in Q2 2022 improved by $159.0 million from Q2 2021. The improvement year-over-year was primarily driven by the reduction in the non-cash impairment loss on goodwill and indefinite-lived intangible assets and the fluctuation in the non-cash gain on revaluation of derivative liabilities. (iii) See "Non-GAAP Measures" for more information, including a reconciliation of adjusted earnings (loss) before interest, taxes, depreciation and amortization ("Adjusted EBITDA") to net income (loss). (iv) Dollar amounts are as of the last day of the period indicated. (v) Capital expenditures represent component information of investing activities and is defined as the sum of purchase of property, plant and equipment, and purchase of intangible assets. Second Quarter 2022 - Net revenue of $23.1 million in Q2 2022 increased by $7.4 million from Q2 2021. The increase year-over-year was primarily driven by an increase in net revenue in the Rest of World ("ROW") segment driven by growth in the Israeli medical market and the Canadian adult-use market. - Gross profit of $4.1 million in Q2 2022 improved by $19.9 million from Q2 2021. The improvement year-over-year was primarily driven by the absence of inventory write-downs in the current period, increased revenue in the ROW segment driven mainly by sales of cannabis flower, a favorable mix of cannabis extract products that carry a higher gross profit and gross margin than other product categories, and lower cannabis biomass costs. Partially offset by lower fixed cost absorption due to the timing of wind down activities associated with the exit of the Peace Naturals Campus. - Adjusted EBITDA of $(18.8) million in Q2 2022 improved by $31.0 million from Q2 2021. The improvement year-over-year was primarily driven by the improvement in gross profit and a decrease in sales and marketing, and general and administrative expenses as a result of the Company's strategic realignment (the "Realignment"). - Capital expenditures of $1.9 million were essentially unchanged. Business Updates Strategic and Organizational Update In the second quarter of 2022, following an evaluation of the U.S. business as part of the Company's Realignment, the Company began a phased exit of the wholesale beauty category to focus the portfolio on adult-use product formats within the direct-to-consumer channel. As a result, the Company reduced sales and marketing headcount in the U.S. to better align the business structure with the new strategy. Due to the restructuring of the U.S. business and other newly identified cost savings opportunities, the Company now expects to incur approximately $6.4 million in expenses in connection with the Realignment, an increase from the previously stated $5.8 million. In addition, the Company anticipates capital expenditures as a result of the Realignment of approximately $2.2 million to modernize information technology systems and build distribution capabilities. As of June 30, 2022, related capital expenditures were $0.3 million. As the Company continues with its transition through the second half of 2022, it anticipates that it will begin to incur the majority of the expected capital expenditures as part of the Realignment. Brand and Product Portfolio In the second quarter of 2022, Spinach ® continued to organically expand market share in the edibles category in Canada. According to Hifyre data, Spinach ® held an approximate 14.3% market share in the edibles category across Canada, which expands to approximately 18.6% within the gummy category during Q2 2022. Furthermore, three out of four SOURZ by Spinach™ gummies ranked in the top-10 for market share in Canada in Q2 2022 and all five of our gummy products across SOURZ by Spinach™ and Spinach FEELZ™ were in the top-15 for the same period. The strong growth and demand for the products in the second quarter culminated in the SOURZ by Spinach™ brand winning 'Favorite Edible Product', in the People's Choice category at the O'Cannabiz Conference & Expo. Subsequent to the second quarter, in July and August 2022, the Company launched two rare cannabinoid products featuring cannabinol ("CBN") across select markets in Canada with intentions to expand across Canada over time. The first was a gummy featuring CBN under the Spinach FEELZ™ brand, Deep Dreamz Blueberry Pomegranate (2:1 THC|CBN), featuring 2 gummies per pack with 10mg THC and 5mg CBN per pack. The addition of a CBN-focused gummy further builds on our borderless rare cannabinoid portfolio and award-winning gummy platform. Additionally, the Company complemented the CBN gummy launch with an offering in the vape category, the Spinach FEELZ™ Deep Dreamz Blackberry Kush (7:1 THC|CBN) 1-gram vape. Intellectual Property Initiatives In June 2022, Cronos announced the achievement of the final productivity target for tetrahydrocannabivarin ("THCV") under its strategic partnership (the "Ginkgo Strategic Partnership") with Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ("Ginkgo"). THCV is hypothesized to reduce the appetite-enhancing property of THC. The Company is excited about the possibilities THCV is expected to provide and looks forward to getting more products with rare cannabinoids into market. Global Supply Chain In the second quarter of 2022, Cronos Growing Company Inc. ("Cronos GrowCo") reported to the Company preliminary unaudited net revenue of approximately $5.2 million to licensed producers excluding sales to the Company. According to preliminary unaudited year-to-date results as of June 30, 2022, Cronos GrowCo has achieved profitability, and continues to build its wholesale customer base and is becoming a meaningful contributor to the Canadian cannabis supply chain. It was always Cronos' belief that large-scale agricultural producers would be the winners in cultivation and we are seeing early signs of this coming to fruition. Appointments In August 2022, the Company appointed Arye Weigensberg as Senior Vice President, Head of Research & Development, after serving in an interim capacity since November 2021. Prior to serving as interim Head of Research and Development, Mr. Weigensberg was the General Manager and Vice President of Research and Technology at Cronos Research Labs. Before joining the Company, Mr. Weigensberg was the CEO of Altria Israel Ltd (an Altria research and development hub). Since joining Cronos, Mr. Weigensberg has played a foundational role developing the scope of our rare cannabinoid work, while advancing our research capabilities to forge new strategies for differentiated cannabis products. Rest of World Results Cronos' ROW reporting segment includes results of the Company's operations for all markets outside of the U.S. Second Quarter 2022 - Net revenue of $21.6 million in Q2 2022 increased by $8.2 million from Q2 2021. The increase year-over-year was primarily driven by an increase in net revenue in the Israeli medical market largely attributable to the cannabis flower category and the Canadian adult-use market driven primarily by cannabis extract products. - Gross profit of $4.3 million in Q2 2022 improved by $20.8 million from Q2 2021. The improvement year-over-year was primarily driven by the absence of inventory write-downs in the current period, increased cannabis flower revenue, the introduction of additional cannabis extract products that carry a higher gross profit and gross margin than other product categories, and lower cannabis biomass costs as we further leverage our joint venture with Cronos GrowCo. Partially offset by lower fixed cost absorption due to the timing of wind down activities associated with the exit of the Peace Naturals Campus. United States Results Cronos' U.S. reporting segment includes results of the Company's operations for all brands and products in the U.S. Second Quarter 2022 - Net revenue of $1.5 million in Q2 2022 decreased by $0.8 million from Q2 2021. The decrease year-over-year was primarily driven by a reduction in volume as a result of a decrease in promotional spending and SKU rationalization efforts as the Company implements the Realignment with respect to the U.S. segment. - Gross profit of $(0.2) million in Q2 2022 decreased by $0.8 million from Q2 2021. The decrease year-over-year was primarily due to lower sales volumes and increased inventory reserves. Conference Call The Company will host a conference call and live audio webcast on Tuesday, August 9, 2022, at 8:30 a.m. ET to discuss 2022 Second Quarter business results. An audio replay of the call will be archived on the Company's website for replay. Instructions for the live audio webcast are provided on the Company's website at https://ir.thecronosgroup.com/events-presentations . About Cronos Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach ® , PEACE NATURALS ® , Lord Jones ® , Happy Dance ® and PEACE+ ® . For more information about Cronos and its brands, please visit: thecronosgroup.com. Forward-Looking Statements This press release contains information that constitutes forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively, "Forward-Looking Statements"), which are based upon our current internal expectations, estimates, projections, assumptions and beliefs. All information that is not clearly historical in nature may constitute Forward-Looking Statements. In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussion of strategy. Forward-Looking Statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact. Forward-Looking Statements include, but are not limited to, statements with respect to: - the uncertainties associated with the COVID-19 pandemic, including our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue our production, distribution and sale of our products, and demand for and the use of our products by consumers; - laws and regulations and any amendments thereto applicable to our business and the impact thereof, including uncertainty regarding the application of U.S. state and federal law to U.S. hemp (including CBD and other U.S. hemp-derived cannabinoids) products and the scope of any regulations by the U.S. Food and Drug Administration, the U.S. Drug Enforcement Administration, the U.S. Federal Trade Commission, the U.S. Patent and Trademark Office and any state equivalent regulatory agencies over U.S. hemp (including CBD and other U.S. hemp-derived cannabinoids) products; - the laws and regulations and any amendments thereto relating to the U.S. hemp industry in the U.S., including the promulgation of regulations for the U.S. hemp industry by the U.S. Department of Agriculture and relevant state regulatory authorities; - expectations related to our Realignment and any progress, challenges and effects related thereto as well as changes in strategy, metrics, investments, reporting structure, costs, operating expenses, employee turnover and other changes with respect thereto; - the timing of our exit from our facility in Stayner, Ontario (the "Stayner Facility") and the expected costs and benefits from the wind-down of the Stayner Facility; - our ability to effectively wind-down the Stayner Facility in an organized fashion and acquire raw materials from other suppliers, including Cronos GrowCo and the costs and timing associated therewith; - the grant, renewal and impact of any license or supplemental license to conduct activities with cannabis or any amendments thereof; - our international activities and joint venture interests, including required regulatory approvals and licensing, anticipated costs and timing, and expected impact; - our ability to successfully create and launch brands and further create, launch and scale U.S. hemp-derived cannabinoid consumer products and cannabis products; - the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, including CBD and other cannabinoids; - expectations regarding the implementation and effectiveness of key personnel changes; - the anticipated benefits and impact of Altria Group Inc.'s investment in the Company (the "Altria Investment"), pursuant to a subscription agreement dated December 7, 2018; - the potential exercise of one warrant of the Company included as part of the Altria Investment, pre-emptive rights and/or top-up rights in connection with the Altria Investment, including proceeds to us that may result therefrom; - expectations regarding the use of proceeds of equity financings, including the proceeds from the Altria Investment; - the legalization of the use of cannabis for medical or adult-use in jurisdictions outside of Canada, the related timing and impact thereof and our intentions to participate in such markets, if and when such use is legalized; - expectations regarding the potential success of, and the costs and benefits associated with, our joint ventures, strategic alliances and equity investments, including the Ginkgo Strategic Partnership; - our ability to execute on our strategy and the anticipated benefits of such strategy, including focusing on rare cannabinoids and focusing the portfolio of our U.S. hemp business on adult-use adjacent products within the direct-to-consumer channel; - expectations of the amount or frequency of impairment losses, including as a result of the write-down of intangible assets, including goodwill; - the ongoing impact of the legalization of additional cannabis product types and forms for adult-use in Canada, including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and our intentions to participate in such markets; - the future performance of our business and operations; - our competitive advantages and business strategies; - the competitive conditions of the industry; - the expected growth in the number of customers using our products; - our ability or plans to identify, develop, commercialize or expand our technology and research and development initiatives in cannabinoids, or the success thereof; - expectations regarding acquisitions and dispositions and the anticipated benefits therefrom; - uncertainties as to our ability to exercise our option to buy Class A shares of common stock of PharmaCann Inc. (the "PharmaCann Option") in the near term or the future in full or in part, including the uncertainties as to the status and future development of federal legalization of cannabis in the U.S. and our ability to realize the anticipated benefits of the transaction with PharmaCann Inc. ("PharmaCann"); - expectations regarding revenues, expenses and anticipated cash needs; - expectations regarding cash flow, liquidity and sources of funding; - expectations regarding capital expenditures; - expectations regarding our future production and manufacturing strategy and operations, the costs and timing associated therewith and the receipt of applicable production and sale licenses; - expectations regarding our growing, production and supply chain capacities; - expectations regarding the resolution of litigation and other legal and regulatory proceedings, reviews and investigations; - expectations with respect to future production costs; - expectations with respect to cultivation, including the success of large scale agriculture producers; - expectations with respect to future sales and distribution channels and networks; - the expected methods to be used to distribute and sell our products; - the impact of the ongoing military conflict between Russia and Ukraine (and resulting sanctions) on our business, financial condition and results of operations or cash flows; - the anticipated future gross margins of our operations; - accounting standards and estimates; - our ability to timely and effectively remediate any material weaknesses in our internal control over financial reporting; and - expectations regarding the costs and benefits associated with our contracts and agreements with third parties, including under our third party supply and manufacturing agreements. Certain of the Forward-Looking Statements contained herein concerning the industries in which we conduct our business are based on estimates prepared by us using data from publicly available governmental sources, market research, industry analysis and on assumptions based on data and knowledge of these industries, which we believe to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. The industries in which we conduct our business involve risks and uncertainties that are subject to change based on various factors, which are described further below. The Forward-Looking Statements contained herein are based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including: (i) our ability to efficiently and effectively exit the Stayner Facility, receive the benefits of the Stayner Facility wind down and acquire raw materials on a timely and cost-effective basis from third parties, including Cronos GrowCo; (ii) our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic and the ability to continue our production, distribution and sale of our products and customer demand for and use of our products; (iii) management's perceptions of historical trends, current conditions and expected future developments; (iv) our ability to generate cash flow from operations; (v) general economic, financial market, regulatory and political conditions in which we operate; (vi) the production and manufacturing capabilities and output from our facilities and our joint ventures, strategic alliances and equity investments; (vii) consumer interest in our products; (viii) competition; (ix) anticipated and unanticipated costs; (x) government regulation of our activities and products including, but not limited to, the areas of taxation and environmental protection; (xi) the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; (xii) our ability to obtain qualified staff, equipment and services in a timely and cost-efficient manner; (xiii) our ability to conduct operations in a safe, efficient and effective manner; (xiv) our ability to realize anticipated benefits, synergies or generate revenue, profits or value from our recent acquisitions into our existing operations; (xv) our ability to realize the expected cost-savings, efficiencies and other benefits of our Realignment and employee turnover related thereto; (xvi) our ability to complete planned dispositions, and, if completed, obtain our anticipated sales price; (xvii) our ability to exercise the PharmaCann Option and realize the anticipated benefits of the transaction with PharmaCann; and (xviii) other considerations that management believes to be appropriate in the circumstances. While our management considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, Forward-Looking Statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the Forward-Looking Statements in this press release and other reports we file with, or furnish to, the Securities and Exchange Commission ("SEC") and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf. Such factors include, without limitation, that we may not be able to exit the Stayner Facility in an organized fashion or achieve the anticipated benefits of the exit or be able to access raw materials on a timely and cost-effective basis from third parties, including Cronos GrowCo; the risk that the COVID-19 pandemic and the military conflict between Russia and Ukraine may disrupt our operations and those of our suppliers and distribution channels and negatively impact the demand for and use of our products; the risk that cost savings and any other synergies from the Altria Investment may not be fully realized or may take longer to realize than expected; the risk that we will not complete planned dispositions, or, if completed, obtain our anticipated sales price; the implementation and effectiveness of key personnel changes; the risks that our Realignment, the closure of the Stayner Facility and our further leveraging of our strategic partnerships will not result in the expected cost-savings, efficiencies and other benefits or will result in greater than anticipated turnover in personnel; future levels of revenues; consumer demand for cannabis and U.S. hemp products; our ability to manage disruptions in credit markets or changes to our credit ratings; future levels of capital, environmental or maintenance expenditures, general and administrative and other expenses; the success or timing of completion of ongoing or anticipated capital or maintenance projects; business strategies, growth opportunities and expected investment; the adequacy of our capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute our business plan (either within the expected timeframe or at all); the potential effects of judicial, regulatory or other proceedings, or threatened litigation or proceedings, on our business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or business conditions; compliance with applicable environmental, economic, health and safety, energy and other policies and regulations and in particular health concerns with respect to vaping and the use of cannabis and U.S. hemp products in vaping devices; the anticipated effects of actions of third parties such as competitors, activist investors or federal (including U.S. federal), state, provincial, territorial or local regulatory authorities or self-regulatory organizations; changes in regulatory requirements in relation to our business and products; legal or regulatory obstacles that could prevent us from being able to exercise the PharmaCann Option and thereby realizing the anticipated benefits of the transaction with PharmaCann; dilution of our fully-diluted ownership of PharmaCann and the loss of our rights as a result of that dilution; our remediation of material weaknesses in our internal control over financial reporting and the improvement of our control environment and our systems, processes and procedures; and the factors discussed under Part I, Item 1A "Risk Factors" of the Annual Report. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on Forward-Looking Statements. Forward-Looking Statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management's current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these Forward-Looking Statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the Forward-Looking Statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-Looking Statements are made as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. We undertake no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such Forward-Looking Statements. The Forward-Looking Statements contained in this press release and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements. As used in this press release, "CBD" means cannabidiol and "U.S. hemp" has the meaning given to the term "hemp" in the U.S. Agricultural Improvement Act of 2018, including hemp-derived CBD. Non-GAAP Measures Cronos reports its financial results in accordance with Generally Accepted Accounting Principles in the United States ("U.S. GAAP"). This press release refers to measures not recognized under U.S. GAAP ("non-GAAP measures"). These non-GAAP measures do not have a standardized meaning prescribed by U.S. GAAP and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management's perspective. Accordingly, non-GAAP measures should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP measures presented in this press release are reconciled to their closest reported U.S. GAAP measure. Reconciliations of historical adjusted financial measures to corresponding U.S. GAAP measures are provided below. Adjusted EBITDA Management reviews Adjusted EBITDA, a non-GAAP measure, which excludes non-cash items and items that do not reflect management's assessment of ongoing business performance of our operating segments. Management defines Adjusted EBITDA as net income (loss) before interest, tax expense (benefit), depreciation and amortization adjusted for: share of income (loss) from equity method investments; impairment loss on goodwill and intangible assets; impairment loss on long-lived assets; (gain) loss on revaluation of derivative liabilities; (gain) loss on revaluation of financial instruments; transaction costs related to strategic projects; impairment loss on other investments; foreign currency transaction loss; other, net; loss from discontinued operations; restructuring costs; share-based compensation; and financial statement review costs (and reserves) related to the restatements of the Company's 2019 and 2021 interim financial statements, including the costs related to the Company's responses to the reviews of such interim financial statements by various regulatory authorities and legal costs defending shareholder class action complaints brought against the Company as a result of the 2019 restatement. Management believes that Adjusted EBITDA provides the most useful insight into underlying business trends and results and provides a more meaningful comparison of period-over-period results. Management uses Adjusted EBITDA for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. The following tables set forth a reconciliation of Net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated: Foreign currency exchange rates All currency amounts in this press release are stated in U.S. dollars ("USD"), which is our reporting currency, unless otherwise noted. All references to "dollars" or "$" are to USD. The assets and liabilities of the Company's foreign operations are translated into USD at the exchange rate in effect as of June 30, 2022, June 30, 2021 and December 31, 2021. Transactions affecting shareholders' equity are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and the consolidated statements of cash flows of the Company's foreign operations are translated into USD by applying the average foreign exchange rate in effect for the reporting period using Bloomberg. The exchange rates used to translate from USD to Canadian dollars ("C$") is shown below: For further information, please contact: Shayne Laidlaw Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com
https://investingnews.com/curaleaf-announces-majority-stake-and-forms-strategic-partnership-with-germany-s-four-20-pharma-a-fully-eu-gmp-gdp-licensed-producer-and-distributor-of-medical-cannabis/
2022-08-09T12:52:07Z
https://investingnews.com/curaleaf-announces-majority-stake-and-forms-strategic-partnership-with-germany-s-four-20-pharma-a-fully-eu-gmp-gdp-licensed-producer-and-distributor-of-medical-cannabis/
true
8
Here today Published: 09 AUG 2022 Daily Maverick © All rights reserved There are many great benefits to being a Maverick Insider. Removing advertising from your browsing experience is one of them - we don't just block ads, we redesign our pages to look smarter and load faster. Click here to see other benefits and to sign-up to our reader community supporting quality, independent journalism. Find out More
https://www.dailymaverick.co.za/cartoon/here-today/
2022-08-09T12:53:01Z
https://www.dailymaverick.co.za/cartoon/here-today/
true
null
—Senior healthcare executive with three decades' global experience across large pharma and diverse start-up organizations in finance and business development— WEST HILLS, Calif., Aug. 9, 2022 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer, today announced the appointment of Vikram Lamba, M.B.M. as chief financial officer (CFO) and head of business development. Mr. Lamba replaces Anat Nursella, who served as CFO at ImmPACT Bio since late 2020. "Vikram is a senior finance executive with extensive global healthcare experience and a demonstrated track record across the industry spectrum covering both large pharma companies as well as diverse startup environments, and I am thrilled to welcome him to ImmPACT Bio as our chief financial officer," said Sumant Ramachandra, M.D., Ph.D., M.B.A., president and CEO, ImmPACT Bio. "His broad industry experience in strategic and operational financial areas, especially creating value and scale at start-up companies, combined with his depth of expertise in business development and M&A, will be of great benefit to ImmPACT Bio as we advance our pipeline of next-generation CAR T-cell therapies that harness the immune system and address key challenges for current cell therapies in cancer." "On behalf of the entire ImmPACT Bio team, I want to sincerely thank Anat for her leadership during the transformative period of growth, including consummation of the merger with Kalthera and the Series B financing. Her expertise and commitment across broad areas have been invaluable, and we look forward to her continued partnership as the general manager of our Israel operations," added Dr. Ramachandra. "It is exciting to join ImmPACT Bio at its current stage of successful product development and help scale-up and deliver the pipeline of next-generation CAR T-cell therapies," said Mr. Lamba. "In addition to generating excellent clinical data, ImmPACT Bio has assembled a world-class team and I look forward to being part of that team to deliver on our mission to bring curative therapies to patients living with cancer." Mr. Lamba is a seasoned healthcare executive with deep and extensive global industry experience across numerous pharmaceutical and biotechnology organizations in the areas of management, M&A, finance, corporate development, and strategic alliances. He joins ImmPACT Bio from ChromaCode, Inc., where he was CFO. Previously, Mr. Lamba served in executive leadership positions at Civica, Inc., (CFO); Fortuna Fix (CFO and chief operating officer); Zosano Pharma Corporation (CEO and member of the board of directors); and Predictive Biosciences, Inc. (CFO and chief business officer). Before then, he was vice president (VP) of corporate development at Advanced Medical Optics, Inc. (acquired by Abbott), and was CFO and VP of finance at GeneOhm Sciences, Inc. (acquired by Becton Dickinson). He also has more than 16 years of global experience in various positions at Bayer AG, where he was a Division CFO, and Burmah Castrol PLC. Mr. Lamba received an undergraduate degree in mechanical engineering from The University of Science and Technology in India and a master's degree in business management (MBM) from the Asian Institute of Management, where he spent his final year as an exchange student at The Wharton School of the University of Pennsylvania. About ImmPACT Bio ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients who have exhausted their treatment options. The company's logic-gate-based CAR T-cell platforms address key biological challenges in treating cancer. ImmPACT Bio's technologies are specifically designed to prevent antigen escape, prevent 'on-target – off-tumor' toxicities, and overcome the immunosuppressive tumor microenvironment. The company's technology is based on the work of pioneering scientists Yvonne Chen, Ph.D., and Antoni Ribas, M.D., Ph.D., both from University of California, Los Angeles (UCLA), and Gideon Gross, Ph.D., from the MIGAL-Galilee Research Institute. For more information, visit www.immpact-bio.com. View original content to download multimedia: SOURCE ImmPACT Bio
https://www.hawaiinewsnow.com/prnewswire/2022/08/09/immpact-bio-names-vikram-lamba-chief-financial-officer-head-business-development/
2022-08-09T12:53:08Z
https://www.hawaiinewsnow.com/prnewswire/2022/08/09/immpact-bio-names-vikram-lamba-chief-financial-officer-head-business-development/
true
11
Climate CoLab's mission of hosting a worldwide community to create actionable climate change solutions to continue and expand to an even larger online, global community CAMBRIDGE, Mass., Aug. 9, 2022 /PRNewswire/ -- The MIT Center for Collective Intelligence (CCI) today announced that its Climate CoLab—a global platform that crowdsources new ideas to address climate change—has spun out and migrated to Wazoku's global Challenge Community InnoCentive, a 500,000-plus community that works together to problem-solve pressing global sustainability issues. Climate CoLab was created by CCI in 2009 to host the exchange of ideas among its members, which includes professionals working in such fields as government, business, academia and non-profits, as well as everyday citizens concerned about environmental issues. Members create teams to compete in a series of contests—there have been 111 to date—in which thousands of proposals were submitted on how to address pressing issues related to climate change. With 120,000 members Climate CoLab has since grown into the world's largest crowdsourcing platform for developing climate change solutions. . Under the new arrangement, CCI will continue its work in developing innovative approaches for applying collective intelligence to tackle climate change and other sustainability challenges. Now, its community members will be able to participate in both Climate CoLab challenges and in the Wazoku Challenge Community, which addresses sustainability-related topics in need of solutions, along with having access to an even larger online, global community and an idea management platform built by Wazoku, InnoCentive's parent company. By joining forces, Climate CoLab and InnoCentive will combine their communities comprised of CEOs, PhD students, engineers, scientists, entrepreneurs, retired technologists, business leaders, and everyday concerned citizens, among others. "Harnessing crowd creativity is a powerful tool to address the complex challenges we face today," said Thomas W. Malone, founding director of the CCI who serves as the Patrick J. McGovern (1959) Professor of Management professor at the MIT Sloan School of Management "Migrating our Climate CoLab community into Wazoku's global crowd of problem solvers can accelerate the development of solutions that will make for a greener, more sustainable future." "Our global clients are increasingly interested in the issue of climate change," said Simon Hill, CEO of Wazoku. "We're excited to bring Climate CoLab's members into our growing Challenge Community. This migration will give our customers and community access to Climate CoLab's dedicated and skilled members, who have a proven track record of developing creative and actionable solutions. Between us, we have built two incredible superminds—large online communities that have achieved amazing things to help our world. I'm looking forward to what we can do together." For further information, contact: Patricia Favreau Associate Director of Media Relations 617-253-3492 pfavreau@mit.edu View original content to download multimedia: SOURCE MIT Sloan School of Management
https://www.wsaw.com/prnewswire/2022/08/09/mit-center-collective-intelligences-climate-colab-spins-out-migrates-wazokus-global-challenge-community-innocentive/
2022-08-09T12:53:32Z
https://www.wsaw.com/prnewswire/2022/08/09/mit-center-collective-intelligences-climate-colab-spins-out-migrates-wazokus-global-challenge-community-innocentive/
true
12
Early Trading Has VivoPower (VVPR) on the Move for August 8 Equities Staff Follow |Shares of VivoPower International PLC (NASDAQ:VVPR) are on the move in pre-market trading for August 8. Ahead of the market's open, VivoPower stock gained 8.48% from the previous session’s close. VivoPower was down $0.02 in the last session and looks to be in play again today. For technical charts, analysis, and more on VivoPower visit the company profile. Pre-market prices and movements as of 08:28:03 est. About VivoPower International PLC VivoPower is an international battery technology, electric vehicle, solar and critical power services company whose core purpose is to deliver sustainable energy solutions to its customers. VivoPower is a certified B Corporation and has operations in Australia, Canada, the United States and the United Kingdom. To get more information on VivoPower International PLC and to follow the company's latest updates, you can visit the company's profile page here: VivoPower International PLC's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info. Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis. DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
https://www.equities.com/news/early-trading-has-vivopower-vvpr-on-the-move-for-august-8
2022-08-09T12:53:45Z
https://www.equities.com/news/early-trading-has-vivopower-vvpr-on-the-move-for-august-8
true
22710
YipitData releases 2Q22 Home Goods Market Share Index: Pure Players NEW YORK, Aug. 9, 2022 /PRNewswire/ -- YipitData, the trusted source of market research and insights, today released the second edition of its Home Goods Market Share Index: Pure Players, a ranked list of the top 30 home goods pure players in the United States. The quarterly index, compiled by YipitData's retail and ecommerce analysts, tracks trends and estimated sales using the company's alternative data solutions. It measures year-over-year growth and quarterly market share changes based on combined sales across digital and brick-and-mortar. "As concerns around consumer spending and inflation heighten and growth of the home goods industry slows, it's becoming more important for retailers to understand their performance relative to the larger market context," says Dan Pellegrinelli, YipitData's VP of Research. "Our Home Goods Market Share Index can help contextualize growth and understand consumer behavior trends like total spend and average order values. This could be a game changer when it comes to staying competitive in the current market." YipitData's research shows that even with the post-pandemic return-to-store movement, monthly GMV for the top 10 home retailers overall has shrunk compared to last year, indicating a noticeable decline in consumer spending on home goods. While overall sales are well above where they were in early-2020, the data suggests we are seeing a return to pre-pandemic levels. - Bed Bath & Beyond (-1.77pp), Ashley Furniture (-1.07pp), Wayfair (-1.04pp) and Overstock (-1.02pp) have seen the largest decreases in market share YoY. While Overstock and Wayfair experienced a huge boom in sales at the beginning of the pandemic, they have not been able to keep up as consumers increasingly return to in-store shopping. - Wayfair continues to have the largest market share (14.41%) but is losing share (-1.04ppt) as omnichannel retailers grow. - Of the top 5 retailers who gained market share in Q2, the majority are considered high price point brands with average order value over $1,000. 1. La-Z-Boy (+1.21pp) 2. Pottery Barn (+1.03pp) 3. Restoration Hardware (+0.80pp) 4. Arhaus (+0.38pp) 5. Crate and Barrel/CB2 (+0.30 pp) 1. Wayfair 2. HomeGoods 3. Big Lots 4. IKEA 5. Bed Bath & Beyond 6. Restoration Hardware 7. Ashley Furniture 8. Pottery Barn 9. La-Z-Boy 10. At Home 11. West Elm 12. Crate & Barrel* 13. Overstock 14. Living Spaces 15. Rooms To Go 16. Raymour & Flanigan 17. Nebraska Furniture Mart 18. Bob's Discount Furniture 19. Williams Sonoma 20. The Container Store 21. Pottery Barn Kids & Teens 22. Arhaus 23. Havertys 24. Badcock Home Furniture 25. Frontgate 26. Ethan Allen 27. Room & Board 28. Furniture Row 29. Rejuvenation 30. Serena & Lily * Crate & Barrel includes CB2 sales Source: Transaction data To find out what's driving these changes, contact press@yipitdata.com. The index will be updated quarterly and is available at yipitdata.com/homegoodsindex. YipitData is a trusted data partner for over 480 of the world's largest investment funds and companies. We answer key questions and enable better business decisions through our data and insights. Since the release of our first Q1 2022 report, the Home Goods Market Share Index methodology has been improved with refined coverage of brick-and-mortar transactions for all merchants. View original content to download multimedia: SOURCE YipitData
https://www.hawaiinewsnow.com/prnewswire/2022/08/09/la-z-boy-sees-largest-gain-bed-bath-amp-beyond-biggest-loss-home-goods-market-share/
2022-08-09T12:53:57Z
https://www.hawaiinewsnow.com/prnewswire/2022/08/09/la-z-boy-sees-largest-gain-bed-bath-amp-beyond-biggest-loss-home-goods-market-share/
false
11
Beach Investment Counsel Inc. PA lessened its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Get Rating) by 57.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,012 shares of the information services provider’s stock after selling 5,434 shares during the quarter. Alphabet comprises approximately 1.2% of Beach Investment Counsel Inc. PA’s portfolio, making the stock its 28th biggest holding. Beach Investment Counsel Inc. PA’s holdings in Alphabet were worth $11,159,000 at the end of the most recent quarter. A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Morling Financial Advisors LLC bought a new position in shares of Alphabet in the fourth quarter valued at approximately $29,000. West Bancorporation Inc. bought a new position in shares of Alphabet in the fourth quarter valued at approximately $29,000. Wealthgate Family Office LLC bought a new position in shares of Alphabet in the fourth quarter valued at approximately $32,000. NS Partners Ltd bought a new position in shares of Alphabet in the fourth quarter valued at approximately $41,000. Finally, AHL Investment Management Inc. bought a new position in shares of Alphabet in the fourth quarter valued at approximately $46,000. Institutional investors own 41.70% of the company’s stock. Insiders Place Their Bets In other Alphabet news, major shareholder 2021 Gp L.L.C. Gv purchased 13,528 shares of Alphabet stock in a transaction dated Tuesday, May 24th. The stock was purchased at an average price of $33.72 per share, with a total value of $456,164.16. Following the transaction, the insider now directly owns 593,402 shares of the company’s stock, valued at $20,009,515.44. The purchase was disclosed in a document filed with the SEC, which is available through this link. In other Alphabet news, major shareholder 2021 Gp L.L.C. Gv purchased 13,528 shares of Alphabet stock in a transaction dated Tuesday, May 24th. The stock was purchased at an average price of $33.72 per share, with a total value of $456,164.16. Following the transaction, the insider now directly owns 593,402 shares of the company’s stock, valued at $20,009,515.44. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Prabhakar Raghavan sold 1,109 shares of the company’s stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $2,166.74, for a total transaction of $2,402,914.66. Following the sale, the senior vice president now directly owns 1,608 shares of the company’s stock, valued at approximately $3,484,117.92. The disclosure for this sale can be found here. In the last 90 days, insiders sold 42,352 shares of company stock valued at $15,690,955. 11.44% of the stock is owned by insiders. Analyst Ratings Changes Alphabet Price Performance Shares of NASDAQ:GOOGL opened at $117.30 on Tuesday. Alphabet Inc. has a fifty-two week low of $101.88 and a fifty-two week high of $151.55. The business has a 50-day simple moving average of $155.37 and a two-hundred day simple moving average of $137.93. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.78 and a current ratio of 2.81. The firm has a market cap of $1.54 trillion, a price-to-earnings ratio of 21.82, a price-to-earnings-growth ratio of 1.90 and a beta of 1.08. Alphabet (NASDAQ:GOOGL – Get Rating) last issued its earnings results on Tuesday, July 26th. The information services provider reported $1.21 earnings per share for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.11). Alphabet had a return on equity of 28.65% and a net margin of 25.89%. During the same period in the previous year, the business posted $27.26 earnings per share. On average, analysts expect that Alphabet Inc. will post 5.22 earnings per share for the current year. Alphabet Company Profile Alphabet Inc provides various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment offers products and services, including ads, Android, Chrome, hardware, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. Read More - Get a free copy of the StockNews.com research report on Alphabet (GOOGL) - Home Depot, Lowe’s On Track To Grow 2022 Earnings - Could Smaller be Better for Investors in Norwegian Cruise Lines? - Walmart Or Target: Which Is The Stronger Stock? - Volume Surges Spark Turnarounds for These 3 Stocks - Can Etsy Continue to Thrive After the Pandemic? Want to see what other hedge funds are holding GOOGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphabet Inc. (NASDAQ:GOOGL – Get Rating). Want More Great Investing Ideas? - Bear Market Game Plan! - The 10 Best Stocks to Own in 2022 - 7 Stocks to Buy and Hold Forever - 3 Stocks to DOUBLE This Year Receive News & Ratings for Alphabet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphabet and related companies with MarketBeat.com's FREE daily email newsletter.
https://www.etfdailynews.com/2022/08/09/beach-investment-counsel-inc-pa-sells-5434-shares-of-alphabet-inc-nasdaqgoogl/
2022-08-09T12:54:21Z
https://www.etfdailynews.com/2022/08/09/beach-investment-counsel-inc-pa-sells-5434-shares-of-alphabet-inc-nasdaqgoogl/
false
1
Comments / 0 FROM LOCAL CONTRIBUTORS Popular retail chain announces plans for another new store location in Minnesota Kristen WaltersWhat Makes Writing Good? Sarah RoseMinneapolis, MNThe Ultimate Minneapolis Girls Getaway Amber GibsonMinneapolis, MNKobenz Talks Latest Single, Working with Katy Rose, and Much More MeikhelMinneapolis, MNFive local restaurants in Minnesota have been ranked as the best places to eat in the entire state Joe MertensMinnesota State Related Video shows Patrick Lyoya shot in head by Michigan officer GRAND RAPIDS, Mich. (AP) — A Black man face-down on the ground was fatally shot in the back of the head by a Michigan police officer, the violent climax of a traffic stop, brief foot chase and struggle over a stun gun, according to videos of the April 4 incident. Musk makes $43 billion offer for Twitter to build 'arena for free speech' April 14 (Reuters) - Billionaire entrepreneur Elon Musk took aim at Twitter Inc (TWTR.N) with a $43 billion cash takeover offer on Thursday, with the Tesla CEO saying the social media company needs to be taken private to grow and become a platform for free speech. "I think it's very... Why Russia's looming offensive in eastern Ukraine might be different — and decisive In the areas around Kyiv and throughout northern Ukraine, residents are counting the dead as officials clear streets of mines and the twisted frames of tanks from the battles their country has survived. But experts say Russia's war looks set to enter a potentially more brutal and focused phase in... State legislature overrides governor's veto of 15-week abortion ban The Kentucky state legislature overrode Gov. Andy Beshear’s veto of a bill banning abortion after 15 weeks along with several other abortion restrictions. RELATED LOCAL CHANNELS Subway shooting suspect had means to carry out more attacks: Prosecutors The man accused of opening fire on a rush-hour subway train in Brooklyn was remanded following his first court appearance Thursday. ABC News Capitol riot defendant: I was following Trump's instructions An Ohio man charged with storming the U.S. Capitol and stealing a coat rack testified that he joined thousands of protesters in ransacking the building last year on what he thought were orders from the president, Donald Trump. Dustin Byron Thompson, 38, of Columbus, Ohio, said Wednesday he took to... Pfizer says booster in kids 5-11 produces ‘high’ immune response Pfizer and BioNTech said Thursday that a third dose of their COVID-19 vaccine in children ages 5 to 11 produced a “high” immune response, and that they will apply for authorization for a booster dose in the age group soon. Pfizer said in a news release that a... Mark Meadows removed from North Carolina voter rolls Donald Trump’s former White House chief of staff Mark Meadows has been removed from North Carolina’s voter rolls, according to the State Board of Elections. Meadows is also being investigated for allegations of voter fraud, the State Bureau of Investigation said. The decision to remove the former North... IN THIS ARTICLE EXPLAINER: Why the term ‘genocide’ matters in Ukraine war WASHINGTON (AP) — When President Joe Biden declares Russia’s Ukraine war “genocide,” it isn’t just another strong word. Calling a campaign that’s aimed at wiping out a targeted group “genocide” not only increases pressure on a country to act, it can oblige it to. That’s partly because of a genocide treaty approved by the U.N. General Assembly after World War II, signed by the United States and more than 150 other nations.
https://www.newsbreak.com/news/2693812716117/no-victims-found-after-isolated-shooting-incident-at-mall-of-america-police-say
2022-08-09T12:55:33Z
https://www.newsbreak.com/news/2693812716117/no-victims-found-after-isolated-shooting-incident-at-mall-of-america-police-say
false
12721
The National Testing Agency (NTA) is likely to release the National Eligibility cum Entrance Test (NEET) UG 2022 answer key today (August 9) at the official website-- neet.nta.nic.in. Candidates who have appeared for the exam will be able to check the NEET UG 2022 answer key at the official website. This year, students were demanding a second chance at the NEET UG 2022 but there is no official announcement for the same. Meanwhile, a video is circulating over social media stating that NEET UG phase 2 registration has been started at the official website. Neither the Ministries of Health and Education nor the National Testing Agency (NTA) has announced phase-wise NEET exam this year. NEET UG 2022: How to check answer key The NEET UG 2022 was conducted on July 17. This year recorded 95 per cent attendance in the medical entrance exam. More than 18 lakh candidates had applied to appear for the exam. The exam was conducted at 3,570 centres in 497 cities, including 14 cities (Colombo, Kathmandu, Bangkok, Kuala Lumpur, Singapore, Dubai, Abu Dhabi, Muscat, Sharjah, Kuwait City, Doha, Manama, Riyadh, Lagos) outside India on Sunday in 'pen and paper mode. A large number of aspirational districts were also added for the first time this year. Read: NTA NEET UG 2022 result, answer key likely soon at neet.nta.nic.in: Here's all important updates
https://www.dnaindia.com/education/report-national-eligibility-cum-entrance-test-neet-natinal-testing-agency-nta-neet-2022-neet-ug-2022-neet-answe-2975198
2022-08-09T12:56:00Z
https://www.dnaindia.com/education/report-national-eligibility-cum-entrance-test-neet-natinal-testing-agency-nta-neet-2022-neet-ug-2022-neet-answe-2975198
true
1
NEW YORK (AP) _ Ralph Lauren Corp. (RL) on Tuesday reported fiscal first-quarter earnings of $123.4 million. The New York-based company said it had profit of $1.73 per share. Earnings, adjusted for non-recurring costs, came to $1.88 per share. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.72 per share. The upscale clothing company posted revenue of $1.49 billion in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $1.41 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RL at https://www.zacks.com/ap/RL
https://www.darientimes.com/business/article/Ralph-Lauren-Fiscal-Q1-Earnings-Snapshot-17361207.php
2022-08-09T12:56:22Z
https://www.darientimes.com/business/article/Ralph-Lauren-Fiscal-Q1-Earnings-Snapshot-17361207.php
true
null
TORONTO, Aug. 9, 2022 /PRNewswire/ - Corus Entertainment Inc. ("Corus" or the "Company") (TSX: CJR.B) announced today that the Toronto Stock Exchange (the "TSX") has accepted the notice filed by the Company to amend its normal course issuer bid ("NCIB"). The amendment increases the maximum number of Class B non-voting shares that may be repurchased, from 9,669,705 Class B non-voting shares, representing approximately 5% of the Company's 'public float' as at January 3, 2022, to 19,339,410 Class B non-voting shares, representing approximately 10% of the Company's 'public float' as at January 3, 2022. Daily repurchases will be limited to a maximum of 231,935 Class B non-voting shares, representing 25% of the average daily trading volume for the six months ended December 31, 2021 (being 927,743 Class B non-voting shares), except where purchases are made in accordance with the "block purchase exception" of the TSX rules. No other terms of the NCIB have been amended. Purchases under the NCIB began on January 17, 2022 and will terminate no later than January 16, 2023, and are made by way of normal course purchases effected through the facilities of the TSX, other designated exchanges and/or alternative Canadian trading systems. Under its current NCIB, as of July 27, 2022, the Company has repurchased 7,646,900 Class B non-voting shares, at a weighted-average price of $4.30. In deciding to amend the NCIB, the Company believes that, while the macroeconomic environment will likely be challenging in the short to medium term, the market price of the Class B non-voting shares may not, from time to time, fully reflect their long-term value. Accordingly, the purchase of the Class B non-voting shares would be in the best interest of the Company and an attractive and appropriate use of available funds. Although the Company has a present intention to acquire its Class B non-voting shares pursuant to the NCIB, the Company will not be obligated to make any purchases and purchases may be suspended by the Company at any time. This press release contains forward-looking information and should be read subject to the following cautionary language: To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking statements and may be "forward-looking information" within the meaning of applicable securities laws (collectively, "forward-looking information"). This forward-looking information relates to, among other things, statements related to the NCIB and future purchases of Class B non-voting shares pursuant to the NCIB, and can generally be identified by the use of words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances may be considered forward-looking information. Although Corus believes that the expectations reflected in such forward-looking information are reasonable, such information involves assumptions and risks and uncertainties and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied with respect to the forward-looking information, including without limitation, factors and assumptions regarding the general market conditions and general outlook for the industry including the potential impact of new competition and industry mergers and acquisitions, interest rates, stability of the advertising, distribution, merchandise and subscription markets, operating and capital costs and tariffs, taxes and fees, the Company's ability to source desirable content and the Company's capital and operating results being consistent with its expectations. Actual results may differ materially from those expressed or implied in such information. Important factors that could cause actual results to differ materially from these expectations include, among other things: the Company's ability to attract and retain advertising revenue; audience acceptance of the Company's television programs and cable networks; the Company's ability to recoup production costs, the availability of tax credits and the existence of co-production treaties; the Company's ability to compete in any of the industries in which it does business; the opportunities (or lack thereof) that may be presented to and pursued by the Company; conditions in the entertainment, information and communications industries and technological developments therein; changes in laws or regulations or the interpretation or application of those laws and regulations; the Company's ability to integrate and realize anticipated benefits from its acquisitions and to effectively manage its growth; the Company's ability to successfully defend itself against litigation and complaints; failure to meet covenants under the Company's senior credit facility or senior unsecured notes; epidemics, pandemics or other public health crises, including the current outbreak of COVID-19 and changes in accounting standards. Additional information about these factors and about the material assumptions underlying any forward-looking information may be found under the heading "Risks and Uncertainties" in the Management's Discussion and Analysis for the year ended August 31, 2021 and under the heading "Risk Factors" in the Company's Annual Information Form. Corus cautions that the foregoing list of important assumptions and factors that may affect future results is not exhaustive. When relying on the Company's forward-looking information to make decisions with respect to Corus, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Unless otherwise specified, all forward-looking information in this document speaks as of the date of this document. Unless otherwise required by applicable securities laws, Corus disclaims any intention or obligation to publicly update or revise any forward-looking information whether as a result of new information, events or circumstances that arise after the date thereof or otherwise. Corus Entertainment Inc. (TSX: CJR.B) is a leading media and content company that develops and delivers high quality brands and content across platforms for audiences around the world. Engaging audiences since 1999, the Company's portfolio of multimedia offerings encompass 33 specialty television services, 39 radio stations, 15 conventional television stations, a suite of digital and streaming assets, animation software, technology and media services. Corus is an internationally-renowned content creator and distributor through Nelvana, a world class animation studio expert in all formats and Corus Studios, a globally recognized producer of hit scripted and unscripted content. The Company also owns innovative full-service social digital agency so.da, lifestyle entertainment company Kin Canada, leading 2D animation software supplier Toon Boom and children's book publishing house, Kids Can Press. Corus' roster of premium brands includes Global Television, W Network, HGTV Canada, Food Network Canada, Magnolia Network Canada, The HISTORY® Channel, Showcase, Adult Swim, National Geographic, Disney Channel Canada, YTV, Global News, Globalnews.ca, Q107, Country 105, and CFOX, along with broadly distributed Canadian streaming platforms STACKTV, Nick+, the Global TV App and Curiouscast. For more information visit www.corusent.com. View original content: SOURCE Corus Entertainment Inc.
https://www.wilx.com/prnewswire/2022/08/09/corus-entertainment-receives-tsx-approval-amend-normal-course-issuer-bid/
2022-08-09T12:57:11Z
https://www.wilx.com/prnewswire/2022/08/09/corus-entertainment-receives-tsx-approval-amend-normal-course-issuer-bid/
false
13
CLEVELAND, Aug. 9, 2022 /PRNewswire/ -- TransDigm Group Incorporated (NYSE: TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the third quarter ended July 2, 2022. The Company also announced that its Board of Directors has authorized and declared a special cash dividend of $18.50 on each outstanding share of common stock and cash dividend equivalent payments under options granted under its stock options plans. The record date for the special dividend is August 19, 2022, and the payment date for the dividend is August 26, 2022. Third quarter highlights include: - Net sales of $1,398 million, up 15% from $1,218 million in the prior year's quarter; - Income from continuing operations of $239 million; - Earnings per share from continuing operations of $4.10; - EBITDA As Defined of $696 million, up 25% from $559 million in the prior year's quarter; - EBITDA As Defined margin of 49.8%, up 390 basis points from the prior year's quarter; - Adjusted earnings per share of $4.85, up 46% from $3.33 in the prior year's quarter; - Strong operating cash flow generation of $309 million; and - Repurchase of $245 million of Company stock during the quarter, equating to 443,598 shares. The Company's full fiscal 2022 guidance remains suspended as a result of the continued disruption in our primary commercial end markets. Refer to the "Fiscal 2022 Outlook" section below for further information. Quarter-to-Date Results Net sales for the quarter increased 14.8%, or $180 million, to $1,398 million from $1,218 million in the comparable quarter a year ago. Organic sales growth as a percentage of net sales was 16.7%. Income from continuing operations for the quarter decreased $78 million, or 24.6%, to $239 million from $317 million in the comparable quarter a year ago. The decrease in income from continuing operations primarily reflects the higher effective tax rate and a pension settlement charge for the Esterline Retirement Plan. The comparable quarter a year ago also included the benefit of the net gain on sale recognized as a result of the divestitures completed during the third quarter of fiscal 2021. These unfavorable items contributing to the decrease in income from continuing operations were partially offset by the increase in net sales described above and favorable sales mix, along with lower one-time refinancing costs. Adjusted net income for the quarter increased 44.8% to $281 million, or $4.85 per share, from $194 million, or $3.33 per share, in the comparable quarter a year ago. EBITDA for the quarter increased 12.4% to $643 million from $572 million for the comparable quarter a year ago. EBITDA As Defined for the quarter increased 24.5% to $696 million compared with $559 million in the comparable quarter a year ago. EBITDA As Defined as a percentage of net sales for the quarter was 49.8% compared with 45.9% in the comparable quarter a year ago. During the thirteen week period ended July 2, 2022, TransDigm repurchased 443,598 shares of its common stock with a weighted-average price per share of $553.62 at an aggregate cost of approximately $245 million. As previously reported, on May 25, 2022, TransDigm completed the acquisition of DART Aerospace ("DART"), a portfolio company of Greenbriar Equity Group, L.P., for approximately $360 million in cash. DART is an industry leader in helicopter mission equipment with established positions on a diverse range of rotary-wing platforms. "Global air traffic continues to trend upwards with the pent-up demand for air travel. This positive momentum bodes well for the commercial aerospace recovery. Domestic air travel remains the leader in the air traffic recovery, but the international air traffic recovery made strides these past few months as more passengers returned to long-haul travel," stated Kevin Stein, TransDigm Group's President and Chief Executive Officer. "I am pleased to see another quarter of sequential improvement in our commercial aftermarket revenues, with the commercial aftermarket bookings for the quarter outpacing revenues. We also saw further sequential expansion of our EBITDA As Defined margin this quarter to 49.8%. This was a result of the continued recovery in our commercial aftermarket revenues, coupled with careful management of our cost structure and focus on our operating strategy. During the quarter, we returned $245 million of capital to shareholders via open market repurchases of our common stock. We view these repurchases like any other capital investment, and we expect this investment will meet or exceed our long-term return objectives. Additionally, given the significant amount of cash currently available, our solid operating performance and ongoing expectations, we believe that this is the appropriate time to declare and pay a special dividend, as we have done in the past. The payout of a special dividend of $18.50 per share will leave us with significant liquidity and financial flexibility to meet any likely range of capital requirements or other opportunities. In the aggregate, thus far this fiscal year, we have deployed approximately $2.4 billion of capital across the DART acquisition, today's announced dividend, and share repurchases. As you know, we are always continuously evaluating our capital allocation options and are pleased to have deployed this amount of capital across the range of options available to us." Year-to-Date Results Net sales for the thirty-nine week period ended July 2, 2022 increased 11.4%, or $400 million, to $3,919 million from $3,519 million in the comparable period a year ago. Organic sales growth as a percentage of net sales was 13.6%. Income from continuing operations for the thirty-nine week period ended July 2, 2022 increased $128 million, or 27.1%, to $601 million from $473 million in the comparable period a year ago. The increase in income from continuing operations primarily reflects the increase in net sales described above and favorable sales mix, along with lower COVID-19 restructuring costs and lower one-time refinancing costs, partially offset by a higher effective tax rate. The comparable period a year ago also included the benefit of the net gain on sale recognized as a result of the divestitures completed during the third quarter of fiscal 2021. GAAP earnings per share were reduced in fiscal 2022 and 2021 by $0.78 per share and $1.24 per share, respectively, as a result of dividend equivalent payments made during each year. As a reminder, GAAP earnings per share are reduced when TransDigm makes dividend equivalent payments pursuant to the Company's stock option plans. These dividend equivalent payments are made during the Company's first fiscal quarter each year and also upon payment of any special dividends. Adjusted net income for the thirty-nine week period ended July 2, 2022 increased 48.9% to $685 million, or $11.68 per share, from $460 million, or $7.88 per share, in the comparable period a year ago. EBITDA for the thirty-nine week period ended July 2, 2022 increased 24.0% to $1,753 million from $1,414 million for the comparable period a year ago. EBITDA As Defined for the period increased 22.0% to $1,894 million compared with $1,552 million in the comparable period a year ago. EBITDA As Defined as a percentage of net sales for the period was 48.3% compared with 44.1% in the comparable period a year ago. During the thirty-nine week period ended July 2, 2022, TransDigm repurchased 1,490,413 shares of its common stock with a weighted-average price per share of $612.13 at an aggregate cost of approximately $912 million. As previously reported, on January 27, 2022, our Board of Directors authorized a new $2,200 million stock repurchase program to replace the existing program permitting the repurchase of a portion of TransDigm's outstanding shares. As of July 2, 2022, the remaining amount of repurchases allowed under the new program was approximately $1,288 million. Please see the attached tables for a reconciliation of income from continuing operations to EBITDA, EBITDA As Defined, and adjusted net income; a reconciliation of net cash provided by operating activities to EBITDA and EBITDA As Defined, and a reconciliation of earnings per share to adjusted earnings per share for the periods discussed in this press release. Fiscal 2022 Outlook Given the considerable uncertainty around the extent and duration of business disruptions related to the COVID-19 pandemic and its impact on our primary commercial OEM and commercial aftermarket end markets, the Company is not providing full fiscal year 2022 guidance. Information regarding fiscal 2022 EBITDA As Defined margins, expected defense market revenue growth, tax rates, interest expense, capital expenditures and select accounting information is included in the slide presentation available for today's earnings call. Earnings Conference Call TransDigm Group will host a conference call for investors and security analysts on August 9, 2022, beginning at 11:00 a.m., Eastern Time. To join the call telephonically, please register for the call at https://register.vevent.com/register/BI198da0d708c042ce9c77cf865ef01588. Once registered, participants will receive the dial-in information and a unique pin to access the call. The dial-in information and unique pin will be sent to the email used to register for the call. The unique pin is exclusive to the registrant and can only be used by one person at a time. A live audio webcast of the call can also be accessed online at http://www.transdigm.com. A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website and click on "Presentations." The call will be archived on the website and available for replay at approximately 2:00 p.m., Eastern Time. About TransDigm Group TransDigm Group, through its wholly-owned subsidiaries, is a leading global designer, producer and supplier of highly engineered aircraft components for use on nearly all commercial and military aircraft in service today. Major product offerings, substantially all of which are ultimately provided to end-users in the aerospace industry, include mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, engineered latching and locking devices, engineered rods, engineered connectors and elastomer sealing solutions, databus and power controls, cockpit security components and systems, specialized and advanced cockpit displays, engineered audio, radio and antenna systems, specialized lavatory components, seat belts and safety restraints, engineered and customized interior surfaces and related components, advanced sensor products, switches and relay panels, thermal protection and insulation, lighting and control technology, parachutes, high performance hoists, winches and lifting devices, and cargo loading, handling and delivery systems. Non-GAAP Supplemental Information EBITDA, EBITDA As Defined, EBITDA As Defined Margin, adjusted net income and adjusted earnings per share are non-GAAP financial measures presented in this press release as supplemental disclosures to net income and reported results. TransDigm Group defines EBITDA as earnings before interest, taxes, depreciation and amortization and defines EBITDA As Defined as EBITDA plus certain non-operating items recorded as corporate expenses, including non-cash compensation charges incurred in connection with TransDigm Group's stock incentive plans, restructuring costs related to TransDigm Group's cost reduction measures in response to the COVID-19 pandemic, foreign currency gains and losses, acquisition-integration costs, acquisition and divestiture transaction-related expenses, and refinancing costs. COVID-19 restructuring costs represent actions taken by the Company to reduce its workforce to align with customer demand, as well as incremental costs related to the pandemic that are not expected to recur once the pandemic has subsided and are clearly separable from normal operations (e.g., additional cleaning and disinfecting of facilities by contractors above and beyond normal requirements, personal protective equipment). Acquisition and divestiture-related costs represent accounting adjustments to inventory associated with acquisitions of businesses and product lines that were charged to cost of sales when the inventory was sold; costs incurred to integrate acquired businesses and product lines into the Company's operations, facility relocation costs and other acquisition-related costs; transaction-related costs for both acquisitions and divestitures comprising deal fees; legal, financial and tax diligence expenses and valuation costs that are required to be expensed as incurred and other acquisition accounting adjustments. TransDigm Group defines adjusted net income as net income plus purchase accounting backlog amortization expense, effects from the sale on businesses, non-cash compensation charges incurred in connection with TransDigm Group's stock incentive plans, restructuring costs related to TransDigm Group's cost reduction measures in response to the COVID-19 pandemic, foreign currency gains and losses, acquisition-integration costs, acquisition transaction-related expenses, and refinancing costs. EBITDA As Defined Margin represents EBITDA As Defined as a percentage of net sales. TransDigm Group defines adjusted diluted earnings per share as adjusted net income divided by the total shares for basic and diluted earnings per share. For more information regarding the computation of EBITDA, EBITDA As Defined and adjusted net income and adjusted earnings per share, please see the attached financial tables. TransDigm Group presents these non-GAAP financial measures because it believes that they are useful indicators of its operating performance. TransDigm Group believes that EBITDA is useful to investors because it is frequently used by securities analysts, investors and other interested parties to measure operating performance among companies with different capital structures, effective tax rates and tax attributes, capitalized asset values and employee compensation structures, all of which can vary substantially from company to company. In addition, analysts, rating agencies and others use EBITDA to evaluate a company's ability to incur and service debt. EBITDA As Defined is used to measure TransDigm Inc.'s compliance with the financial covenant contained in its credit facility. TransDigm Group's management also uses EBITDA As Defined to review and assess its operating performance, to prepare its annual budget and financial projections and to review and evaluate its management team in connection with employee incentive programs. Moreover, TransDigm Group's management uses EBITDA As Defined to evaluate acquisitions and as a liquidity measure. In addition, TransDigm Group's management uses adjusted net income as a measure of comparable operating performance between time periods and among companies as it is reflective of changes in pricing decisions, cost controls and other factors that affect operating performance. None of EBITDA, EBITDA As Defined, EBITDA As Defined Margin, adjusted net income or adjusted earnings per share is a measurement of financial performance under U.S. GAAP and such financial measures should not be considered as an alternative to net income, operating income, earnings per share, cash flows from operating activities or other measures of performance determined in accordance with U.S. GAAP. In addition, TransDigm Group's calculation of these non-GAAP financial measures may not be comparable to the calculation of similarly titled measures reported by other companies. Although we use EBITDA and EBITDA As Defined as measures to assess the performance of our business and for the other purposes set forth above, the use of these non-GAAP financial measures as analytical tools has limitations, and you should not consider any of them in isolation, or as a substitute for analysis of our results of operations as reported in accordance with U.S. GAAP. Some of these limitations are: - neither EBITDA nor EBITDA As Defined reflects the significant interest expense, or the cash requirements, necessary to service interest payments on our indebtedness; - although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and neither EBITDA nor EBITDA As Defined reflects any cash requirements for such replacements; - the omission of the substantial amortization expense associated with our intangible assets further limits the usefulness of EBITDA and EBITDA As Defined; - neither EBITDA nor EBITDA As Defined includes the payment of taxes, which is a necessary element of our operations; and - EBITDA As Defined excludes the cash expense we have incurred to integrate acquired businesses into our operations, which is a necessary element of certain of our acquisitions. Forward-Looking Statements Statements in this press release that are not historical facts, including statements under the heading "Fiscal 2022 Outlook," are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "may," "will," "should," "expect," "intend," "plan," "predict," "anticipate," "estimate," or "continue" and other words and terms of similar meaning may identify forward-looking statements. All forward-looking statements involve risks and uncertainties that could cause TransDigm Group's actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, TransDigm Group. These risks and uncertainties include but are not limited to: the impact that the COVID-19 pandemic has on the TransDigm Group's business, results of operations, financial condition and liquidity; the sensitivity of TransDigm Group's business to the number of flight hours that its customers' planes spend aloft and its customers' profitability, both of which are affected by general economic conditions; future geopolitical or other worldwide events; cyber-security threats, natural disasters and climate change-related events; TransDigm Group's reliance on certain customers; the U.S. defense budget and risks associated with being a government supplier including government audits and investigations; failure to maintain government or industry approvals; failure to complete or successfully integrate acquisitions; TransDigm Group's indebtedness; potential environmental liabilities; liabilities arising in connection with litigation; climate-related regulations; increases in raw material costs, taxes and labor costs that cannot be recovered in product pricing; risks and costs associated with TransDigm Group's international sales and operations; and other factors. Further information regarding the important factors that could cause actual results to differ materially from projected results can be found in TransDigm Group's Annual Report on Form 10-K for the fiscal year ended September 30, 2021 and other reports that TransDigm Group or its subsidiaries have filed with the Securities and Exchange Commission. Except as required by law, TransDigm Group undertakes no obligation to revise or update the forward-looking statements contained in this press release. View original content to download multimedia: SOURCE TransDigm Group Inc.
https://www.keyc.com/prnewswire/2022/08/09/transdigm-group-reports-fiscal-2022-third-quarter-results-declares-special-cash-dividend-1850-per-share/
2022-08-09T12:57:34Z
https://www.keyc.com/prnewswire/2022/08/09/transdigm-group-reports-fiscal-2022-third-quarter-results-declares-special-cash-dividend-1850-per-share/
true
12
Comments / 0 FROM LOCAL CONTRIBUTORS Missing Inglewood Woman Last Seen With Two Men Caught On Ring Doorbell Camera Removing Items From Her Home The Vivid Faces of the VanishedInglewood, CAWindsor Hills, Los Angeles Crash Leaves 6 Dead Bri HView Park-windsor Hills, CAThis is the Best Chinese Takeout in California Let's Eat LALos Angeles, CAYou won't believe how good the Pizza is in Los Angeles Vivid SnacksLos Angeles, CASomerhalder Helps Clean Huntington Beach with the Shiseido Blue Project Susan HornikHuntington Beach, CA
https://www.newsbreak.com/news/2693814126059/angels-tie-mlb-record-with-7-solo-hrs-but-lose-to-athletics
2022-08-09T12:59:07Z
https://www.newsbreak.com/news/2693814126059/angels-tie-mlb-record-with-7-solo-hrs-but-lose-to-athletics
true
null
HOUSTON (AP) _ Sysco Corp. (SYY) on Tuesday reported fiscal fourth-quarter earnings of $510 million. The Houston-based company said it had net income of 99 cents per share. Earnings, adjusted for restructuring costs and costs related to mergers and acquisitions, came to $1.15 per share. The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.12 per share. The food distributor posted revenue of $18.96 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $18.27 billion. For the year, the company reported profit of $1.36 billion, or $2.64 per share. Revenue was reported as $68.64 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SYY at https://www.zacks.com/ap/SYY
https://www.myplainview.com/business/article/Sysco-Fiscal-Q4-Earnings-Snapshot-17361230.php
2022-08-09T13:01:28Z
https://www.myplainview.com/business/article/Sysco-Fiscal-Q4-Earnings-Snapshot-17361230.php
true
null
Taiwan has required a new batch of companies to report their greenhouse gas emissions data on an annual basis, with a primary focus on electronics components manufacturers, one of the pillars of the island’s economy. Taiwan extends emissions reporting requirements to manufacturing firms Taiwan has required a new batch of companies to report their greenhouse gas emissions data on an annual basis, with a primary focus on electronics components manufacturers, one of the pillars of the island's economy. A Carbon Pulse subscription is required to read this content. Subscribe today to access our unrivalled news and intelligence, as well as our premium content including all job listings. Click here for details. We offer a FREE TRIAL of our subscription service and it only takes a minute to register. If you already have a Carbon Pulse account, login here. We offer a FREE TRIAL of our subscription service and it only takes a minute to register. If you already have a Carbon Pulse account, login here.
https://carbon-pulse.com/168956/
2022-08-09T13:01:31Z
https://carbon-pulse.com/168956/
false
null
ATLANTA, Aug. 9, 2022 /PRNewswire/ -- Fusion Connect, a leading provider of managed security and collaboration services, today announced two strategic appointments designed to continue to strengthen the culture of high performance and drive revenue growth while reinforcing the strategic growth vision of the organization. As CFO, Langford will lead the financial strategy for Fusion Connect, with a focus on financial execution to drive global revenue growth and profitability. Andrew brings over 20 years of global experience in telecommunications, financial technology and healthcare industries. Most recently he served as CFO of Claims Cost Solutions (CCS) at Zelis, a private equity-owned healthcare and financial technology company. Before Zelis, he was Senior Vice President of Business Financial Services in the Americas at Global Payments Inc., where he was responsible for the company's finance functions in the U.S., Canada, Brazil, and Mexico. "Andrew's experience supporting innovative and international growth, deep knowledge of the technology space, and a long history of financial leadership is a great addition to Fusion Connect's leadership team, and will enable us to continue our business transformation journey and accelerate our growth," said Brian Crotty, CEO at Fusion Connect. "Fusion Connect's award-winning client service is what differentiates the company from other managed service providers and is the key to creating new value for clients, partners, and investors," Langford said. "The company is on the precipice of an exciting phase of growth and I'm eager to take Fusion Connect's success to new levels." In her new role, Lisa Matthews will lead all areas of the company's human resource functions, with a particular focus on people and corporate culture. Matthews is an accomplished, results-oriented leader with 25 years of global leadership experience in human resources across multiple industries, including technology and professional services. Prior to joining Fusion Connect, Matthews was at Alight Solutions, where she served as Vice President of Human Resources. Before Alight, Matthews was Director of Human Resources for Aon Hewitt. There she led the organizational design, onboarding architecture, and business integration efforts with a focus on operational excellence. "Lisa's relentless dedication to people and her leadership will be invaluable to our organization," said Crotty. "Her experience collaborating with business leaders to develop and implement effective talent strategies will enhance company culture and help continue to rapidly build our team." "In today's hybrid work environment, we need to consider people beyond the location they're working from and empower them with all the tools and resources they need to keep Fusion Connect on a successful trajectory," said Matthews. "This company has an established culture of candor and strong leadership that I look forward to building upon as Fusion Connect continues to grow." Fusion Connect manages, orchestrates, and secures the critical technology infrastructure that enables the connected enterprise. We tailor our highly available and secure cloud communication, collaboration, security, and network management platforms to meet the unique needs of our mid-market and enterprise customers. Our AI-based management systems, along with our highly skilled technicians, dynamically ensure world-class application performance under any conditions. For more information, go to www.fusionconnect.com or call us at +1-866-829-4318. Press Contact: Ruzanna Tantushyan Director of Corporate Communications, Fusion Connect PR@fusionconnect.com View original content to download multimedia: SOURCE Fusion Connect
https://www.witn.com/prnewswire/2022/08/09/fusion-connect-appoints-andrew-langford-chief-financial-officer-lisa-matthews-senior-vice-president-human-resources-rounding-out-executive-team/
2022-08-09T13:02:48Z
https://www.witn.com/prnewswire/2022/08/09/fusion-connect-appoints-andrew-langford-chief-financial-officer-lisa-matthews-senior-vice-president-human-resources-rounding-out-executive-team/
false
11
George Bartlett: Somerset batter signs one-year extension Last updated on .From the section Cricket Somerset batter George Bartlett has signed a one-year contract extension with the club to stay until the end of the 2023 season. The 24-year-old progressed through the club's academy from the age of 10 and made his senior debut in 2017. Bartlett, a right-handed batter, has since made 1,9000 first-class runs for Somerset, scoring five centuries. He scored his first half-century of the County Championship season last month against Yorkshire. As well as Somerset, Bartlett has played for England's Young Lions and in 2017 scored 179 for the Under-19 team against India - the highest overseas score made by an England Under-19 batsman. "It's really good to have the backing of the club for another year. We've had some good times over the last few years and hopefully we can continue that and bring more success to Somerset," Bartlett said. "The number one priority now is to help the club win trophies. I just want to be making match winning contributions across all formats and helping Somerset to win matches."
https://www.bbc.com/sport/cricket/62479431
2022-08-09T13:03:24Z
https://www.bbc.com/sport/cricket/62479431
true
2
Artificial Intelligence can have a powerful impact on business, but two major challenges make implementation critical and difficult: (1) getting the target right, and (2) getting the process right. The problem is that these challenges are rooted in pervasive, thorny management issues, and many AI initiatives focus largely on its technical viability. Managers who fail to address these critical issues from the start are in danger of simply optimizing bad processes (i.e. optimizing in the sense of improving the likelihood of achieving the process goals) and locking them in place. The deeper issue is not whether AI works, but instead, whether managers are so enamored with AI/ML (artificial intelligence-machine learning) as a new management “wonder drug” that they fail to work through the deeper management issues needed to configure it correctly and determine where it is appropriate. This is a pressing issue: a recent authoritative study reported that only a small minority of executives were satisfied with the returns from their AI investments. AI: New Wonder Drug? AI has all the hallmarks of a new wonder drug for business: It is very powerful at optimizing through pattern recognition processes characterized by massive, complex information. To get a perspective on why AI is sweeping through business today, as well as a brief understanding of how it works and its strengths and weaknesses, here are a few observations: • Computation keeps getting half as expensive roughly every couple of years, and this trend has persisted for over a century, cutting the cost of computing by a whopping million million million (1018) since 1900. • Neural networks, a family of computational models loosely based on how brain neurons send signals to each other, have recently started dominating the AI subfield known as Machine Learning—the study of algorithms that improve through experience. • In overview, MIT’s Max Tegmark notes, “Just as we don’t fully understand how our children learn, we still don’t understand how such neural networks learn, and why they occasionally fail.” Many authoritative studies confirm this view. In essence, AI/ML is a generalized process to optimize things based purely on pattern recognition without the need for understanding either the broader context or understanding why the optimizations are effective. The essential question for managers is whether they are willing to bet their company’s prospects on a mechanistic pattern recognition process. Getting the Targets Right Establishing targets and goals for an AI/ML system is one of the most important challenges to successful implementation. First and foremost, the question of what is being optimized is neither clear nor uncontroversial. What is being optimized The most important choice is whether the system is set up to maximize net profits or to optimize a narrower target, such as maximizing advertisement conversion rates or minimizing delivery costs. This is a critical issue because mitigating these narrow problems in a way that is divorced from the big picture can decrease rather than increase net profits. The reason for this seeming paradox is that some revenues are very costly to serve, while other revenues are ample to support higher costs. In our experience accelerating the profitability of tens of billions of dollars of client revenues, we have found that gross margin does not predict net profits. For example, in one well-run company, 15% of the customers produce 135% of the profits, while 20% of the customers drain 55% of the profits; and 25% of the products produce 150% of the profits, while 25% of the products drain 75% of the profits. In this company, maximizing the advertising conversion rate for money-losing Profit Drain customers and minimizing the delivery costs for service-sensitive Profit Peak customers are both counterproductive. This is true in most companies. The reason why so many managers incorrectly focus on gross margin, which leads them to the intuitively “obvious” but empirically incorrect assumption that revenue-increasing and cost-decreasing objectives are always good to optimize is that in the prior Age of Mass Markets (in most of the prior century), pricing was relatively uniform and cost to serve was uniform as well. Today, pricing varies by customer, and even within customers, while the cost to serve varies enormously, ranging from highly integrated vendor-managed inventory systems to simply dropping boxes at the receiving dock. This means that companies need an Enterprise Profit Management (EPM) system, which is a SaaS system that can be configured in a few weeks and creates an all-in P&L on each transaction—each product sold to each customer each time. Because a well-targeted AI/ML system will maximize the net profitability of each transaction, it must “learn” from historical data at this level of granularity. In our experience, EPM enables managers to produce 10-30% year-on-year sustainable profit increases. The bottom line is that installing an AI/ML system, for example, to maximize revenues for the sales group, while installing a separate AI/ML system to minimize costs for the supply chain group—as so many companies today are doing—will not maximize net profits, no matter how elegant the AI/ML algorithms might be. Whose profits are optimized A related critical question is: Whose net profits are to be maximized? The goals of a local regional sales manager, an SBU head, the CEO, shareholders, investors and others differ in fundamental ways. This is a very common problem in business. In my graduate course at MIT, I teach a case in which a bleach purchasing manager has to respond to a supplier offer for a price cut. An alternative supplier can reduce the customer’s supply chain costs, but while this offering reduces total cost, it carries a higher price. What will the bleach buyer do? The answer depends on his or her control system: according to standard practice, the bleach buyer will be trained, evaluated, promoted and compensated on purchase price, while the supply chain cost reduction benefits another department. It is clear what the bleach buyer will do—and this ironically is what the company’s control system is instructing him or her to do. And, just as a human purchaser incentivized to minimize cost will do so at the expense of net profit, so too will an AI/ML purchasing system whose objective function is to minimize cost. In fact, the latter could be even worse, because there is less chance of anyone noticing the problem. If this sounds like a familiar management problem, it is. The management problem is the same, whether or not AI/ML is used. The difference is that AI/ML systems are so technically dazzling, that managers tend not to focus on the core management issues. Complexity and sub-optimization Similarly, AI/ML systems have to be configured to address the complexity and sub-optimization that is endemic in business. This is extremely hard to set and maintain. For example, companies have very different strategic goals at different stages of market and company development. At times, a company’s objective may be to establish a market presence (even investing in reduced prices), later developing widespread distribution (even offering marketing support to new distributors and giving free samples to opinion/style leaders) and sometimes tying up essential channels (through package deals or special returns allowances). Strategic paradigm shifts Capturing strategic paradigm shifts is extremely important to a company’s long-term success. These paradigm shifts are exogenous to the historical and current experience. Think about forecasting the demand for cameras on phones for a traditional camera company. Steve Jobs famously never used market research because it reflected opinions on current products, but not opportunities to discover breakthrough paradigm-changing products. AI/ML cannot do this because the paradigm change is by definition outside the range of experiences that the system has “learned.” Managing the Process of AI Just as managers must take care in specifying the targets and goals of AI/ML, they must be very thoughtful and systematic about structuring the business processes in which it is embedded. User trust and process fit First and foremost, managers have to gain user trust in the AI/ML output recommendations, and it has to fit into current business processes. This is a surprisingly difficult set of needs. This difficulty is rooted in the fact that most business processes are not deterministic. For example, if an AI/ML system “learns” to predict a customer’s next purchase (based on that customer’s past history in the context of the history of all customers’ purchases), the likely next purchase is really a probability distribution because human behavior is not fixed. If the system issues a “recommendation,” it will have an implicit likelihood of “errors” because the recommendation is the most likely single point, while the actual probability distribution is a range of points. Although this is a natural artifact of the nature of the underlying business processes, it will generally seem like an “error” to unsophisticated users and will appear to discredit the “accuracy” of the system’s output. Because AI/ML is simply a mechanistic pattern recognition process, users will not have a way to develop an intuitive sense of the “rightness” of the output. Contrast this with a very powerful system that compares each transaction, customer or product with the company’s own observed best practice (controlling for a variety of salient factors like customer industry, size and so on). Here, the user can actually look at the best practice instances to see what the differences are in order to judge the best next step and can even call the colleagues involved to talk over the situation. In short, in this situation, the user will experience a feeling of understanding and control, which is essential to acceptance. In our experience using advanced analytics, it is necessary to root them in an intuitively clear comparison of the customer or product to the company’s own best practice. We have found that without this level of intuitive understanding, users are reluctant to use system output information. In AI/ML systems, this problem is exacerbated by a lack of understanding of why they occasionally fail. In studies of system acceptance, users place enormous weight on occasional errors, neglecting average performance. (Think about your likelihood of returning to a restaurant in which you had nine good meals, then a tenth meal that really made you sick.) A related issue arises in structuring the processes in which AI/ML is embedded. These systems can produce so much new information that most companies’ traditional business processes cannot accommodate it. For example, although an AI/ML system may be able to predict when a small customer is likely to leave, most companies do not have systems and processes to act on this information—and developing such a system might be a low priority. Managers must have a way to estimate the benefits of each candidate AI/ML application and weigh its value against the change management needed to realize the practical benefits. By contrast, today many companies are implementing AI/ML systems in a one-off way based on local priorities and interests. Intuitive understanding and paradigm shifts A deeper problem with relying on AI/ML is that the managers involved tend to lose the stream of primary customer, product and market information that they need to develop an intuitive understanding of the subtle shifts that lead to the early discovery of new opportunities and risks, especially paradigm-changing ones. As managers simply apply AI/ML output to their business, there is a danger that they will distance themselves from their first-hand experiences of their customers, products and markets. AI/ML can only develop patterns based on the range of past experience, but humans have the unique capability to infer creative new opportunities to shape the future in ways that fundamentally move beyond past experience. For example, Nalco sells chemicals for water treatment systems. The company had high delivery costs because customer orders were difficult to predict. In response, a manager developed a program to install wireless meters on the customers’ tanks to read inventory levels. This allowed the company to optimize its delivery routes. However, a creative manager saw that this information also enabled Nalco to compare the rate of actual chemical use to the optimum for the customer’s system—leading Nalco to develop a new initiative to call customers when they saw that the actual use indicated that the system was operating sub-optimally, and this created customer benefits that dwarfed the cost of the chemicals. If Nalco had simply installed an AI/ML system to minimize its delivery costs, it probably would have completely missed the opportunity to become a strategic partner to its customers, a move that transformed it from a commodity supplier into a high-value-added partner. Accommodating customer diversity In most companies, the portfolio of customers is diverse, ranging from Profit Peaks customers (high-revenues, high-profits) to Profit Drain customers (high-revenues, money-losing) to Profit Desert customers (low-revenues, low-profits). It is very important to manage the Profit Peak customers very differently from the Profit Drain customers, and to manage the Profit Desert customers very differently from the two large-customer segments. Moreover, using AI/ML extensively in Profit Peak customers would be problematic in many cases because these key customers tend to be price-insensitive but very service-sensitive, and they respond very well to paradigm-changing service innovations. Profit Peak customers often want innovative extended products, like vendor-managed inventory and category management, which can transform the relationship into a strategic partnership. In these customers, sales reps and others often need to sub-optimize their pricing and other areas for a time in order to gain political advantage in a large customer’s complex buying center. Similarly, many times the decision at hand is unprofitable but critical to a larger series of following high-profit decisions. These are crucial issues in a company’s most important high-profit customers. Simply punting product mix, pricing and related decisions to AI/ML offers the false prospect of data-based optimization, when the real issues are political and organizational. Organizing for Successful AI In our experience, the most productive way to manage the implementation of powerful AI/ML systems is to structure a two-level process. • At the top level, upper management, working through a Managing Profitable Growth Committee comprised of upper-mid level managers (e.g. directors and vice presidents), determines and monitors the targets of the AI/ML systems. It plans and oversees the company’s AI/ML program, and explicitly scans for paradigm-changing strategic opportunities and risks that AI/ML cannot address. It focuses on getting the processes in which AI/ML is embedded right, along with discovering game-changing situations that must modify or supersede the AI process. In particular, it is essential and necessary to devise a separate AI/ML strategy for each customer profit segment (Profit Peaks, Profit Drains and Profit Deserts). This enables the MPG Committee managers to custom-tailor the AI/ML-based processes to the widely differing priorities, nature and needs of each profit-based set of customers and products. • At the grassroots management level, managers operate the profit-enhancement processes in which the AI/ML is embedded. At this level, the key to effectiveness is to present the AI/ML recommendations in parallel with non-AI/ML best practice-based, intuitively understandable recommendations. This makes all the difference in user acceptance. By getting your business right at these two cornerstone levels, you can deploy AI/ML in a systematic way that realizes its full potential. As always, business success comes down to thoughtful management—no matter how dazzling the technology involved.
https://chiefexecutive.net/2-critical-challenges-to-effective-business-ai/
2022-08-09T13:04:36Z
https://chiefexecutive.net/2-critical-challenges-to-effective-business-ai/
false
1
More than 350,000 Institute students can receive a 10% tuition grant and a seamless transfer to ACE. INDIANAPOLIS, Aug. 9, 2022 /PRNewswire/ -- As a part of its mission to make high quality education both affordable and accessible, American College of Education (ACE) announced its partnership with The IGA Coca Cola Institute and Retail Learning Institute, an organization supported by The Coca Cola Company. The agreement offers more than 350,000 students a 10% tuition grant toward ACE programs. Students with a certificate of completion from IGA Institute are eligible for a seamless transfer of six credits toward ACE's B.S. in Applied Management and Leadership program. Through the two benefits, continuing education is even more affordable and shortens the pathway to a degree. "Our goal at ACE is to continuously ensure our programs are as accessible as possible, and that means working with outstanding partners like the Institute to make this happen," ACE President Shawntel Landry said. "Our work together will bring even more meaningful opportunities to those who are committed to enriching their professional skills and growing their careers." The Institute is an educational organization that provides branded online courses to more than 10,000 grocery stores globally. This includes over 250 industry-specific courses covering onboarding, compliance, department/positions and specialty area in the food retail industry. The courses are free to IGA members and available for a membership fee to all retailers. Courses earn users certificates and badges. Assistant Director of Strategic Partner Development Darryl Brown said, "This partnership is a great opportunity as both ACE and the Institute share a deep commitment to professional development and educational growth. We are looking forward to extending the reach of our programs to students of the Institute." American College of Education (ACE) is an accredited, 100% online college specializing in high-quality, affordable programs in education, business, leadership, healthcare and nursing. Headquartered in Indianapolis, ACE offers more than 70 innovative and engaging programs for adult students to pursue a doctorate, specialist, master's or bachelor's degree, along with micro-credentials and graduate-level certificate programs. In addition to being a leader in online education, ACE is a Certified B Corporation. Certified B Corporations are leaders of a global movement to use the power of business to solve social and environmental problems. IGA Institute is a people development organization supported by The Coca-Cola Company. The Institute does business as the IGA Coca-Cola Institute, Retail Learning Institute, Grocery Start, and NGA Online Education Center. Since 1988 the Institute has been dedicated to serve retailers worldwide offering online food retail courses in English, Spanish, Portuguese and Mandarin. It provides a full LMS service that includes more than 600 courses that cover onboarding, compliance, department/position, and specialty areas. As an educational organization, it serves more than 15,000 retail locations with blended training programs that include a mobile app and support materials and services to the retailers. The Institute also provides retailers and associations with their own branded online corporate universities and tailored courses. Media contact: Catherine Masri catherine.masri@hkstrategies.com 214-886-5870 View original content to download multimedia: SOURCE American College of Education
https://www.wtvm.com/prnewswire/2022/08/09/american-college-education-partners-with-iga-coca-cola-institute-advance-leadership-vocational-learning-college-level/
2022-08-09T13:08:53Z
https://www.wtvm.com/prnewswire/2022/08/09/american-college-education-partners-with-iga-coca-cola-institute-advance-leadership-vocational-learning-college-level/
false
12
- Partnership is with HTDK Group, wholly owned by Warburg Pincus - HTDK Group is a leading healthcare solutions provider which sells into 1,700+ medical institutions - The strategic partnership in the region extends across expertise in advancing Sofwave’s product registration and approval with the NMPA (China’s FDA) TUSTIN, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that it has entered a key collaboration and distribution agreement with HTDK Group to advance Sofwave™ sales in China. This strategic partnership will be an important step for Sofwave to tap into the rapidly growing market. Under the terms of the agreement, HTDK Group will help Sofwave accelerate its product registration approval with China’s National Medical Products Administration (NMPA) — a necessary regulatory step required prior to marketing and selling medical devices in China. The NMPA is equivalent to the Food and Drug Administration (FDA) in the US. In addition, HTDK will also support Sofwave with its product marketing, distribution and sales in China once regulatory approvals are obtained. “We are excited to enter into this strategic partnership with HTDK Group with the intention to accelerate Sofwave’s penetration into China’s massive and growing $29 billion medical aesthetic market,” said Louis Scafuri, Sofwave Medical’s CEO. “With a projected double-digit compounded annual growth rate, and a medical aesthetic market that is growing at a higher rate than the rest of the world, China remains strategically important, warranting our attention for the foreseeable future. Additionally, we are impressed not only with HTDK’s deep expertise in the high-value medical devices industry to assist in regulatory affairs but also with their large selling and distribution presence across China,” Mr. Scafuri concluded. HTDK Group is a leading commercialization solutions provider offering specialized market entrance and penetration solutions for high-value medical devices, covering over 1,700 medical institutions in China. The Company is wholly owned by Warburg Pincus, a leading global growth investor with more than $85 billion in assets under management. “We are delighted to partner with Sofwave, whose innovative solutions on aesthetic care are well-regarded in the market. Our entire team is incredibly motivated by the opportunity to bring the industry-leading product, Sofwave™ to market in China. As a leading comprehensive commercial platform, HTDK has deep expertise and extensive experience in the high-value medical device industry. We look forward to working closely with Sofwave to support its market entry and business success in the market,” said Teresa Chen, HTDK’s CEO. About Sofwave Medical Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction and lifting using proprietary breakthrough technology. Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: Info@sofwave.com About HTDK Group HTDK is a leading cross-border commercial solutions platform in China offering end-to-end specialized commercial solutions to high-value medical device brands, with particular strength in serving global brands. HTDK has solid and long-lasting partnerships with global high-value medical device brands of multiple medical specialties, such as ophthalmology, IVD, orthopedics, cardiology, neurology, obstetrics, gynecology, vascular surgery, endocrinology, respiratory, and high-value medical consumables. HTDK’s brand partners are leading global brands in their respective sectors, such as Alcon, MicroVention, Illumina, Smith & Nephew, Roche, Abbott, and P&G. For more information, please visit http://www.htdkgroup.com/. Investor Contact: Brian Ritchie LifeSci Advisors LLC (212) 915-2578 britchie@lifesciadvisors.com Media Contact: Jasmine Wang HTDK Group 86(21)6033 9588 jasmine.l.wang@htdkgroup.com
https://www.globenewswire.com/news-release/2022/08/09/2494897/0/en/Key-Collaboration-and-Distribution-Agreement-Signed-With-Major-Partner-To-Advance-Sofwave-Sales-In-China-s-Growing-29-Billion-Aesthetic-Medicine-Market.html
2022-08-09T13:09:18Z
https://www.globenewswire.com/news-release/2022/08/09/2494897/0/en/Key-Collaboration-and-Distribution-Agreement-Signed-With-Major-Partner-To-Advance-Sofwave-Sales-In-China-s-Growing-29-Billion-Aesthetic-Medicine-Market.html
true
2
Meta-owned messaging platform WhatsApp has confirmed that it is now letting users delete messages up to two days after they are sent. On the microblogging platform Twitter, WhatsApp announced the change in the option to delete sent messages. "Rethinking your message? Now you will have a little over two days to delete your messages from your chats after you hit send," the platform wrote on Twitter. WhatsApp will allow users to delete a message up to two days and 12 hours after sending it. Previously, this limit was only 1 hour, 8 minutes, and 16 seconds. Meanwhile, the platform will soon release a new feature that will allow group admins the ability to delete messages for everyone. WhatsApp is rolling out a new update through the Google Play Beta Program, bringing the version up to 2.22.17.12 and that will let group admins delete any message for everyone. The Meta-owned platform is also working on letting users edit their text messages for a future update of the app. Recently, a screenshot shared by the website showed that the messaging platform is developing a new option to let users fix any typo after sending a message. Meta Founder and CEO Mark Zuckerberg on Tuesday also announced three key privacy features in WhatsApp, giving users more control over their conversations and added layers of protection when messaging. New features allow WhatsApp users to exit group chats without notifying everyone, control who can see when you're online and prevent screenshots on view once messages. "We'll keep building new ways to protect your messages and keep them as private and secure as face-to-face conversations," said Zuckerberg. WhatsApp users will now be able to exit a group privately without having to notify everyone. "Now, instead of notifying the full group when leaving, only the admins will be notified. This feature starts to roll out to all users this month," said the social network. WhatsApp also introduced the ability to select who can and can't see when you're online. The feature will start rolling out to all users this month. WhatsApp is also enabling screenshot blocking for 'View Once' messages for an added layer of protection. This feature is being tested and will be rolled out to users soon. "Over the years, we've added interlocking layers of protection to help keep their conversations secure, and the new features are one way we continue to deliver on our commitment to keep messages private," said Ami Vora, Head of Product at WhatsApp. "To spread the word about these new features, we're also kicking off a global campaign, starting with the UK and India, to educate people about how we work to protect their private conversations on WhatsApp," Vora added.
https://www.thenewsminute.com/article/edit-texts-exit-group-chats-silently-whatsapp-get-six-new-features-166670
2022-08-09T13:09:49Z
https://www.thenewsminute.com/article/edit-texts-exit-group-chats-silently-whatsapp-get-six-new-features-166670
false
3
This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement. What better time than now to purchase a new pair of walking shoes for the wide variety of amazing terrain this country has to offer? Best walking shoes at a glance - Best hiking all-rounder: Keen Ridge Flex Waterproof - Best on test: Haglofs Trail Fuse GTX - Best for all-weather walks: Merrell Moab Speed - Best for fast-paced hiking: On Cloudadventure - Best for country walking: Scarpa Cyprus - Best for aquatic adventures: Vivo Barefoot Ultra III Bloom - Best for style points: Ryka Switchback - Best leather shoe: AKU Unisex’s Bellamont Iii Fg GTX Low Rise Hiking Boots Why walking shoes, not boots? Walking shoes differ in a number of key ways from boots - they’re more lightweight, less clumpy, often more comfortable and easy to transport. They also work better in terms of dual usage - we would be very comfortable putting on a pair of walking shoes to go into town or to the shops, for instance. They can be breathable, very comfortable and easy to walk in. Walking boots however, not so much - everyday usage of more clumpy, higher boot options can be tiring, hot and blister-inducing. Summer’s a great time to invest in more breathable shoes like the ones we’ve listed here. Why walking shoes, and not exercise trainers? They may look like trainers but make no mistake, these shoes mean business. If you’re frustrated by the poor performance of everyday trainers or sports shoes (and in some circumstances, taking these kinds of shoes out and about on certain terrain can be downright dangerous), then these options will make traipsing around in the muddy woods or trails a piece of cake. What to look for in a walking shoe Look for good ankle support, as these shoes are lower than standard hiking boots, so you’ll need some extra padding there to make sure you don’t injure yourself. An easily cleanable upper material will work to your advantage too - leather or a wipe clean or easily machine washable material works the best here (if you use them right, you’ll definitely get them muddy!) Look for good laces that do up well and nice and securely, and be sure to pay close attention to width - too narrow a shoe and your walking experience is likely to be rather less than optimum, indeed highly uncomfortable. Get kitted out for your hiking and backpacking adventures. We have detailed guides to the best backpacking tents for your adventures here. Want to steady your stride? These are the best walking poles for hiking. Keep it comfy with the best camping folding chairs, and sleep on the best air beds around, as listed here. And keep things illuminated with a great camping head torch. Here are eight of our favourite hiking shoes for women on the market at the moment. Keen Ridge Flex Waterproof Best for: best hiking all-rounder Key specs – Weight: N/A; Waterproof? Yes; Colour options: 3; Sizes: 2.5-9. If you want a walking shoe that can still tackle tough mountain adventures like your favourite hiking boots can, Keen’s low shoe version of their popular new Ridge Flex hiking boot might be your new best mate. This shoe uses Keen’s latest innovation to help you hike further – ‘Bellows Flex’ is a concertina-like insert in the top of the shoe that’s designed to move with your foot and offer better comfort over long distances. These are definitely a comfortable pair of shoes to wear when you’re covering the miles or taking on a multi-day walk, and are also waterproof enough to keep your feet dry in a sudden downpour. A great choice for summer hikes. Haglofs Trail Fuse GTX Best for: best on test Key specs – Weight: 260g; Waterproof? Yes; Colour options: 4; Sizes: 36-42. Do you hate the clunky, heavy feeling of traditional hiking boots? Swap them for Haglofs’ light-as-anything Trail Fuses, which weigh just 130g per shoe. It may feel barely-there, but this trail shoe means business, with a sticky grip, a tough outer sole and great waterproofing thanks to Gore-Tex technology. Haglofs have borrowed running shoe brand Asics’ know-how to design the gel insoles in these walking shoes – the result is a super comfortable shoe that moulds to your feet. These are the holy grail of walking shoe – waterproof in the wet, but breathable in the heat. Top marks. Merrell Moab Speed GTX Best for: all-weather walks Key specs –Weight: 600g; Waterproof? Yes; Colour options: 4; Sizes: 2.5-8.5. If comfort is top of your walking shoe shopping list, plump for a pair of Merrell’s new Moab Speeds – they’re impressive comfortable to wear straight out of the box. This rugged design is perhaps not as breathable or as lightweight as some of the lightest shoes we tested out, but it stands out in tough weather, when the Moab Speed offers great grip even on wet or slippery terrain thanks to ever-reliable Vibram soles, great waterproofing, so you can stride through puddles without a problem, and enough warmth to work on ‘shoulder season’ hikes in autumn and spring. We like Merrell’s commitment to using recycled materials, too. On Cloudventure Best for: fast-paced hikes Key specs – Weight: 240g; Waterproof? No; Colour options: 5; Sizes: 3-9. These trainers may have been designed with trail runners in mind, but we like the Cloudventure just as much for hiking – this is a great investment if you want one trusty shoe that can tackle both disciplines. At just 240g, On’s design is are the lightest shoe in our round-up, and feels so freeing and comfortable you’ll barely know you’re wearing it – until you hit tough terrain, when the Cloudventure offers impressive grip even on slick wet rocks. For moving fast over long distances on dry terrain, you can’t go wrong with the Cloudventure, and a waterproof version is also available for £150 if you’re heading outdoors in more challenging weather. Scarpa Cyrus Best for: country walking Key specs – Weight: 940g; Waterproof? Yes; Colour options: 1; Sizes: 4-8. There’s nothing better for the mercurial – and often downright chilly - British summertime than a sensible pair of leather walking shoes. Scarpa’s Cyrus hiking shoe may look so classic it’s almost retro But when it comes to technology this design is bang-up-to-date, with a fully waterproof Gore-Tex membrane and grippy Vibram soles – this combo is ideal for taking on sudden changes in the weather when you’re off the beaten track. That smart and warm nubuck leather outer material makes these boots heavy at 940g, so they’re better suited to shorter distances rather than to challenging multi-day hikes. Best Deals Available {{/hasItems}} {{#items}} {{/items}}Vivo Barefoot Ultra III Bloom Best for: aquatic adventures Key specs – Weight: 340g; Waterproof? No; Colour options: 2; Sizes: 3-9. Vivo Barefoot’s shoes are designed to be ‘foot shaped, not shoe shaped’, and their flexible soles allow your feet to feel more of the terrain underfoot, barefoot-style, as you walk, while still offering some protection. Their futuristic Ultra III Bloom is the perfect summer walking shoe if you’re exploring by the sea or stopping for a wild swim, as it can be worn both in water and on land. These perforated shoes aren’t waterproof, obviously, but they provide good protection from rocks underwater and dry quickly and keep feet cool when you’re back on the trail. Ryka Switchback Best for: style points Key specs – Weight: N/A; Waterproof? No; Colour options: 3; Sizes: 5-11. If you want the looks of an urban trainer but the performance of a trail shoe, Ryka’s affordable Switchback could be your new wear-anywhere summer shoe. It’s a pity this smart sneaker isn’t waterproof, but for dry days when you want to hit the trail and the city streets in just one pair of comfortable shoes, they’re a great choice, and the breathability of the Switchback makes them a good quiver-of-one pair of shoes for taking with you on holiday for walking, city sightseeing and wearing to the gym. They’re well-priced at around the £50 mark, too. Aku Bellamont III Lux GTX Best for: best leather shoe Key specs – Weight: 430g; Waterproof? Yes; Colour options: 2; Sizes: 3-13.Who knew sensible trainers could look this smart? Aku’s Italian-designed hiking boots are the last word in style-meets-substance, and the same goes for their walking shoes. These Gore-Tex-treated nubuck leather trainers will go anywhere you do, and can deal with sudden mountain storms as well as just popping down the pub. Thick Vibram soles make these one of the heavier walking shoes we tested, but that rugged grip is worth the extra few grams. We’d recommend cleaning the Bellamonts’ suede leather outer material regularly, to keep it looking smart.
https://www.thesouthernreporter.co.uk/recommended/8-best-walking-shoes-women-on-cloudadventure-merrell-on-3271869
2022-08-09T13:10:42Z
https://www.thesouthernreporter.co.uk/recommended/8-best-walking-shoes-women-on-cloudadventure-merrell-on-3271869
false
48
Athletico is looking forward to continuing its quality of care throughout the state of Wisconsin HARTFORD, Wis., Aug. 9, 2022 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Hartford, Wisconsin, located near Starbucks across from Taco Bell. This location offers convenient hours, including early morning, late evening and Saturday appointments, and does not require a referral or prescription to start treatment. To learn more, or to schedule a free assessment, visit www.athletico.com/Hartford. Athletico is committed to keeping employees and patients safe during COVID-19 and has taken several measures, including additional screening procedures, enhanced cleaning practices, and appropriate distancing of patients during treatment sessions. In addition to in-clinic treatment at the Hartford clinic, Athletico is also offering telehealth virtual treatment options where patients can connect with a physical therapist through a secure online video chat. "I became a physical therapist because I wanted to positively impact peoples' lives by helping to improve their quality of life, so they can get back to doing the things they love," said Andrew Rolland, PT, DPT and Clinic Manager of Athletico Hartford. "From my own sports injuries in high school to my mom's rehabilitation after a spinal cord injury, I was able to personally see how large of an influence physical therapy can have on one's life. Now, as a clinic manager at Athletico, I'm excited to help members of the Hartford community move and feel better." Services available at Athletico Hartford include: - Physical therapy – Our physical therapists treat you to reduce pain, improve or restore mobility, and to help you remain at your optimal health without further risk of injury. We also offer joint replacement therapy, headache treatment, concussion therapy and more. - Free assessments – If you have a strain, sprain or nagging pain, you can see one of our experts for a free, 30-minute assessment. We evaluate your injury and recommend treatment. If needed, we can begin treatment immediately, no referral necessary. Please note, restrictions apply. - Work injuries – We are committed to helping everyone practice safety at work. Our workers' compensation specialists are trained to assess workplace environments and worker behaviors to provide customized intervention techniques and programs. In addition to treating injuries that occur on the job, our services include work conditioning, ergonomics, post-offer/pre-employment testing and more. - ACL 3P Program – Anterior cruciate ligament (ACL) tears sideline more than 200,000 athletes each year. Our ACL 3P clinicians are committed to helping you minimize the risk of these injuries, as well as helping athletes who have sustained ACL injuries progress through rehabilitation to perform at their highest level. - Dry needling – If you are experiencing pain, you may benefit from dry needling. This technique involves placing ultra-thin needles into painful areas of the body to stimulate the pain-causing trigger points in the muscle and connective tissues. Additionally, Athletico Hartford: - Accepts all major insurance plans, so you don't need to worry about your visits not being covered. - Offers convenient hours, including early mornings, late evenings and Saturdays. - Does not require a physician referral or prescription to start treatment. - Schedules each initial evaluation quickly, sometimes the same or next day, but always within 24-48 hours. - Provides ongoing patient education on diagnosis, treatment plans and prescribed home-exercise programs. - Practices clear, consistent communication between therapist, physician and patient regarding progress. Athletico – Hartford 1504 East Sumner St. Hartford, WI 53207 Phone: 262-709-8466 www.athletico.com/Hartford Hartford@athletico.com About Athletico Physical Therapy Athletico Physical Therapy provides the highest quality orthopedic rehabilitation services to communities, employers and athletes. With its recent acquisition of Pivot Health Solutions, the company has nearly 8,000 employees across more than 900 locations throughout 25 states and the District of Columbia. Athletico is committed to our patients and referring physicians through our patient-centric focus, positive work environment, attention to quality and high standard of care. Athletico measures patient outcomes and satisfaction and is dedicated to continuous improvement. Athletico was named #1 Workplace in Chicago, "Best Physical Therapy Practice in the Nation" by ADVANCE magazine, Top Workplace in the Nation and has been recognized as a leader in employee volunteering and charitable giving. Our services include physical and occupational/hand therapy, workers' compensation, women's health therapy, concussion management and athletic training. For more information, or to schedule a free assessment in clinic or now online with our virtual free assessments, visit http://www.athletico.com and follow us on Twitter at @athletico. Media Contact: Dana Andreoli Athletico Physical Therapy dana.andreoli@athletico.com 630-259-5156 View original content to download multimedia: SOURCE Athletico Physical Therapy
https://www.wtap.com/prnewswire/2022/08/09/athletico-physical-therapy-opens-hartford-wisconsin/
2022-08-09T13:15:05Z
https://www.wtap.com/prnewswire/2022/08/09/athletico-physical-therapy-opens-hartford-wisconsin/
true
85
New York State Common Retirement Fund raised its holdings in Peloton Interactive, Inc. (NASDAQ:PTON – Get Rating) by 0.7% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 328,155 shares of the company’s stock after purchasing an additional 2,300 shares during the quarter. New York State Common Retirement Fund’s holdings in Peloton Interactive were worth $8,670,000 as of its most recent filing with the Securities & Exchange Commission. Several other institutional investors and hedge funds have also recently bought and sold shares of the business. California Public Employees Retirement System raised its stake in Peloton Interactive by 3.7% in the first quarter. California Public Employees Retirement System now owns 532,089 shares of the company’s stock valued at $14,058,000 after buying an additional 18,922 shares during the period. BlackDiamond Wealth Management Inc. bought a new position in shares of Peloton Interactive during the first quarter worth approximately $301,000. Advisor Group Holdings Inc. increased its stake in shares of Peloton Interactive by 21.8% during the first quarter. Advisor Group Holdings Inc. now owns 52,278 shares of the company’s stock worth $1,021,000 after purchasing an additional 9,368 shares during the period. Legacy Financial Advisors Inc. bought a new position in shares of Peloton Interactive during the first quarter worth approximately $274,000. Finally, Clearstead Advisors LLC increased its stake in shares of Peloton Interactive by 133.7% during the first quarter. Clearstead Advisors LLC now owns 1,573 shares of the company’s stock worth $42,000 after purchasing an additional 900 shares during the period. Institutional investors own 82.42% of the company’s stock. Wall Street Analyst Weigh In PTON has been the topic of a number of recent research reports. Oppenheimer initiated coverage on Peloton Interactive in a research note on Wednesday, August 3rd. They set an “outperform” rating and a $20.00 target price on the stock. Truist Financial lowered their target price on Peloton Interactive from $45.00 to $15.00 in a research note on Wednesday, May 11th. JMP Securities upgraded Peloton Interactive from a “market perform” rating to an “outperform” rating and set a $25.00 target price on the stock in a research note on Wednesday, May 11th. Loop Capital reduced their price target on Peloton Interactive from $55.00 to $27.00 in a research report on Wednesday, May 11th. Finally, Robert W. Baird reduced their price target on Peloton Interactive from $46.00 to $25.00 in a research report on Wednesday, May 11th. Fifteen analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $40.50. Peloton Interactive Stock Up 1.0 % Peloton Interactive (NASDAQ:PTON – Get Rating) last announced its earnings results on Tuesday, May 10th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.85) by ($0.13). The company had revenue of $964.30 million for the quarter, compared to the consensus estimate of $969.81 million. Peloton Interactive had a negative return on equity of 78.79% and a negative net margin of 49.10%. The firm’s revenue for the quarter was down 23.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.03) earnings per share. Analysts predict that Peloton Interactive, Inc. will post -5.64 earnings per share for the current year. Insider Buying and Selling In related news, CFO Jill Woodworth sold 4,530 shares of the firm’s stock in a transaction on Monday, May 16th. The stock was sold at an average price of $15.65, for a total transaction of $70,894.50. Following the completion of the transaction, the chief financial officer now directly owns 6,528 shares of the company’s stock, valued at approximately $102,163.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 13.18% of the stock is owned by corporate insiders. About Peloton Interactive Peloton Interactive, Inc provides interactive fitness products in North America and internationally. It offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, and Peloton Tread+ names. The company also provides connected fitness subscriptions for various household users, and access to various live and on-demand classes, as well as Peloton Digital app for connected fitness subscribers to provide access to its classes. Further Reading - Get a free copy of the StockNews.com research report on Peloton Interactive (PTON) - Home Depot, Lowe’s On Track To Grow 2022 Earnings - Could Smaller be Better for Investors in Norwegian Cruise Lines? - Walmart Or Target: Which Is The Stronger Stock? - Can Etsy Continue to Thrive After the Pandemic? - MarketBeat Podcast: Investing in What You Know Has Changed Want to see what other hedge funds are holding PTON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Peloton Interactive, Inc. (NASDAQ:PTON – Get Rating). Want More Great Investing Ideas? - Bear Market Game Plan! - The 10 Best Stocks to Own in 2022 - 7 Stocks to Buy and Hold Forever - 3 Stocks to DOUBLE This Year Receive News & Ratings for Peloton Interactive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peloton Interactive and related companies with MarketBeat.com's FREE daily email newsletter.
https://www.etfdailynews.com/2022/08/09/new-york-state-common-retirement-fund-acquires-2300-shares-of-peloton-interactive-inc-nasdaqpton/
2022-08-09T13:21:37Z
https://www.etfdailynews.com/2022/08/09/new-york-state-common-retirement-fund-acquires-2300-shares-of-peloton-interactive-inc-nasdaqpton/
true
1
WB Police Excise Constable Final Merit List 2022 released on wbpolice.gov.in WB Police Excise Constable Final Merit List has been released by the West Bengal Police today, August 9, 2022 on the official website of the WB Police, wbpolice.gov.in. Candidates who appeared for the exam of WB Police Excise Constable can check the result now. UP NEXT The West Bengal Police has officially released the WB Police Excise Constable Final Merit List on the official site, wbpolice.gov.in. As per the notice released for the final merit list, candidates note that the results have been uploaded on prb.wb.gov.in and on excise.wb.gov.in as well. The merit list of the Excise Constable along with the lady constable result has been released. Candidates note that the final merit list of provisionally selected candidates is also available on the notice board of the West Bengal recruitment board, Araksha Bhawan, Saltlake City, Kolkata. Candidates can go the website and see the complete notice of the final merit list along with the address. Candidates who appeared for the WB Police Excise Constable Exam can check the final merit list now. As per the notice candidates will have to key in their application SI Number and date of birth on the link provided. - Visit the website – wbpolice.gov.in - Then click on the recruitment board and you will be able to see the link which says Final Merit list - Once done, enter the details - Download the list and keep a copy The list of candidates along with the roll number, date of birth, interview marks, total marks and remarks etc., have also been released. Post the release of the merit list, candidates will be called for the further process and notice will be released soon. Latest News Haryana Minister says 5 lakh tablets purchased for govt school students of class 10 to 12 Ministry of Education holds meeting for inputs on National Curriculum Framework 2022 Pakistan: Karachi security guard kicks pregnant woman; gruesome act captured on CCTV Expansion of sewage system in Delhi crucial for clean Yamuna: Delhi Jal Board Ditch your junk food for these healthy options that taste better Shrikant Tyagi case: Self-proclaimed Noida politician 'got MLA sticker from Swami Prasad Maurya' - Police NMDC Ltd releases notification for Apprentice Recruitment on nmdc.co.in, see interview schedule Raksha Bandhan Gifting Guide - Tech: Gifts for your sister at the best prices End of Article
https://www.timesnownews.com/jobs/wb-police-excise-constable-final-merit-list-2022-released-on-wbpolice-gov-in-article-93457902
2022-08-09T13:21:46Z
https://www.timesnownews.com/jobs/wb-police-excise-constable-final-merit-list-2022-released-on-wbpolice-gov-in-article-93457902
true
1
The Industry Leader in Modern Canvas Art EXPANDS PORTFOLIO WITH Exclusive NEW Prints and Designs Featuring Sports Superstars and Legends CARLSBAD, Calif., Aug. 9, 2022 /PRNewswire/ -- Brevettar, a full-service sports licensing agency that maximizes revenue by connecting best-in-class brands with strategic collaborations and licensing opportunities, is excited to announce a new collaboration between Upper Deck and Ikonick, a leader in e-commerce canvas wall art, to create a new collection of inspiration designs showcasing current and past sports superstars. This multi-year agreement will authorize the creation of a unique collection of limited-edition digital art photography on canvas and other mediums showcasing legendary athletes Wayne Gretzky, LeBron James, and Tiger Woods. An offering of exclusive designs will be created by renowned digital artist and co-founder of Ikonick, Jeff Cole. "With a lot of traditional art, it's subjective and left open for interpretation. Our art serves a more direct functional purpose; that's a major differentiator for us. Our DNA represents personal accountability. There's power to our product and how we feel when we use them. Brevettar was instrumental in creating this collaboration with Upper Deck's top athletes and allowing us to showcase the unique aspects of our brand," said artist and Ikonick co-founder, Jeff Cole. "We are honored and excited to re-imagine these iconic, inspiring athletes with our brand's DNA," said Mark Mastrandrea, co-founder of Ikonick. "Brevettar is very pleased to extend Upper Deck's relationship with some of the world's most celebrated athletes into the category of inspirational wall art through Ikonick." said Stu Crystal, General Manager of Brevettar. "This is a tremendous opportunity to offer life-long sports fans a modern and innovative way to celebrate the athletes they most admire." The new collection is now available at Ikonick.com and in select retail outlets. Brevettar, the exclusive licensing agent for Upper Deck, is a full-service sports licensing agency that maximizes revenue by connecting best-in-class brands with strategic collaborations and licensing opportunities. Licensees include Funko, Fathead, Enterbay, FOCO and Trends International, to name a few. Learn more and view Brevettar's portfolio of exclusive licensed collectibles at www.brevettar.com Ikonick is a West-Coast based art brand putting a new spin on the business of inspiring others. Embodying popular culture, their exclusive collections exist to motivate in a way that's entirely their own. Started as a passion project in 2016, Ikonick is now one of the biggest e-commerce art players in the world. They partnered up with entrepreneurial icon Gary Vaynerchuk and obtained licensing rights from some of the world's most iconic properties, individuals, and artists. The brand's goal is to expand into as many homes, offices, and gyms as possible across the globe. View original content to download multimedia: SOURCE Brevettar
https://www.wvlt.tv/prnewswire/2022/08/09/brevettar-announces-multi-year-deal-with-ikonick/
2022-08-09T13:23:17Z
https://www.wvlt.tv/prnewswire/2022/08/09/brevettar-announces-multi-year-deal-with-ikonick/
false
10
SHENZHEN, China, Aug. 9, 2022 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider in China, today announced its financial results for the second quarter ended June 30, 2022. Ms. Renmei Ouyang, the Chief Executive Officer of the Company, stated, "We made tremendous progress in growing and enhancing our business during the second quarter of fiscal year 2022, despite the many challenges presented by the resurgence of the COVID-19 pandemic. We continued to see increased demand for our services, highlighting the breadth and resilience of our business model against a challenging macro environment. To achieve the growth potential of our business, we will continue to expand our business by executing strategic initiatives, exploring growth opportunities, and providing high-quality products and services to our customers. We remain focused on providing invaluable services and support to best serve the demand of our customers. Specifically, we will continue to make progress and work toward on our strategic expansion, including expanding sales channels, growing our customer base, and keeping explore growth opportunities in the global gold spot trading market, digital cloud warehouse market and lightweight new materials market. In addition to our strategic expansion, we aim to manage expenses prudently and improve operating efficiency. We believe these initiatives will support us to generate new business growth and build momentum toward our growth objectives. As we look ahead to the fiscal year 2022 and beyond, we will strive to expand our capabilities to serve our customers, grow our business, and provide higher returns to our shareholders." Financial Highlights In the quarter ended June 30, 2022 - Total revenue was $53.68 million, consisting of $53.11 million from sales of commodity products, and $0.57 million from supply chain management services for the quarter ended June 30, 2022, a decrease of 10% from $59.84 million for the same quarter ended June 30, 2021. - Net income was $1.43 million, compared with $0.36 million for the same quarter ended June 30, 2021. - Basic and diluted earnings per share was $0.01, compared with $nil for the same quarter ended June 30, 2021. In the six months ended June 30, 2022 - Total revenue was $101.84 million, consisting of $100.69 million from sales of commodity products, and $1.15 million from supply chain management services for the six months ended June 30, 2022, an increase of 14% from $89.42 million for the same period ended June 30, 2021. - Net income was $3.02 million, as compared with net loss of $1.18 million for the same period ended June 30, 2021. - Basic and diluted earnings per share was $0.01, compared with basic and diluted loss per share of $0.01 for the same period ended June 30, 2021. Financial Results In the three months ended June 30, 2022 Revenues For the three months ended June 30, 2022, the Company sold non-ferrous metals to 22 customers at fixed prices, and earned revenues when the product ownership was transferred to its customers. The Company earned revenues of $53.11 million from sales of commodity products for the three months ended June 30, 2022, compared with $59.51 million from sales of commodity products for the three months ended June 30, 2021, among which, $1.52 million was generated from the related party. For the three months ended June 30, 2022, the Company earned revenue of $0.57 million from supply chain management services to third-party customers, compared with $0.33 million to third-party customers for the three months ended June 30, 2021. Cost of revenue Cost of revenue primarily includes cost of revenue associated with commodity product sales and cost of revenue associated with management services of supply chain. Total cost of revenue decreased by $6.22 million, or 10% to $53.24 million for the three months ended June 30, 2022, from $59.47 million for the three months ended June 30, 2021, primarily due to a decrease of $4.68 million in cost of revenue associated with commodity product sales from the third party. The decreased cost of revenue is in line with the decrease in revenue. Selling, general, and administrative expenses Selling, general and administrative expenses decreased by $0.18 million or 9%, to $1.88 million for the three months ended June 30, 2022, from $2.05 million for the three months ended June 30, 2021. Selling, general and administrative expenses primarily consisted of salary and employee benefits, office rental expense, amortizations of intangible assets and convertible promissory notes, professional service fees and finance offering related fees. There is no big decrease for the three months ended June 30, 2022 compared with the three months ended June 30, 2021. Interest income Interest income was primarily generated from loans made to third parties and related parties. Interest income increased by $1.42 million or 48%, to $4.37 million for the three months ended June 30, 2022, from $2.95 million for the three months ended June 30, 2021. The increase was full due to loans made to third-party vendors for the three months ended June 30, 2022. Amortization of relative fair value of warrants relating to service provider For the three months ended June 30, 2022, the item represented the amortization of beneficial conversion feature of $0.32 million and relating to the convertible promissory notes. For the three months ended June 30, 2021, no such expenses incurred. Net income Net income was $1.43 million for the three months ended June 30, 2022, compared with $0.36 million for the three months ended June 30, 2021. In the six months ended June 30, 2022 Revenues For the six months ended June 30, 2022, the Company sold non-ferrous metals to 22 third-party customers at fixed prices, and earned revenues when the product ownership was transferred to its customers. The Company earned revenues of $100.69 million from sales of commodity products for the six months ended June 30, 2022, compared with $88.95 million for the six months ended June 30, 2021. For the six months ended June 30, 2022, the Company earned commodity distribution commission fees of $1.15 million from 16 third-party vendors, compared with commission fees of $0.47 million from third-party vendors for the six months ended June 30, 2021. Cost of revenue Cost of revenue primarily includes cost of revenue associated with commodity product sales, cost of revenue associated with management services of supply chain. Total cost of revenue increased by $11.96 million, or 13% to $100.85 million for the six months ended June 30, 2022, from $88.89 million for the six months ended June 30, 2021, primarily due to an increase of $11.96 million in cost of revenue associated with commodity product sales. The increased cost of revenue is in line with the increase in sales volume. Selling, general, and administrative expenses Selling, general and administrative expenses increased by $0.50 million or 14%, to $4.12 million for the six months ended June 30, 2022, from $3.62 million for the six months ended June 30, 2021. Selling, general and administrative expenses primarily consisted of salary and employee benefits, office rental expense, amortizations of intangible assets and convertible promissory notes, professional service fees and finance offering related fees. The increase was mainly attributable to 1) salary and employee benefits increased by $0.62 million and, 2) amortization of convertible promissory notes increased by $0.22 million. Interest income Interest income was primarily generated from loans made to third parties and related parties. Interest income increased by $3.71 million or 74%, to $8.76 million for the six months ended June 30, 2022, from $5.05 million for the six months ended June 30, 2021. The increase was primarily due to loans made to third-party vendor customers, among which, $0.70 million was attributed to related parties and $8.05 million was generated from third-party vendors. Share-based payment for service On March 4, 2021, the Company issued 750,000 fully-vested warrants with an exercise price of $0.01, with a five-year life, to an agent who was engaged to complete the warrant waiver and exercise agreements. The Company applied Black-Scholes model and determined the fair value of the warrants to be $1,695,042. Significant estimates and assumptions used included stock price on March 4, 2021 of $2.27 per share, risk-free interest rate of one year of 0.08%, life of 5 years, and volatility of 71.57% for the six months ended June 30, 2021. For the six months ended June 30, 2022, no such expenses incurred. Amortization of beneficial conversion feature and relative fair value of warrants relating to issuance of convertible notes For the six months ended June 30, 2022, the item represented the amortization of beneficial conversion feature of $0.53 million relating to the convertible promissory notes. For the six months ended June 30, 2021, no such expenses incurred. Net income (loss) Net income was $3.02 million for the six months ended June 30, 2022, compared with net loss of $1.18 million for the six months ended June 30, 2021. Six Months Ended June 30, 2022 Cash Flows As of June 30, 2022, the Company had cash and cash equivalents of $3.93 million, as compared with $4.31 million as of December 31, 2021. Net cash provided by operating activities was $0.47 million for the six months ended June 30, 2022, compared with net cash used in operating activities of $3.79 million for the six months ended June 30, 2021. Net cash used in investing activities was $60.10 million for the six months ended June 30, 2022, compared with $15.81 million for the six months ended June 30, 2021. Net cash provided by financing activities was $59.92 million for the six months ended June 30, 2022, compared with $23.10 million for the six months ended June 30, 2021. About TD Holdings, Inc. TD Holdings, Inc. is a service provider currently engaging in commodities trading business and supply chain service business in China. Its commodities trading business primarily involves purchasing non-ferrous metal product from upstream metal and mineral suppliers and then selling to downstream customers. Its supply chain service business primarily has served as a one-stop commodity supply chain service and digital intelligence supply chain platform integrating upstream and downstream enterprises, warehouses, logistics, information, and futures trading. For more information, please visit http://ir.tdglg.com. Safe Harbor Statement This press release may contain certain "forward-looking statements" relating to the business of TD Holdings, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: there is uncertainty about the spread of the COVID-19 virus and the impact it will have on the Company's operations, the demand for the Company's products and services, global supply chains and economic activity in general. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website at http://www.sec.gov. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. For more information, please contact: Ascent Investor Relations LLC Ms. Tina Xiao Email:tina.xiao@ascent-ir.com Tel: +1 917 609 0333 View original content: SOURCE TD Holdings, Inc.
https://www.wtap.com/prnewswire/2022/08/09/td-holdings-inc-reports-second-quarter-2022-financial-results/
2022-08-09T13:24:06Z
https://www.wtap.com/prnewswire/2022/08/09/td-holdings-inc-reports-second-quarter-2022-financial-results/
false
12
Leading Consumer Growth Equity Firm Expands Its Differentiated Investment Strategy ORANGE COUNTY, Calif., Aug. 9, 2022 /PRNewswire/ -- RX3 Growth Partners, a consumer growth equity firm backed by a community of professional athlete, celebrity, and influencer investors, is deepening its value-add strategy with the addition of new Advisors Kevin Hart, via his firm Hartbeat Ventures, Vanessa Hudgens, Actress and Co-Founder of Caliwater and KNOW Beauty, and Raissa Gerona, Chief Brand Officer for Revolve. Each brings a unique perspective to the firm, and collectively, provides unparalleled value to RX3's portfolio of brands. RX3 was co-founded by Green Bay Packers quarterback Aaron Rodgers, Nate Raabe and Byron Roth, and has approximately $150 million in assets under management across two funds. The firm has a proven track record of translating proprietary sourcing and value-add capabilities into strong returns, as demonstrated by five exits in just over three years from its inaugural fund. RX3 continues to focus its efforts on supporting leading consumer brands, including: Therabody, Orgain, Hydrow, Full Swing, Super Coffee, and MANSCAPED, among others. "RX3's focus on wellness and lifestyle brands aligns perfectly with my own interests," shares Vanessa Hudgens. "In partnering with RX3, I'm excited to bring my passion for brand-building to its portfolio." "It's no secret that influencer marketing is evolving, and having been at the forefront of the space, I've witnessed firsthand the power of authentic brand relationships," adds Raissa Gerona. "RX3 is leading the industry by providing more than just capital to brands. I'm thrilled to share my expertise with the RX3 team, as we amplify the reach of their portfolio companies to create value for all stakeholders." Additionally, RX3 is pleased to announce two senior firm hires, Andrew Costa, previously Chief Investment Officer at ROTH Capital, as Partner, and Kira Jackson, previously Vice President of Brand Strategy at global marketing agency Power Digital, as Head of Partnerships. Each has nearly a decade of experience working with and scaling leading consumer brands. "RX3 was created to grow brands through authentic influencer relationships. The performance and multiple exits of Fund I validate that our model can drive tangible results," says Nate Raabe, RX3's Managing Partner. "In today's environment, the best companies will have their pick on who to take capital from. We believe we have a significant advantage given our unique platform, and this differentiation continues to be strengthened as we add new investors, athletes and influencers to our community." RX3 Growth Partners is a consumer growth equity firm that was co-founded in 2018 by Aaron Rodgers and counts a number of celebrities and professional athletes as investors across its two funds. The firm seeks to align itself with high-quality brands that resonate with this network to help drive consumer awareness and long-term growth. More information about RX3 Growth Partners can be found at www.rx3growthpartners.com. View original content to download multimedia: SOURCE RX3 Growth Partners
https://www.wbko.com/prnewswire/2022/08/09/rx3-growth-partners-adds-kevin-harts-hartbeat-ventures-vanessa-hudgens-raissa-gerona-advisers/
2022-08-09T13:24:17Z
https://www.wbko.com/prnewswire/2022/08/09/rx3-growth-partners-adds-kevin-harts-hartbeat-ventures-vanessa-hudgens-raissa-gerona-advisers/
true
11
President Joe Biden is preparing to sign a $280 billion bipartisan bill to boost domestic high-tech manufacturing, part of his administration's push to boost U.S. competitiveness over China. The Rose Garden ceremony on Tuesday will include lawmakers, union officials, local politicians and business leaders, the White House said, as the president looks to highlight a new law that will incentivize investments in the American semiconductor industry in an effort to ease U.S. reliance on overseas supply chains for critical, cutting-edge goods. “We are going to invest it in America,” Biden said Friday. “We’re going to make it in America. We’re going to win the economic competition of the 21st century in America.” The White House said Micron is announcing a $40 billion plan to boost domestic manufacturing of memory chips, and Qualcomm and GlobalFoundries are announcing a $4.2 billion expansion of an upstate New York chip plant.
https://www.nbcsandiego.com/news/national-international/biden-signs-chips-act-to-boost-us-manufacturing-of-semiconductors/3018944/
2022-08-09T13:25:29Z
https://www.nbcsandiego.com/news/national-international/biden-signs-chips-act-to-boost-us-manufacturing-of-semiconductors/3018944/
false
null
New York State Common Retirement Fund grew its position in Allegro MicroSystems, Inc. (NASDAQ:ALGM – Get Rating) by 1.4% during the first quarter, HoldingsChannel.com reports. The fund owned 322,178 shares of the company’s stock after acquiring an additional 4,477 shares during the quarter. New York State Common Retirement Fund’s holdings in Allegro MicroSystems were worth $9,150,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. M&T Bank Corp boosted its holdings in shares of Allegro MicroSystems by 5.2% in the 4th quarter. M&T Bank Corp now owns 9,496 shares of the company’s stock worth $344,000 after purchasing an additional 469 shares during the period. Advisor Group Holdings Inc. boosted its holdings in shares of Allegro MicroSystems by 14.9% in the 4th quarter. Advisor Group Holdings Inc. now owns 5,414 shares of the company’s stock worth $196,000 after purchasing an additional 704 shares during the period. Point72 Hong Kong Ltd purchased a new position in shares of Allegro MicroSystems in the 4th quarter worth approximately $33,000. West Bancorporation Inc. purchased a new position in shares of Allegro MicroSystems in the 4th quarter worth approximately $36,000. Finally, Envestnet Asset Management Inc. boosted its holdings in shares of Allegro MicroSystems by 2.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 39,491 shares of the company’s stock worth $1,429,000 after purchasing an additional 1,110 shares during the period. Hedge funds and other institutional investors own 46.35% of the company’s stock. Analyst Ratings Changes A number of research firms recently issued reports on ALGM. Cowen began coverage on Allegro MicroSystems in a report on Wednesday, May 25th. They set an “outperform” rating for the company. Cowen began coverage on Allegro MicroSystems in a report on Wednesday, May 25th. They set an “outperform” rating and a $30.00 price objective for the company. Barclays dropped their price objective on Allegro MicroSystems from $31.00 to $26.00 and set an “overweight” rating for the company in a report on Monday, July 25th. Mizuho dropped their price objective on Allegro MicroSystems from $44.00 to $42.00 in a report on Wednesday, May 11th. Finally, Wells Fargo & Company dropped their price objective on Allegro MicroSystems from $35.00 to $30.00 and set an “overweight” rating for the company in a report on Monday, July 11th. Seven research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $32.50. Allegro MicroSystems Trading Down 1.6 % Allegro MicroSystems (NASDAQ:ALGM – Get Rating) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.22 by $0.02. The firm had revenue of $217.80 million during the quarter, compared to analyst estimates of $207.63 million. Allegro MicroSystems had a return on equity of 15.32% and a net margin of 13.44%. The business’s revenue for the quarter was up 17.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.16 EPS. Analysts expect that Allegro MicroSystems, Inc. will post 0.8 earnings per share for the current fiscal year. Insider Transactions at Allegro MicroSystems In other news, Director Joseph R. Martin sold 8,278 shares of the business’s stock in a transaction on Monday, May 23rd. The stock was sold at an average price of $24.17, for a total value of $200,079.26. Following the completion of the transaction, the director now directly owns 43,522 shares of the company’s stock, valued at approximately $1,051,926.74. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 13.60% of the company’s stock. Allegro MicroSystems Profile Allegro MicroSystems, Inc designs, develops, manufactures, and markets sensor integrated circuits (ICs) and application-specific analog power ICs for motion control and energy-efficient systems. Its products include magnetic sensor ICs, such as position, speed, and current sensor ICs; power ICs comprising motor driver ICs, and regulator and LED driver ICs; and photonic and 3D sensing components, including photodiodes, eye-safe lasers, and readout ICs for LiDAR applications. Recommended Stories - Get a free copy of the StockNews.com research report on Allegro MicroSystems (ALGM) - Home Depot, Lowe’s On Track To Grow 2022 Earnings - Could Smaller be Better for Investors in Norwegian Cruise Lines? - Walmart Or Target: Which Is The Stronger Stock? - MarketBeat Podcast: Investing in What You Know Has Changed - Can Etsy Continue to Thrive After the Pandemic? Want to see what other hedge funds are holding ALGM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allegro MicroSystems, Inc. (NASDAQ:ALGM – Get Rating). Want More Great Investing Ideas? - Bear Market Game Plan! - The 10 Best Stocks to Own in 2022 - 7 Stocks to Buy and Hold Forever - 3 Stocks to DOUBLE This Year Receive News & Ratings for Allegro MicroSystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegro MicroSystems and related companies with MarketBeat.com's FREE daily email newsletter.
https://www.etfdailynews.com/2022/08/09/new-york-state-common-retirement-fund-purchases-4477-shares-of-allegro-microsystems-inc-nasdaqalgm/
2022-08-09T13:26:00Z
https://www.etfdailynews.com/2022/08/09/new-york-state-common-retirement-fund-purchases-4477-shares-of-allegro-microsystems-inc-nasdaqalgm/
true
1
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SentinelOne (NYSE: S), an autonomous cybersecurity platform company, today announced a new integration with Armis, the leading unified asset intelligence platform. The collaboration helps protect organizations from modern threats and provides unified and unparalleled visibility across endpoints, cloud, mobile, IoT, OT devices, and more. Visibility is essential for security and operations teams, but as networks become more complex, maintaining visibility and reducing the attack surface becomes increasingly challenging. IoT and OT environments present unique complexities, limiting asset visibility and control, particularly in healthcare, manufacturing, and critical infrastructure verticals. These diverse environments introduce new ransomware and malware risks in the context of today’s evolving threat landscape. “Unmanaged devices present an extremely attractive attack surface for threat actors. Armis provides unparalleled asset intelligence and visibility into both managed and unmanaged devices, allowing customers to rapidly reduce attack surfaces in order to protect their organizations from malicious intruders,” said Ed Barry, VP Strategic Alliances, Armis. “SentinelOne’s autonomous approach to prevention and remediation coupled with Armis’s comprehensive visibility takes attack assessment and mitigation to new levels.” SentinelOne and Armis jointly deliver three best-of-breed solutions: - SentinelOne Singularity XDR app for Armis - provides additional context and enrichment to accelerate the triage and investigation of threats to managed and unmanaged endpoints, IoT, and OT devices. - Armis integration for SentinelOne Singularity XDR - offers unified visibility of devices with broad coverage for user endpoints, IoT, and OT devices. It also integrates device health, asset metadata, and application inventory into risk models to improve vulnerability prioritization and remediation. - SentinelOne Singularity Ranger app for Armis - delivers network visibility and control with real-time device metadata from Armis. Organizations are enabled to automatically isolate suspicious devices or block user endpoints from communication with IoT and OT devices. “With every piece of new technology, the challenge of IT orchestration grows, particularly from a security perspective,” said Yonni Shelmerdine, Vice President of Product Management, SentinelOne. “It’s hard enough to keep track of all the devices on the network, let alone what these devices are doing. SentinelOne and Armis are coming together to solve this problem, providing unified solutions that address comprehensive asset visibility and risk reduction.” SentinelOne and Armis will present at the Black Hat Conference in Las Vegas: - August 10, 2022: Booth 1120 at 2PM PT and Convention Center Lobby Lounge at 3PM PT - August 11, 2022: Convention Center Lobby Lounge at 2PM PT For additional information on SentinelOne and Armis, visit www.s1.ai/marketplace and www.armis.com/sentinelone/ About SentinelOne SentinelOne’s cybersecurity solution encompasses AI-powered prevention, detection, response and hunting across endpoints, containers, cloud workloads, and IoT devices in a single autonomous XDR platform.
https://www.businesswire.com/news/home/20220809005176/en/SentinelOne-Partners-with-Armis-for-Unparalleled-Asset-Intelligence/?feedref=JjAwJuNHiystnCoBq_hl-d0q77hRjGWvCunvqSsMC5PkKuEqWGdtYcKRejd3o8qMqnKfqP6Z7nZVMLG-WqUNUuIFBOuQU34x9_qUrqnb9IFt3G9xeKEyIFKgj2nxZILuWb2_mZzaa2HVGkrPJ34F1Q==
2022-08-09T13:26:06Z
https://www.businesswire.com/news/home/20220809005176/en/SentinelOne-Partners-with-Armis-for-Unparalleled-Asset-Intelligence/?feedref=JjAwJuNHiystnCoBq_hl-d0q77hRjGWvCunvqSsMC5PkKuEqWGdtYcKRejd3o8qMqnKfqP6Z7nZVMLG-WqUNUuIFBOuQU34x9_qUrqnb9IFt3G9xeKEyIFKgj2nxZILuWb2_mZzaa2HVGkrPJ34F1Q==
true
1
New York State Common Retirement Fund raised its position in Fulton Financial Co. (NASDAQ:FULT – Get Rating) by 1.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 503,642 shares of the bank’s stock after buying an additional 5,908 shares during the quarter. New York State Common Retirement Fund’s holdings in Fulton Financial were worth $8,371,000 at the end of the most recent quarter. Several other hedge funds have also recently bought and sold shares of the company. State Street Corp increased its holdings in Fulton Financial by 3.8% in the 4th quarter. State Street Corp now owns 8,209,865 shares of the bank’s stock valued at $140,717,000 after buying an additional 300,809 shares during the period. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Fulton Financial by 11.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,910,691 shares of the bank’s stock valued at $49,482,000 after purchasing an additional 294,174 shares in the last quarter. Fulton Bank N.A. boosted its stake in shares of Fulton Financial by 0.7% in the 1st quarter. Fulton Bank N.A. now owns 1,982,373 shares of the bank’s stock valued at $32,947,000 after purchasing an additional 14,004 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Fulton Financial by 0.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,749,546 shares of the bank’s stock valued at $29,743,000 after purchasing an additional 9,812 shares in the last quarter. Finally, Palisade Capital Management LLC NJ boosted its stake in shares of Fulton Financial by 0.4% in the 4th quarter. Palisade Capital Management LLC NJ now owns 1,700,623 shares of the bank’s stock valued at $28,911,000 after purchasing an additional 7,523 shares in the last quarter. 64.05% of the stock is owned by institutional investors. Analysts Set New Price Targets A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group reduced their price target on shares of Fulton Financial from $17.00 to $14.00 in a research note on Monday, July 11th. Stephens upgraded shares of Fulton Financial from an “equal weight” rating to an “overweight” rating and set a $20.50 price target on the stock in a research note on Thursday, April 21st. Finally, DA Davidson restated a “neutral” rating on shares of Fulton Financial in a research note on Wednesday, July 27th. Insider Transactions at Fulton Financial Fulton Financial Stock Down 0.1 % NASDAQ:FULT opened at $16.54 on Tuesday. The firm’s 50 day simple moving average is $15.20 and its 200 day simple moving average is $16.27. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.89 and a quick ratio of 0.89. Fulton Financial Co. has a one year low of $13.72 and a one year high of $19.17. The company has a market cap of $2.66 billion, a PE ratio of 10.21 and a beta of 0.80. Fulton Financial (NASDAQ:FULT – Get Rating) last posted its earnings results on Tuesday, July 19th. The bank reported $0.42 EPS for the quarter, topping the consensus estimate of $0.36 by $0.06. Fulton Financial had a net margin of 28.15% and a return on equity of 11.01%. During the same quarter in the prior year, the firm posted $0.38 EPS. On average, research analysts anticipate that Fulton Financial Co. will post 1.7 earnings per share for the current year. Fulton Financial Announces Dividend The company also recently declared a quarterly dividend, which was paid on Friday, July 15th. Stockholders of record on Friday, July 1st were given a $0.15 dividend. The ex-dividend date of this dividend was Thursday, June 30th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.63%. Fulton Financial’s dividend payout ratio (DPR) is currently 37.04%. About Fulton Financial Fulton Financial Corporation operates as a financial holding company that provides consumer and commercial banking products and services. It accepts various checking accounts and savings deposit products, certificates of deposit, and individual retirement accounts. The company also offers secured consumer loans, including home equity loans and lines of credit, automobile loans, personal lines of credit, and checking account overdraft protection; construction and jumbo residential mortgage loans; and commercial lending products comprising commercial real estate, commercial and industrial, and construction loans, as well as equipment lease financing loans. Featured Articles - Get a free copy of the StockNews.com research report on Fulton Financial (FULT) - Home Depot, Lowe’s On Track To Grow 2022 Earnings - Could Smaller be Better for Investors in Norwegian Cruise Lines? - Walmart Or Target: Which Is The Stronger Stock? - MarketBeat Podcast: Investing in What You Know Has Changed - Can Etsy Continue to Thrive After the Pandemic? Want to see what other hedge funds are holding FULT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fulton Financial Co. (NASDAQ:FULT – Get Rating). Want More Great Investing Ideas? - Bear Market Game Plan! - The 10 Best Stocks to Own in 2022 - 7 Stocks to Buy and Hold Forever - 3 Stocks to DOUBLE This Year Receive News & Ratings for Fulton Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulton Financial and related companies with MarketBeat.com's FREE daily email newsletter.
https://www.etfdailynews.com/2022/08/09/new-york-state-common-retirement-fund-purchases-5908-shares-of-fulton-financial-co-nasdaqfult/
2022-08-09T13:26:13Z
https://www.etfdailynews.com/2022/08/09/new-york-state-common-retirement-fund-purchases-5908-shares-of-fulton-financial-co-nasdaqfult/
true
1
LOS ANGELES, Aug. 9, 2022 /PRNewswire/ -- In a new research paper, DoubleLine Global Bond Portfolio Manager Bill Campbell concludes Russia's financial resilience in the face of Western sanctions has demonstrated the China-Russia axis as a viable political and economic rival to the West. "In light of Russian resilience, including the strength of Russia's currency and current account surplus," Mr. Campbell writes, "the China-Russia axis has gained credibility as an exemplar to other sovereign governments seeking alternatives to a world order once dominated by the G-7 countries. "Western sanctions against Russia have not only failed to work as intended, they also have accelerated trends in global trade and finance to the disadvantage of the West. Investors should keep these developments on their radar, as resulting opportunities in emerging markets and infrastructure projects are likely to become more apparent in the quarters and years ahead." To read the paper, please click on this link: https://doubleline.com/wp-content/uploads/China-Russia-Axis_Campbell_8-8-2022.pdf About DoubleLine DoubleLine provides its services through investment advisers registered under the Investment Advisers Act of 1940. As of the June 30 close of the second quarter of 2022, DoubleLine managed $107 billion in assets across all vehicles, including open-end mutual funds, collective investment trusts, closed-end funds, exchange-traded funds, hedge funds, variable annuities, UCITS and separate accounts. DoubleLine's offices can be reached by telephone at (213) 633-8200 or by e-mail at [email protected]. News media can reach DoubleLine by e-mail at [email protected]. DoubleLine® is a registered trademark of DoubleLine Capital LP. SOURCE DoubleLine
https://www.prnewswire.com:443/news-releases/doubleline-publishes-paper-the-ruble-as-weatherglass-of-a-competing-trade-and-finance-axis-301602347.html
2022-08-09T13:27:56Z
https://www.prnewswire.com:443/news-releases/doubleline-publishes-paper-the-ruble-as-weatherglass-of-a-competing-trade-and-finance-axis-301602347.html
false
16
DUBLIN, Aug. 9, 2022 /PRNewswire/ -- The "European and North American Agency Sales Model in PV Retail Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service analyzes the impact of the agency sales model implementation on the European & North American (the United States and Canada) new passenger vehicle (PV) market. It provides an overview of the influence on the stakeholders in the retail value chain. This study discusses potential trends and implications and examines the North American and European regulatory landscape. The base year is 2021, and cost impact/spending analysis is done for key stakeholders in the agency sales model. In addition, the study examines customers' online journeys, the agency model's impact on each retail activity, and the stance of key OEMs regarding agency sales model implementation. Growth opportunities for the agency sales model are investigated, and the publisher offers actionable insight to market participants to leverage these opportunities. In brief, the key areas covered in the study are: - Change in the role of dealerships and OEMs in the retail value chain with the emergence of the agency sales model. - The cost impact on dealers and OEMs at various levels of agency sales model implementation. - Scope of the emergence of new business models alongside the growth of agency sales. - The current stance of key OEMs about the agency sales model adoption. Key Topics Covered: 1. Strategic Imperatives - Why is It Increasingly Difficult to Grow? - The Strategic Imperative - The Impact of the Top 3 Strategic Imperatives on Agency Sales Model in PV Retail - Growth Opportunities Fuel the Growth Pipeline Engine 2. Growth Opportunity Analysis, Agency Sales Model - Agency Sales Model - Market Overview - Agency Sales Model - Research Methodology - Key Questions this Study will Answer - Agency Sales Model - Stakeholder Segmentation - Agency Sales Model - Key Competitors - Agency Sales Model - Key Growth Metrics, Cost Type - Agency Sales Model - Key Growth Metrics, Cost Segment - Agency Sales Model - Growth Drivers - Agency Sales Model - Growth Restraints - Agency Sales Model - Competitive Environment 3. Agency Sales Model, Overview - Overview - Traditional Sales Model versus Agency Sales Model - Agency Sales Model - Customer Journey - Agency Sales Model - Sales Process and Stakeholder Activities - Agency Sales Model - Stakeholder Roles/Responsibilities/Transformation - Agency Sales Model - Key Retail Area to Witness Phased Transition - Agency Sales Model - OEM SWOT Analysis - Agency Sales Model - Dealer/Agent SWOT Analysis - Agency Sales Model - Characteristics & Way Forward - Agency Sales Model - Cost Type, Stakeholder Contribution - Agency Sales Model - Cost Segment, Stakeholder Contribution - Potential Trends Impacting Agency Sales Model - Agency Sales Model - Implications of Potential Trends - Laws and Regulations - Implication on Agency Sales Model - Agency Sales Model - Key Findings/Current and Future Outlook 4. Key Retail Activities - Traditional Sales Model versus Agency Sales Model - OEM Value Chain and Key Retail Activities - Transition in Key Retail Activities - Pricing and Margin - Transition in Key Retail Activities - Vehicle Ownership - Transition in Key Retail Activities - Inventory Management - Transition in Key Retail Activities - Lead Generation - Transition in Key Retail Activities - Consultation - Transition in Key Retail Activities - Payment/Billing - Transition in Key Retail Activities - Data Access/Ownership 5. Dealer - Spend and Cost Analysis - Dealer Cost Type Analysis - Traditional versus Agency Sales - Dealer Cost Segment Analysis - Traditional versus Agency Sales 6. OEM - Spend & Cost Analysis - OEM Cost Type Analysis - Traditional versus Agency Sales - OEM Cost Segment Analysis - Traditional versus Agency Sales 7. OEM - New Business Models - Inevitable Business Models with the Growth of Agency Sales - OEM Business Model - Data Monetization - OEM Business Model - Subscription/Leasing - OEM Business Model - Captive Financing - OEM Business Model - Independent Agents (Probable Future Model) - Dealer Business Model - Used Cars - Dealer Business Model - After-sales and Service 8. Competitive Environment - Agency Model Adoption by Key Participants - Agency Model Adoption - Status by Key Participants - Factors Limiting Agency Model Adoption in North America - Case Study 1 - Volkswagen AG - Case Study 2 - Stellantis N.V. - Case Study 3 - Mercedes Benz - Case Study 4 - Toyota Motor - Case Study 5 - Genesis Motor 9. Growth Opportunity Universe - Growth Opportunity 1 - OEM Omnichannel Focus to Provide Choice in the Sales Process for Customers - Growth Opportunity 2 - OEMs Enhance Sales Efficiency through Complete Access of Customer Data - Growth Opportunity 3 - Dealer's Bundled After-sales Services for Improved Profits 10. Next Steps Companies Mentioned - Genesis Motor - Mercedes Benz - Stellantis N.V. - Toyota Motor - Volkswagen AG For more information about this report visit https://www.researchandmarkets.com/r/7kib43 Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg SOURCE Research and Markets
https://www.prnewswire.com:443/news-releases/european-and-north-american-passenger-vehicle-retail-agency-sales-model-report-2022-transformational-growth-in-pv-retail-enhances-opportunities-with-more-control-over-customer-data-and-sales-network-301602304.html
2022-08-09T13:28:02Z
https://www.prnewswire.com:443/news-releases/european-and-north-american-passenger-vehicle-retail-agency-sales-model-report-2022-transformational-growth-in-pv-retail-enhances-opportunities-with-more-control-over-customer-data-and-sales-network-301602304.html
true
3
Sairaj Matkar, the owner of Acexmedia, went through his share of failures in its time. However, his moxie, paired with valor and boldness, made him keep going and come back with a bang! While most entrepreneurs relive and retell their success stories, Sairaj Matkar never shied away from expressing the vulnerable moments that transformed him completely. As with every business, Acexmedia went through a roller coaster of events starting with scaling a brand-new company to nearly $90,000 in the first 3 months to losing an essential client within four months. Having shifted his focus entirely to service delivery while neglecting other crucial aspects of a company cost him a lot and called for recoupment. Sairaj shares how at the start of his career, having been blinded by ambition and excitement, he often signed clients without considering if they'll be able to help them and ended up putting up with their toxicity. Sairaj Matkar felt he was a troublemaker for the company because of this blinding effect and growing toxicity of some clients. It was then that he realized the limits of the self and the company and how certain sacrifices need to be made from time to time for the greater good. Amidst other failures, Sairaj regrets not seeking a mentor soon enough as he believes there is no relation in this world as precious and honorable as that of a mentor-mentee. Being a stern believer that people only learn from their mistakes, Sairaj does repent for not having approached a mentor for advice and guidance earlier. He advises the young, ambitious entrepreneurs to take the help of someone more experienced than them as he believes there is nothing wrong in asking for help! Finding yourself a mentor can not only ease one's path but also help them elude dangers. Complacency and not jumping into action make the critical markers of failure in Sairaj’s career life. He reveals how his perfectionist nature landed his company in trouble as he would while away his time planning but not executing. Similarly, when things did start to look up for Acexmedia, he would grow complacent, that not only hindered the growth of his company but also of himself. These few failures paved their way into Sairaj Matkar's consciousness and motivated him to learn from his mistakes. However, one should remember that for Sairaj, these failures did not define him or make him question his potential. They were the key ingredients needed for his recipe of success. It is Sairaj's zealous nature and pioneering work that has helped him climb up the success ladder. Success and failure are two sides of the coin; acknowledging both is essential for growth, which Sairaj values and profoundly believes in.
https://www.outlookindia.com/business-spotlight/-success-is-not-final-failure-is-not-fatal-it-is-the-courage-to-continue-that-counts-said-winston-churchill-and-is-believed-and-experienced-by-sairaj-matkar-news-215208
2022-08-09T13:30:05Z
https://www.outlookindia.com/business-spotlight/-success-is-not-final-failure-is-not-fatal-it-is-the-courage-to-continue-that-counts-said-winston-churchill-and-is-believed-and-experienced-by-sairaj-matkar-news-215208
false
1
The Indigenous People of Biafra (IPOB) has dismissed as useless and fabricated reports alleging that it has replaced its leader, Mazi Nnamdi Kanu with its head, Directorate of State (DOS), Mazi Chika Edoziem. The group, in a statement by its Media and Publicity Secretary, Emma Powerful, described the report as the handiwork of mischievous elements bent on causing confusion, urging the public to disregard it. It insisted that Kanu remains its leader while Chika Edoziem remains Head of DOS. The statement reads: “We condemn the useless and fabricated media propaganda and blackmail from some media houses that IPOB has another or acting leader replacing our indefatigable liberator and prophet Mazi Nnamdi KANU. “Those peddling this kind these lies are those criminals who zoo gutter media are publishing this to confuse the weak-minded people. “We want everybody to bear in mind that Mazi Chika Edoziem is the head of IPOB Directorate of State, DOS and not IPOB Acting Leader. “There was never a time that Emma Powerful the Publicity Secretary of IPOB issued any statement purporting that our Leader had been replaced by Mazi Chika Edoziem as IPOB Acting Leader. The said statement was the handiwork of mischievous elements bent on causing confusion in IPOB. “It is unfortunate that some mischievous elements twisted an unambiguous statement by IPOB where we clarified that in the meantime that our Leader is in detention, the Head of DOS, Mazi Edoziem will be providing direction on the day-to-day activities of IPOB. We never said that Edoziem has become the Acting Leader of IPOB. “For the avoidance of doubts, Mazi Nnamdi Kanu remains the Leader of IPOB. The entire IPOB family all over the world is loyal to him. IPOB has no Acting Leader. Chika Edoziem is only the Head of DOS of IPOB not the Leader. “We urge our family members, supporters, friends and members of the public to ignore the misleading and mischievous media report.”
https://www.xtra.net/news/nigeria/ipob-nnamdi-kanu-remains-leader
2022-08-09T13:31:14Z
https://www.xtra.net/news/nigeria/ipob-nnamdi-kanu-remains-leader
false
1
Linux 6.0 Promotes Its H.265/HEVC User-Space API To Stable With the Linux 6.0 multimedia subsystem changes, the H.265/HEVC user-space API is now being considered stable. Linux 6.0 has picked up the patches that move the HEVC stateless controls out of staging and makes "HEVC uapi stable and usable for hardware decoder." Exercising the Linux kernel's HEVC user-space API are the Cedrus driver for Allwinner SoCs and the Hantro media driver for the Hantro video IP for the VPU within various Rockchip and NXP SoCs. Additionally, there is the currently out-of-tree Rockchip RKVDEC and Raspberry Pi "RPI" drivers that make use of this HEVC user-space API. Through these drivers using the API and continued open-source code refinements, everything is now buttoned up to treat it as stable rather than as a staging interface. In addition to finalizing that user-space API, the media subsystem updates for Linux 6.0 add a Semi AR0521 sensor driver, updates to Cedrus and Hantro around their H.265 support, the STKWebCam driver was promoted out of staging, the Intel AtomISP driver has seen some fixes / clean-ups, and other smaller driver fixes/improvements. See this pull for the complete list of media subsystem updates for Linux 6.0. Linux 6.0 has picked up the patches that move the HEVC stateless controls out of staging and makes "HEVC uapi stable and usable for hardware decoder." Exercising the Linux kernel's HEVC user-space API are the Cedrus driver for Allwinner SoCs and the Hantro media driver for the Hantro video IP for the VPU within various Rockchip and NXP SoCs. Additionally, there is the currently out-of-tree Rockchip RKVDEC and Raspberry Pi "RPI" drivers that make use of this HEVC user-space API. Through these drivers using the API and continued open-source code refinements, everything is now buttoned up to treat it as stable rather than as a staging interface. In addition to finalizing that user-space API, the media subsystem updates for Linux 6.0 add a Semi AR0521 sensor driver, updates to Cedrus and Hantro around their H.265 support, the STKWebCam driver was promoted out of staging, the Intel AtomISP driver has seen some fixes / clean-ups, and other smaller driver fixes/improvements. See this pull for the complete list of media subsystem updates for Linux 6.0.
https://www.phoronix.com/news/Linux-6.0-Media
2022-08-09T13:33:52Z
https://www.phoronix.com/news/Linux-6.0-Media
false
1